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Sex biased expression characterizes ~1,000 genes in mammalian liver, and impart 
sex differences in metabolism and disease susceptibility. The sex-dependent temporal 
patterns of pituitary growth hormone (GH) secretion, pulsatile in males and more 
continuous in females, are known to sex-differentially activate transcriptional regulators 
(TFs), leading to widespread sex-differences in the mouse liver transcriptome. This thesis 
elucidates sex-biased gene expression patterns in the following studies. Gene structures, 
expression patterns and species conservation are characterized for ~15,000 liver-
expressed intergenic long noncoding RNAs (lncRNAs), many of which are novel. 
Analysis of intergenic lncRNA promoters revealed unexpected high conservation and 
significant enrichment of TF binding compared to protein-coding promoters. A subset of 
intergenic lncRNAs showed strong sex-specific and GH-dependent gene expression, and 
whose transcription was tightly correlated with the surrounding chromatin environment 
	
	 viii 
and TF binding patterns. The pervasive role of genetic factors to regulate sex-biased 
genes was revealed by analyzing livers with matched genotype and gene expression data 
from Diversity Outbred (DO) mice, an outbred population with high natural allelic 
variance derived from eight inbred strains. Significant associations between genetic 
variants and gene expression (eQTLs) were identified, including many eQTLs with a 
strong sex-biased association. Remarkably, a large fraction of these sex-biased eQTLs 
were linked to either gain or loss of sex-specific gene expression in the DO founder strain 
predicted to be regulated by the eQTL. Thus, genetic factors are a major contributor to 
the variability of sex-biased genes, which has important consequences related to the 
individual variability of liver phenotypes with known sex-differences. Natural genetic 
perturbations in DO mice were leveraged to identify candidate lncRNAs that may 
regulate hypophysectomy (hypox) responsiveness. Co-regulated protein-coding gene 
clusters were discovered based on gene expression correlations across DO mouse livers, 
many of which are enriched for distinct hypox response classes. LncRNAs whose 
expression showed unexpected significant negative correlation with protein-coding gene 
clusters enriched for genes of the opposite-sex bias and inverse hypox class were 
hypothesized to play negative regulatory role. In sum, these studies expand the 
characterization of the sex-biased hepatic transcriptome and reveal contributions of 
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Chapter 1 Introduction 
1.A Summary 
The liver plays key physiological functions, including the metabolism of drug and lipid, 
as well as bile acid synthesis. Sex-differences are widespread in mammalian liver 
transcriptome, where, in mouse, there are >1,000 genes with significant sex-bias 
expression. Many liver sex-specific genes are implicated in the sex differences of 
clinically important variables, such as liver disease susceptibility and function. Growth 
hormone (GH) is known to be a key regulator of sex-biased genes through its secretion 
pattern that are different between the two sexes. In male, GH is secreted in pulsatile 
manner, whereas in female, it is secreted near continuously. Sex differences in GH 
plasma level sex-differentially activates STAT5b and other GH-dependent transcription 
factors (TF), propagating sex differences to the entire liver transcriptome. GH, by 
mechanisms that are not yet understood, impart sex-differences in the liver chromatin 
structure, histone marks and methylation status. 
 
The goal of this thesis is to characterize the sex-biased liver transcriptome and its 
associated gene regulation mechanisms in mouse liver, which were accomplished by 
discovering liver-expressed long noncoding RNAs (lncRNAs; Chapter 2) and their 
putative regulatory roles (Chapter 4), as well as elucidating genetic factors altering gene 
expression of liver sex-biased genes (Chapter 3).  Briefly, in Chapter 2, I discovered 
liver-expressed intergenic lncRNAs (lincRNAs), and characterized their gene expression 




data were integrated to show their tight correlation with the transcription of sex-biased 
lncRNAs. Chapter 3 delineates the role of genetic component in the regulation of sex-bias 
gene expression in the Diversity Outbred (DO) mouse, an outbred mouse population with 
high genetic diversity. In Chapter 4, I discovered gene co-expression modules in male, 
and separately in female liver, and showed their enrichment for biologically relevant 
traits. I used the identified gene modules to reveal broad characteristics of sex-bias gene 
regulation mechanisms, as well as a tool to generate hypothesis for lncRNA regulatory 
roles. 
 
1.B GH secretion patterns regulate liver sex-biased genes 
Sex differences in gene expression have been observed in liver, kidney, brain, and other 
tissues in mammals (Gur et al. 1999, Rinn et al. 2004, Rinn and Snyder 2005). Sex 
specific genes in liver are perhaps the best studied, where many are implicated in sex 
differences in the metabolism of drugs, steroids and xenometabolites (Anthony and Berg 
2002, Guengerich 2006, Klaassen and Aleksunes 2010, Liu et al. 2013, Zanger and 
Schwab 2013), as well as disease susceptibility, including hepatocellular carcinoma 
(Ruggieri et al. 2010, Baik et al. 2011), polygenic dyslipidemia (Bittner 2006) and 
coronary artery disease (Zhang et al. 2011). Rodent studies revealed growth hormone 
(GH) to be a major regulator of liver sex-biased genes (Jansson et al. 1985, Jaffe et al. 
2002, Waxman and O'Connor 2006) through its sex-differential secretion patterns (Jaffe 
et al. 2002). In male rats, growth hormone is secreted in a highly pulsatile manner with 




undetectable amount. In contrast, the female growth hormone pattern in rats is continuous 
due to more frequent pulses (Tannenbaum and Martin 1976, Eden 1979). Similar sex-
dependent GH secretion patterns, albeit less striking, were observed in mouse (MacLeod 
et al. 1991), and to a much weaker degree in human (Pincus et al. 1996). The male GH 
secretion pattern, in rat, was imprinted by early exposure to neonatal androgens (Jansson 
et al. 1985). The sexual dimorphic growth hormone secretion patterns result in sex 
differences in the plasma GH level, which in turn activates transcriptional regulators 
(TFs) through GH signaling in a sex-differential manner (Waxman et al. 1991, Waxman 
et al. 1995, Zhang et al. 2012). GH-dependent TFs activate or repress their target genes 
differently in males and females, propagating sex differences to the entire liver 
transcriptome (Holloway et al. 2008, Conforto et al. 2012, Conforto et al. 2015). Ablation 
of circulating GH through the surgical removal of pituitary gland (hypophysectomy; 
hypox) leads to a near global loss of sex-biased gene expression pattern (Wauthier et al. 
2010, Connerney et al. 2017), whereas continuous infusion of GH in male mice, 
delivered via an osmotic pump, leads to the feminization of liver gene expression 
(Holloway et al. 2006, Lau-Corona et al. 2017). It is therefore, through the sex-dependent 
GH secretion patterns, liver sex-biased genes are mainly regulated. Due to its prominent 






1.C GH-dependent TFs 
Sex differences in the temporal plasma GH profiles result in the activation of GH 
signaling in a dynamic, sex-differential manner (Waxman et al. 1995, Gebert et al. 1999).  
GH binding to a growth hormone receptor activates JAK2, which in turn phosphorylates 
the signal transducer and activator of transcription 5 (STAT5) (Brooks and Waters 2010, 
Sedek et al. 2014). Phosphorylated STAT5 would then translocate to the nucleus and 
bind to a TTC(C/T)N(G/A)GAA motif to regulate transcription of gene targets (Soldaini 
et al. 2000). STAT5 activity is pulsatile in male rat liver, as a direct response to GH 
secretion pulses, while in female rat liver, STAT5 activity show a persistent low level 
(Choi and Waxman 2000). Between the two members of STAT5 proteins, STAT5B, not 
STAT5A, mediates most GH signaling in liver (Udy et al. 1997), and is responsible for 
the loss of ~90% of sex-biased gene expression in STAT5-deficient mouse model 
(Clodfelter et al. 2006). Sex-biased STAT5 binding sites were shown to be enriched for 
correspondingly sex-biased genes, confirming the action of STAT5 to positively regulate 
gene transcription (Zhang et al. 2012). STAT5 binding sites are proximal to 35% of sex-
biased genes, suggesting a substantial fraction of sex-biased genes are regulated by 
STAT5, but also leaving the possibility open for other GH-dependent factors in the 
regulation of sex-bias genes (Zhang et al. 2012). The male-biased transcriptional 
repressor BCL6 was shown to preferentially bind to female-biased STAT5 target genes in 
male liver, indicating BCL6 competition for STAT5 binding sites as a mechanism to 
repress female-biased genes in male liver (Zhang et al. 2012). A similar negative 




repressor CUX2, which was shown to repress male-biased genes (Conforto et al. 2012). 
In contrast, binding sites for CUX2 overlap female-biased binding sites for HNF6 at a 
subset of female-biased genes, indicating a role for CUX2 to indirectly activate female-
biased genes. Overall, HNF6 mostly show positive regulatory role as shown by its male-
biased binding sites that are proximal to male-biased genes in male liver (Conforto et al. 
2015). Taken together, a network of GH-dependent TFs is essential to maintain sex-
biased gene expression in mouse liver. 
 
1.D Classification of sex-biased genes in response to hypophysectomy 
Surgical removal of the pituitary gland (hypophysectomy; hypox) ablates all circulating 
hormone, including pituitary GH, which is used as a model to tease out GH-dependent 
gene regulations. There are two major classes of liver sex-biased genes as defined by 
their sex-dependent positive or negative responsiveness to hypox. Class 1 genes are 
activated by the GH secretion pattern in the sex where they are highly expressed, whereas 
class 2 genes are repressed by the GH secretion pattern in the sex where they are less 
highly expressed (Fig. S4-1) (Wauthier et al. 2010, Connerney et al. 2017). 
Consequently, class 1 genes are down regulated and class 2 are de-repressed (up 
regulated) after hypox. 
 
1.E GH-dependent sex differences in liver epigenome 
GH-dependent sex differences are also apparent in the mouse liver epigenome, including 




on DNaseI hypersensitive sites (DHS) (Ling et al. 2010). Sex-biased DHS are 
significantly enriched for nearby sex-biased genes with matching sex-specificity, 
implying the tight connection between sex-biased DHS with sex-biased gene 
transcription (Ling et al. 2010). The majority of sex-biased DHS, however, are distal, 
suggesting long-range interactions are involved in the regulation of liver sex-bias genes. 
The majority of male-biased DHS are suppressed in response to the feminization of GH 
secretion pattern via continuous GH infusion, delivered via an osmotic pump, while a 
subset of female-biased DHS is induced. Even more striking, a subset of male-biased 
DHS showed dynamic opening and closing in response to GH pulses (Connerney et al. 
2017).  
 
Analysis of male and female chromatin state maps, based on six chromatin marks and 
DHS, identified the use of H3K27me3 repressive mark to down regulate highly female-
specific genes in male liver (Sugathan and Waxman 2013). Sex-differential chromatin 
states also characterize sex-biased DHS, not sex-biased genes, highlighting the 
importance of distal regulatory sites. Integration of chromatin state maps and genome-
wide binding data for five GH-regulated TFs highlight the regulatory role for sex-
differential chromatin states, including to facilitate sex-dependent chromatin opening at 
male-biased DHS and sex-dependent transcription activation through sex-biased STAT5 
bindings (Sugathan and Waxman 2013).  All of these results suggest an epigenetic-driven 
mechanism plays a major role in the maintenance of sex-specific gene expression in 




is, however, poorly understood. Long noncoding RNAs were shown to interact with 
chromatin modifying enzyme to regulate gene transcription (Tsai et al. 2010, Guttman et 
al. 2011, Engreitz et al. 2013). We hypothesize that sex-biased chromatin state 
regulations are mediated by sex-specific lncRNAs, which prompted us to characterize 
liver-expressed lncRNAs in Chapter 2.  
 
1.F Sex-biased genes during mouse liver development 
Widespread sex differences in mouse liver transcriptome are not seen until puberty 
(Conforto and Waxman 2012, Lowe et al. 2015), where at 4 weeks of age, 13% of adult 
sex-biased genes showed significant sex-biased expression, as compared to 85% of adult 
sex-biased genes at 8 weeks of age (Conforto and Waxman 2012). The majority of sex-
biased genes in fetal liver, however, are retained in adulthood (Lowe et al. 2015). Male 
liver showed extensive changes during liver development, where 76% of male-biased 
genes were up regulated and 47% of female-biased genes were down regulated by 8 
weeks of age, as compared to 33% sex-specific genes that are regulated in female liver 
(Conforto and Waxman 2012). Sex-specific genes showing early sex-biased expression, 
at 4 weeks of age, include transcriptional repressor CUX2, highlighting the need to 






Chapter 2 Hepatic lincRNAs: high promoter conservation and dynamic, sex-
dependent transcriptional regulation by growth hormone1 
 
2.A Abstract 
Long intergenic non-coding RNAs (lincRNAs) are increasingly recognized as key 
chromatin regulators, yet few studies have characterized lincRNAs in a single tissue 
across diverse conditions. Here, we analyzed 45 mouse liver RNA-seq datasets collected 
under diverse conditions to systematically characterize 4,961 liver lincRNAs, 59% of 
them are novel, with regards to gene structures, species conservation, chromatin 
accessibility, transcription factor binding, and epigenetic states. To investigate potential 
for functionality, we focused on the responses of the liver lincRNAs to growth hormone 
stimulation, which imparts clinically relevant sex differences to hepatic metabolism and 
liver disease susceptibility. Sex-biased expression characterized 247 liver lincRNAs, with 
many being nuclear-enriched and regulated by growth hormone. The sex-biased lincRNA 
genes are enriched for nearby, and correspondingly sex-biased, accessible chromatin 
regions, as well as sex-biased binding sites for growth hormone-regulated transcriptional 
activators (STAT5, HNF6, FOXA1, FOXA2), and transcriptional repressors (CUX2, 
BCL6). Repression of female-specific lincRNAs in male liver, but not that of male-
                                                
 
1 A modified version of this chapter was published in Molecular and Cellular Biology. Melia, T., 
Hao, P., Yilmaz, F., and D.J. Waxman (2015). “Hepatic long intergenic noncoding RNAs: high 
promoter conservation and dynamic, sex-dependent transcriptional regulation by growth 
hormone.” Mol Cell Biol 36:50. qPCR on somatostatin-deficient and STAT5a/STAT5b-KO mice 
were carried out by Feyza Yilmaz, as noted in appropriate places in this chapter. Dr. Pengying 





specific lincRNAs in female liver, was associated with enrichment of H3K27me3-
associated inactive and poised enhancer states. Strikingly, we find that liver-expressed 
lincRNA promoters are more highly species-conserved and have a significantly higher 
frequency of proximal binding by liver transcription factors than liver-expressed protein-
coding promoters. Orthologs in one or more supraprimates were identified for many liver 
lincRNAs, including two rat lincRNAs that show the same growth hormone-regulated, 
sex-biased expression as their mouse counterparts. The integrated analysis of liver 
lincRNA chromatin states, transcription factor occupancy and growth hormone regulation 
provides novel insights into the expression of sex-specific lincRNAs and their potential 
for regulation of sex-differences in liver physiology and disease.   
 
2.B Introduction 
High-throughput sequencing of mammalian transcriptomes has revealed near-ubiquitous 
transcription of the genome and the generation of large numbers of non-coding (nc) 
transcripts. ncRNAs have drawn much attention as potential chromatin regulators, 
exemplified by classical ncRNAs, such as Xist (Yang et al. 2014). Several thousand 
ncRNAs have been discovered in human (Cabili et al. 2011, Derrien et al. 2012), mouse 
(Guttman et al. 2009, Guttman et al. 2010, Kutter et al. 2012, Luo et al. 2013), zebrafish 
(Ulitsky et al. 2011, Kaushik et al. 2013), and fruit fly (Li et al. 2009, Young et al. 2012), 
where they exert diverse regulatory roles in gene expression (Rinn et al. 2007, Huarte et 
al. 2010, Guttman et al. 2011, Ulitsky et al. 2011, Sauvageau et al. 2013); however, the 




experimentally. Many ncRNAs share salient features of protein-coding genes, including 
transcription by RNA polymerase II, 5’ capping, splicing, polyadenylation, and 
deposition of histone marks associated with transcription, specifically H3K4me3 at the 
promoter and H3K36me3 across the gene body (Guttman et al. 2009). These ncRNAs are 
typically >200 nt in length (long ncRNAs) and can be classified based on their genomic 
location in relation to the nearest protein-coding genes, as antisense, intronic, divergent, 
and intergenic (Rinn and Chang 2012, Kung et al. 2013).  
 
Long ncRNAs have diverse functions, which can be broadly categorized as 
scaffolds/guides, decoys, enhancers, and others (Rinn and Chang 2012). Scaffold (guide) 
long ncRNAs bind one or more proteins to form complexes that can direct ncRNA 
binding partners to target genes. Examples include long ncRNA scaffolds that bind 
chromatin-modifying complexes capable of reading, writing, and/or erasing histone 
modifications, indicating a role for long ncRNAs in epigenetic control (Khalil et al. 2009, 
Tsai et al. 2010, Zhao et al. 2010, Guttman et al. 2011, Wang et al. 2011). HOTAIR, a 2.2 
kb long intergenic ncRNA (lincRNA) encoded within the HOXC gene cluster, regulates 
its distal target genes via two modular binding domains: one domain binds PRC2, which 
deposits H3K27me3 (repressive) marks, and a second domain binds LSD1, which 
demethylates the active chromatin mark H3K4me2 (Tsai et al. 2010). Decoy long 
ncRNAs, such as Gas5, contain binding motifs that titrate DNA binding proteins. Gas5, 
which contains a glucocorticoid response element motif embedded within a hairpin 




and thereby suppress the expression of metabolic genes (Kino et al. 2010). Other long 
ncRNAs have enhancer-like functions and can activate the transcription of genes either in 
cis or trans (Orom et al. 2010, Engreitz et al. 2013, Hacisuleyman et al. 2014). In one 
study, 7 of 12 long ncRNAs examined exerted positive transcriptional effects within 300 
bp of their sites of transcription (Orom et al. 2010). Other long noncoding RNAs bind 
microRNAs (Wang et al. 2010, Braconi et al. 2011, Ulitsky et al. 2011), regulate 
alternative splicing (Tripathi et al. 2010), or pair with mRNAs via Alu repeats (Gong and 
Maquat 2011). Thus, long ncRNAs constitute a rich regulatory layer that can shape gene 
expression by diverse mechanisms.  
 
Mammalian liver plays a critical role in the metabolism of structurally diverse drugs, 
steroids, fatty acids and environmental chemicals (Waxman and Holloway 2009, Baik et 
al. 2011, Gu and Manautou 2012). The expression of genes that control liver metabolism 
and other functions can be dramatically altered by diverse stimuli, making the liver an 
ideal model for studies of condition-specific gene regulation and for investigation of 
ncRNAs that may contribute to these processes. Recent studies report the discovery of 
10,571 mouse lincRNAs across six tissues, including liver (Luo et al. 2013). Examination 
of liver lincRNA transcription evolution in three rodent models revealed that nearly half 
of 388 identified lincRNAs were acquired or lost since the divergence of rat and mouse 
(Kutter et al. 2012). Another study investigated long ncRNA expression during liver 
maturation and identified 433 pairs of long ncRNAs and their neighboring protein-coding 




adult stages of liver development (Peng et al. 2014), indicating cis regulation. Despite 
these efforts, large numbers of liver-expressed long ncRNAs are uncharacterized, and 
their expression dynamics under conditions that affect liver physiology and disease, 
including diverse hormonal environments, remain unknown. Comprehensive analyses 
that connect the responses of lincRNAs to diverse stimuli to changes in chromatin 
environment, transcription factor (TF) binding, and gene expression are needed to 
understand liver lincRNA function within the context of gene regulatory networks. 
 
Liver gene expression is highly responsive to many drugs and environmental chemicals 
(Amacher 2010, Zanger and Schwab 2013), which activate nuclear receptors, such as 
CAR and PXR, master regulators of hepatic drug and fatty acid metabolism (Tojima et al. 
2012, Kodama and Negishi 2013, Banerjee et al. 2014). Hormonal factors also induce 
large changes in gene expression in the liver (Waxman and O'Connor 2006, Ruiz et al. 
2013), in particular genes showing sex-differential expression (Lichanska and Waters 
2008, Waxman and Holloway 2009), as is also seen in several other non-reproductive 
tissues (Rinn and Snyder 2005, Isensee et al. 2008, Sakakibara et al. 2013). In liver, sex-
biased gene expression is regulated by the sex-dependent patterns of pituitary growth 
hormone (GH) release (Waxman and O'Connor 2006): pulsatile GH release in males 
versus persistent (near continuous) GH release in females (Jansson et al. 1985, Veldhuis 
et al. 2001, Adams et al. 2015). The resulting sex differences in plasma GH profiles 
activate the TF STAT5 (Kang et al. 2013) by JAK2-catalyzed tyrosine phosphorylation 




et al. 1999), which is linked to downstream sex differences in liver chromatin 
accessibility and epigenetic (histone) marks (Ling et al. 2010, Sugathan and Waxman 
2013). These sex-differential chromatin states are associated with sex differences in the 
binding of STAT5 and other GH-regulated TFs (Conforto et al. 2012, Zhang et al. 2012, 
Conforto et al. 2015), which together regulate the sex-biased transcription of ~1,000 
liver-expressed genes (Clodfelter et al. 2006, Wauthier and Waxman 2008, Wauthier et 
al. 2010). Little is known, however, about the mechanisms whereby GH establishes and 
maintains the unique chromatin states seen in male and female liver (Sugathan and 
Waxman 2013).  
 
Sex-biased liver gene expression, as seen in mice, rats and humans, is associated with 
hormone-dependent sex differences in susceptibility to fatty liver disease (Ayonrinde et 
al. 2011), hepatocellular carcinoma (Ruggieri et al. 2010, Baik et al. 2011), polygenic 
dyslipidemia, and coronary artery disease (Zhang et al. 2011, Papp et al. 2012). Previous 
studies identified several lincRNAs, including H19 (Matouk et al. 2007, Zhang et al. 
2013), Meg3 (Braconi et al. 2011, Anwar et al. 2012) and HULC (Panzitt et al. 2007, 
Wang et al. 2010), which are associated with diseases showing a significant sex-biased 
prevalence in humans, notably hepatocellular carcinoma, liver fibrosis and liver 
regeneration (He et al. 2014, Takahashi et al. 2014). However, it is unknown whether 
these or other lincRNAs are expressed in a sex-dependent manner in liver, or whether 
they might be subject to tight regulation by GH and have the potential to contribute to the 





Here, we use the mouse model to elucidate gene structures, species conservation, and 
expression patterns for 4,961 liver-expressed lincRNAs. Strikingly, we find that liver 
lincRNAs show exceptional per-base conservation and a significantly higher frequency of 
TF occupancy in their proximal promoter regions than promoters of liver-expressed 
RefSeq protein-coding genes. We identify a subset of liver lincRNAs showing strong 
sex-biased expression regulated by pituitary GH secretion profiles, with enrichment for 
nearby sex-dependent Dnase I hypersensitive sites (DHS) and sex-differential binding by 
GH-regulated TFs. These findings are integrated with chromatin state analysis, which 
reveals distinct roles for sex-differential patterns of chromatin states in regulating male-
specific compared to female-specific lincRNAs. These findings are discussed in the 
context of mechanisms of GH regulation of sex-specific liver lincRNAs and their 
potential for regulation of sex-differences in hepatic physiology and disease.   
 
2.C Materials and methods 
Mouse treatment and liver RNA isolation. Intact and hypophysectomized adult male 
and female CD1 mice (8-12 weeks old) were purchased from Charles River Laboratories 
(Wilmington, MA). Livers from male and female wild type and somatostatin-deficient 
mice (9-12 week old) were provided by Drs. R. M. Luque and R. D. Kineman (University 
of Illinois at Chicago, Chicago, IL) and were described previously (Meyer et al. 2009, 
Cordoba-Chacon et al. 2011). Liver tissues were collected from 8-12 week old male and 




mice, provided Dr. L. Hennighausen (NIDDK, NIH, Bethesda, MD) (Holloway et al. 
2007). RNA was isolated from individual mouse livers using TRIzol reagent (Invitrogen 
Life Technologies, Inc., Carlsbad, CA). Animals were treated using protocols specifically 
reviewed for ethics and approved by the Boston University Animal Care and Use 
Committee. 
 
Mouse liver RNA-Seq and data analysis. RNA-seq data was obtained from 45 poly(A)-
selected mouse liver RNA-Seq samples representing five biological conditions. 
Individual RNA samples were prepared from either total liver RNA (22 samples) or 
nuclear liver RNA (23 samples). The biological conditions represented in the total liver 
RNA datasets are untreated male and untreated female mouse liver, and livers of male 
mice treated with chemical activators of the nuclear receptors CAR, PXR and PPARA. 
Biological conditions represented in the nuclear RNA datasets are untreated male and 
female mouse liver, and livers of male mice treated with chemical activators of the 
nuclear receptors CAR and PXR. A detailed analysis of the lincRNAs responsive to 
chemical activators of the nuclear receptors will be presented elsewhere. Liver RNA 
samples were divided into 8 sets, each comprised of RNA samples sequenced in the same 
run (Table S7 in (Melia et al. 2016), Gene Expression Omnibus (GEO) series GSE66140 
and GSE48109, and ENCODE series GSE36025 and GSE6026). All datasets were 
mapped to the mouse genome (mm9) using TopHat2 (Kim et al. 2013) with default 
parameters. A mouse genome mm9 annotation, derived from the UCSC repository, was 




point for Tophat2 to discover splice junctions. For paired-end reads, the r parameters 
were calculated by subtracting the length of the adaptor sequence (2 x 120 nt) and read 
length from the average fragment size. The fragment size was determined experimentally 
from Agilent Bioanalyzer tracings or was determined computationally by mapping 
paired-end reads to the mm9 genome using Bowtie (Langmead et al. 2009) and then 
computing the mean distance between every mapped paired read. Mapping percentages 
varied from 68% (ENCODE samples) to 98%, with a median of 85% reads mapped. 
 
Defining lincRNAs. All 45 RNA-Seq samples were used for transcript assembly by 
Cufflinks (Trapnell et al. 2010), which finds the minimum number of transcripts that 
encompass all the reads while including each read in at least one transcript. The mouse 
genome mm9 annotation was used as the starting point for transcript reconstruction. 
Fragment bias correction and multi-read correction options were both applied; all other 
arguments were set to default values. A total of 31,792 transcribed loci (transcribed 
genes), 120,376 isoforms, and 63,656 splicing variants were identified. The initial list of 
31,792 transcribed genes was reduced to 7,088 transcribed loci after filtering to remove 
transcripts that overlap RefSeq protein-coding genes in either the sense or antisense 
direction. We next applied three filters to remove transcripts that are lowly expressed 
(low expression filter, described below), short (RNA length < 200 nt), or exhibit 
similarity to protein-coding genes (protein-coding potential filter; described below), 
reducing the number of transcripts to 4,961 (liver-expressed lincRNAs). To obtain a 




removing: 1) lincRNAs that overlap with any of the 1,626 miRNAs, 334 rRNAs, 433 
tRNAs, 1,424 snRNAs or 10,517 pseudogenes annotated in Ensembl version 
NCBIM37.67, in either the sense or antisense direction; and 2) lincRNAs whose longest 
ORF was > 150 amino acids, resulting in a set of 4,454 stringent lincRNAs (Fig. 2-1A).  
 
Low expression filter. The quality of transcript reconstruction results depends on the 
depth of sequencing, and to a certain extent, the level of gene expression; genes that are 
highly expressed are more likely to have reads covering their full gene bodies than lowly 
expressed genes. Accordingly, we excluded lowly expressed genes, as their gene 
boundaries definitions are likely truncated. We quantified the expression of each gene (in 
FPKM) by rerunning Cufflinks with the –G option turned on. To determine the proper 
gene expression cutoff for each RNA-Seq sample, we varied the expression cutoff (in 
FPKM) while counting the fraction of RefSeq noncoding gene ends that are correctly 
predicted (i.e. covered by reads from the 5’ to the 3’ end) versus those are incorrectly 
predicted for each cutoff value. We plotted a receiver operating characteristic (ROC) 
curve for each RNA-Seq sample based on the number of correct and incorrect predictions 
for each cutoff interrogated, and then selected the cutoff with the greatest true positive 
rate while keeping the false positive rate below 15%. We thus identified optimized 
FPKM cutoffs tailored to the sequencing depth and read length of each RNA-Seq sample. 
Genes that passed the expression cutoff in at least two biological replicates in at least one 
dataset were retained. For the G81 dataset (Table S7 in (Melia et al. 2016)), we retained 




cutoff values ranged from 0.01 to 0.09 FPKM for 35 of the 45 RNA-seq samples, and 
from 0.6 to 1.4 FPKM for the other 10 samples (G78, and ENCODE S1, S2 samples; 
Table S7 in (Melia et al. 2016)).  
 
Protein-coding filter. Transcripts that contain a known protein domain, or do not exhibit 
codon degeneracy when looking at their multiple genome alignments, were identified 
(see below) and removed. To identify known protein domains, we created mature RNA 
sequences for each isoform of every gene by downloading their genomic sequences, 
removing introns and then concatenating consecutive exonic sequences. Bases that were 
not assigned to any of the four bases were replaced with either A, C, T or G with equal 
probabilities. The resulting mature RNA sequences were then translated to amino acid 
sequences in all 6 reading frames. For each amino acid sequence, we calculated the 
probability that it belongs to one of the 13,672 protein families defined in Pfam (Finn et 
al. 2014) using HMMER (Finn et al. 2011), which enabled us to identify, and then filter 
out, 480 transcribed loci that contain at least one protein domain. 
 
Codon evolutionary analysis. Codon evolutionary analysis was used to distinguish 
coding from noncoding regions based on the observation that protein-coding genes are 
depleted from non-synonymous and nonsense substitutions during evolution to retain 
their amino acid sequence (Lin et al. 2011). Briefly, based on the assumption that each 
codon evolved independently as a Markov process along a phylogenetic tree, we 




represents a coding region compared to another phylogenetic tree for a noncoding region. 
Both trees are identical in terms of branch lengths and structures; the difference lies in the 
frequency of a specific codon evolving to another codon (i.e. codon substitution matrix). 
The rate of codon substitution among identical and synonymous codons is expected to be 
higher for the coding compared to noncoding region. We downloaded 64 x 64 codon 
substitution matrices for coding regions and non-coding regions along with a 
phylogenetic tree of 29 mammals from Lindblad-Toh et al (Lindblad-Toh et al. 2011), 
which were empirically derived from sequence alignments of many known coding and 
noncoding sequences and maximized using an expectation-maximization approach. We 
used PhyloCSF (Lin et al. 2011) with these downloaded parameters to calculate the 
probability of each gene being coding or noncoding, as follows. For each gene, we 
extracted 46 species whole-genome multiple alignment data from the UCSC genome 
browser sequence and annotation downloads server (Karolchik et al. 2014), removed 
species that were not in the defined set of 29 mammals, enumerated all possible complete 
start-to-stop codon regions in the 6 possible reading frames, calculated the log-likelihood 
ratio based on the coding model versus the noncoding model for each reading frame and 
reported the highest score. The resulting log-likelihood score is termed coding potential 
score, where a positive score indicates that the gene being interrogated is likely to encode 
conserved peptides. We identified 126 genes with positive coding potential out of 4,252 
putative lincRNA genes that could be multi-genome aligned. 4,961 lincRNA genes 





Other high-throughput datasets. We downloaded genome-wide chromatin mark and 
transcription factor binding data sets for mouse liver, as follows: H3K4me3 marks from 
Sugathan and Waxman (GEO series GSE44571) (Sugathan and Waxman 2013) and 
Kutter et al (ArrayExpress E-MTAB-867) (Kutter et al. 2012); H3K36me3 from 
Sugathan and Waxman (GEO series GSE44571) (Sugathan and Waxman 2013) and the 
mouse ENCODE project (GEO series GSE31039) (Stamatoyannopoulos et al. 2012); 
RNA polymerase II from Sun et al (GEO series GSE21773) (Sun et al. 2011) and the 
mouse ENCODE project (GEO series GSE36027) (Stamatoyannopoulos et al. 2012); 
STAT5 and BCL6 from Zhang et al (GEO series GSE31578; STAT5-high male liver 
peak set using antibody C-17, Santa Cruz Biotechnology #sc-835x; male and female liver 
peak sets for BCL6 using antibody N-3, Santa Cruz Biotechnology #sc-858x (Zhang et 
al. 2012) (Table S11 in (Melia et al. 2016), and see below); HNF6 from Conforto et al 
(GEO series GSE60014; male liver peak set) (Conforto et al. 2015); CUX2 from 
Conforto et al (GEO series GSE35985) (Conforto et al. 2012);FOXA1 and FOXA2 from 
Li et al (ArrayExpress E-MTAB-805; merged male and female liver peak sets) (Li et al. 
2012); HNF4A from Schmidt et al (GEO series GSE22078) (Schmidt et al. 2010); 
PPARA, LXR and RXR from Boergesen et al (GEO series GSE35262) (Boergesen et al. 
2012); HNF1A from Faure et al (ArrayExpress E-MTAB-941) (Faure et al. 2012); 
CEBPA and CEBPB from Jakobsen et al (GEO series GSE42321) (Jakobsen et al. 2013); 
GR from Everett et al (GEO Series GSE45674) (Everett et al. 2013); DHS from Ling et 
al (GEO series GSE21777; combined set of 70,048 male-specific and sex-independent 




(Derti et al. 2012). We also downloaded 2,651,801 multi-tissue, mouse-specific CAGE 
clusters from the FANTOM consortium (Balwierz et al. 2009).  
 
Expression quantification. Gene expression was quantified using HTSeq (Anders et al. 
2015) using default settings. The same mouse genome mm9 annotation that was used for 
mapping reads was used to define RefSeq gene and exon boundaries for quantifying gene 
expression. To facilitate quantification of gene expression, each gene whose direction of 
transcription is unknown was assigned a provisional directionality based on a simple 
majority vote of reads mapping to the plus versus the minus strand across the set of 18 
stranded RNA-Seq samples examined. In the case of a tie, the direction of transcription 
was arbitrarily assigned to the plus strand by default. In this manner, 1,171 lincRNAs 
were assigned to the plus strand, 1,150 to the minus strand, and 67 lincRNAs defaulted to 
the plus strand. The geometric mean normalization method (Anders and Huber 2010) was 
used to normalize reads across samples for most analysis. For expression distribution 
analysis, reads were normalized across samples by calculating FPKM values. The 
prcomp function in R (Gentleman et al. 2004) was used to compute principal components 
of read counts across samples that were normalized with a variance stabilizing 
transformation (Anders and Huber 2010) to remove the dependence between mean and 
variance of count data. The set of 500 lincRNAs with the highest gene expression 
variance across the 45 samples was used to calculate the principal components. We 
plotted the first against the fifth principal components, as they separate the samples either 





Subcellular localization. Differential analysis was carried out using DESeq (Anders and 
Huber 2010) to compare the normalized gene expression values for nuclear versus total 
liver RNA samples for the G78 RNA-Seq dataset, and separately, for the G81 RNA-Seq 
dataset (Table S7 in (Melia et al. 2016)). The two differential analyses were performed 
separately on liver-expressed lincRNAs and RefSeq protein-coding genes. For each 
dataset (i.e. G78 and G81), lincRNAs and RefSeq protein-coding genes that have < 50 
reads summed up across conditions in all samples were excluded. Subcellular localization 
was assigned when at least one dataset showed significant enrichment for gene 
expression in either nuclear or total RNA at fold-change ≥ 2 and adjusted p ≤ 0.05.  
 
Liver-specificity. 42 paired-end RNA-Seq samples collected from 21 mouse tissues 
(GSE39524; Table S8 in (Melia et al. 2016)) were downloaded from the mouse 
ENCODE project (Stamatoyannopoulos et al. 2012). Each sample was mapped to the 
mouse genome. The expression in liver and in the other 24 non-liver samples was 
quantified for each of the 4,961 liver-expressed lincRNA and 14,057 liver-expressed 
RefSeq protein-coding genes (see ‘Expression quantification’, above). The tissue-
specificity of each gene (lincRNA or RefSeq protein-coding gene) was quantified by 
dividing its expression level in a given tissue over the sum of its expression levels across 
all 22 tissues. To correct for the over representation of liver samples in the full tissue 
panel (which includes data for only two samples for all tissues except liver), all liver data 




across 42 total liver RNA samples and the other based on the maximum expression across 
23 nuclear liver RNA samples. These 65 liver RNA-seq data sets encompass the 45 
samples used to discover lincRNA gene structures, as well as 8 RNA-seq samples from 
the hypophysectomy study (G85 samples) and 12 RNA-seq samples from the continuous 
GH treatment study (G88 samples) (Table S1, Table S7 in (Melia et al. 2016); GEO 
series GSE66140). A gene was considered as solely expressed in a given tissue when no 
sequence reads were detected in other tissues. Tissue specificity was also determined 
based on the maximum expression level of each lincRNA in a given tissue, measured in 
FPKM. The highest FPKM amongst all RNA-seq samples in a given tissue was used to 
represent the gene expression level for such tissue. RNA-seq data was also downloaded 
from ArrayExpress E-MTAB-2582 (Stubbington et al. 2015) and mapped as described 
above (Table S8 in (Melia et al. 2016)) to identify GH-regulated sex-specific liver 
lincRNAs expressed in three T cell subtypes where STAT5 activity is high. 
 
Conservation analysis. We used Phastcons (Siepel et al. 2005) to calculate per base 
conservation scores based on the multiple genome alignment of 10 selected species from 
the supraprimate (Euarchontoglires) clade (rat, guinea, rabbit, human, chimp, orangutan, 
rhesus, marmoset, bushbaby, treeshrew), downloaded from the UCSC genome browser 
sequence and annotation downloads server (Karolchik et al. 2014). A multi-genome 
alignment was derived from the 30 vertebrate species multi-genome alignment by 
removal of the 19 species excluded from our analysis (i.e. retaining only mouse and the 




identified based on sequence similarity, as follows. First, we collapsed all isoforms of 
each mouse lincRNA gene into a single transcript by taking the union of all exons. 
Second, we downloaded each genome, where all of the repeats are hardmasked (i.e. 
replaced by N’s). Third, we used Exonerate (Slater and Birney 2005) to find sequences in 
each genome that are similar to each lincRNA with the affine:local model selected and 
softmasking of lincRNA introns. Up to 20 top hits were retained. Fourth, we 
concatenated neighboring hits, i.e., hits within 2 kb of each other. Fifth, we realigned the 
concatenated hits with their orthologous lincRNA sequence using Exonerate with the 
global alignment option selected. Where no global alignment was produced, we accepted 
any local alignment of the two sequences. Based on this final realignment, we calculated 
the percent overall identity of the two sequences. Sixth, we removed any hit that 
overlapped with an annotated RefSeq protein-coding gene in the genome of interest and 
retained alignments that spanned at least 10% of the mature mouse lincRNA gene and 
were > 600 bp in length. These cutoffs were chosen to maximize the frequency of correct 
prediction of known lincRNA orthologs (Fig. S10A, Fig. S10B in (Melia et al. 2016)). 
No alignment percent identity cutoff was required, as the lowest percent identity match 
was ~60% (Fig. S10C in (Melia et al. 2016)). To identify genomic regions in the rat that 
are syntenic with mouse lincRNAs, we used the LiftOver tool from the UCSC genome 
browser (Karolchik et al. 2014) by relaxing the identity match to 60% and by not 





qPCR. Primers used for confirmatory quantitative PCR to assess the sex-specificity and 
GH-responsiveness of five mouse lincRNAs and two orthologous rat lincRNA regions 
are listed in Table S10 in (Melia et al. 2016). Real-time PCR analysis was performed on 
RNA samples isolated from individual mouse and rat livers using Power SYBR green 
PCR master mix and an ABS 7900HT sequence detection system (both from Applied 
Biosystems). 
 
Overlap analysis. Overlap with a known lincRNA found in lncRNAdb (Amaral et al. 
2011) was established by the overlap between the liver-expressed lincRNA or its 
orthologs, identified as described above, in either the sense or antisense direction. 
Overlap between a liver-expressed lincRNA and a PRC2-interacting RNA (Zhao et al. 
2010) further required that the lincRNA be transcribed in the same direction as the PRC2-
interacting RNA, as annotated in the original study.  
 
Comparison of TF occupancies for FPKM-matched lincRNA and protein-coding 
genes. For each liver-specific lincRNA whose median FPKM across datasets was > 0.52 
FPKM, we randomly chose a liver-specific protein-coding gene with a similar FPKM (± 
0.1 FPKM). This FPKM-matched lincRNA and protein-coding gene set was used to 
determine the TF occupancy rate of the promoter region for each gene set. Liver-specific 
lincRNA and liver-specific protein-coding genes were defined as genes whose expression 
in liver is > 60% of their cumulative expression across 22 mouse tissues. Multi-tissue 




than 10% of their cumulative-expression across 22 tissues occurring in liver, and < 60% 
of their cumulative-expression across 22 tissues occurring in any non-liver tissue. 
 
Sex-specificity and GH regulation of liver lincRNAs. Normalized gene expression 
values from six sets of male and female mouse liver RNA-Seq samples were compared 
by differential expression analysis to identify sex-specific lincRNAs, as follows. DESeq 
and edgeR (Robinson et al. 2010) were used to analyze the total RNA datasets G78 (T1), 
G83 (T2) and G85 (T3). Normalized gene expression ratios were used for two 
unreplicated G78 nuclear RNA samples (N1). Multi-factor DESeq was used to account 
for different sequencing runs for the merged dataset of G83 and G85 total RNA samples 
(T4), and DESeq was used for the merged dataset of G81 and G86 nuclear RNA samples 
(N2). Liver-expressed lincRNAs that showed a > 4-fold difference in expression between 
male and female liver at adjusted p < 0.05 in one or more of the 6 datasets, by either 
DESeq or edgeR, were tentatively designated sex-specific lincRNAs. For the G78 nuclear 
dataset, a threshold of > 50 read counts, summed across all male and female samples, was 
used in place of a p-value cutoff. Further, for nuclear RNA datasets, we excluded from 
the sex-specific list any lincRNA that did not show a response to either hypophysectomy 
(at fold change > 4 and adjusted p < 0.05) or continuous GH infusion (at fold change > 2 
and adjusted p < 0.05), resulting in a list of 247 sex-specific liver-expressed lincRNAs. 
172 of the sex-specific lincRNAs were expressed at > 1 FPKM (Table S1 in (Melia et al. 
2016)). 171 of the 247 lincRNAs were designated stringent sex-specific lincRNAs, based 




in male liver following continuous infusion of GH for 1, 4 or 7 days (female-like GH 
pattern) or following hypophysectomy, and were used for TF enrichment analysis. 141 of 
the 171 stringent sex-specific lincRNAs could be classified based on their responsiveness 
to hypophysectomy (class 1 or class 2 responses; Table 2-2). The GH-regulated sex-
specific lincRNAs showed a sex-difference in expression ranging from 4-fold to 190-
fold, for male-specific lincRNAs, and 4.2-fold to 1,240-fold, for female-specific 
lincRNAs (see Fig. 2-4B, below). Any lincRNA from the list of 4,961 liver-expressed 
lincRNAs that was not included in the list of 247 sex-specific lincRNAs was deemed sex-
independent; the latter list was used as a background when calculating the enrichment of 
sex-specific lincRNAs nearby sex-specific protein-coding genes. The 857 sex-
independent lincRNAs showing < 1.2-fold sex-difference in at least 3 of 4 datasets (G78 
nuclear, G78 total, G83 and G85 datasets) were designated stringent sex-independent 
lincRNAs. DESeq and edgeR were used to identify liver-expressed lincRNAs showing 
differential expression between intact and hypophysectomized mice, and those showing 
differential expression between male mice treated with GH as a continuous infusion for 1, 
4 or 7 days compared to vehicle-treated control male mice based on normalized gene 
expression values. Hypophysectomy and GH infusion both lead to widespread 
dysregulation of sex-specific protein-coding genes in mouse and rat liver (Wauthier and 
Waxman 2008, Wauthier et al. 2010). The significance level was set at fold-change > 4 
for the hypophysectomy model and fold-change > 2 for at least one of the time points in 
the continuous GH infusion model, and adjusted p < 0.05 for both. RNA-seq data sets are 





Sex-specific protein-coding genes. DESeq and edgeR were used to identify a set of 840 
sex-specific RefSeq genes based on the normalized gene expression values in the G78, 
G83 and G85 total RNA datasets, of which 33 are ncRNAs. Thus, 807 protein-coding 
genes were identified as sex-specific based on the criteria adjusted p < 0.05 in at least 2 
of the 3 total RNA datasets, as determined by either DESeq or edgeR. The 807 RefSeq 
coding genes showed a sex-difference in expression ranging from 1.41-fold to 884-fold, 
for male-specific genes, and 1.41-fold to 10,030-fold, for female-specific genes, when 
considering the highest fold change across the three datasets (see Fig. 2-4B, below). Any 
RefSeq protein-coding gene that was not included in the sex-specific protein-coding 
genes list was considered as sex-independent.  
 
Enrichments. 1) Gene proximity enrichment: Enrichment scores (ES) for the proximity 
of sex-specific lincRNAs to be nearby (within 25 kb) sex-specific RefSeq protein-coding 
genes of the same sex specificity were calculated as follows: ES = (number of sex-
specific lincRNAs nearby matched sex-specific RefSeq protein-coding genes) / (number 
of sex-specific lincRNAs nearby sex-independent RefSeq protein-coding genes), as 
compared to (number of sex-independent lincRNAs nearby any sex-specific RefSeq 
protein-coding genes) / (number of sex-independent lincRNAs nearby sex-independent 
RefSeq protein-coding genes). 2) Enrichment of DHS and TF binding events (except for 
CUX2 binding sites): ES values for having a female-specific TF binding site or DHS 




(number of stringent female-specific lincRNAs that have a nearby female-specific DHS, 
or a nearby stringent female-specific TF binding site) / (number of stringent female-
specific lincRNAs nearby non female-specific (i.e. male-specific + sex-independent) 
DHS, or TF binding sites), as compared to (number of non female-specific lincRNAs (i.e. 
male-specific + stringent sex-independent lincRNAs) that have a nearby DHS, or female-
specific TF binding site) to (number of non female-specific lincRNAs nearby non female-
specific DHS, or TF binding sites). Enrichment analysis was carried out in the same 
manner for a control gene set, comprised of 267 sex-independent lincRNAs that are 
hypophysectomy-responsive (see Fig. 2-4C, below), which were compared to the set of 
sex-independent lincRNAs that are not responsive to hypophysectomy. A corresponding 
analysis was performed for male-specific DHS and TF binding site enrichments. 3) 
CUX2 binding enrichment: Enrichment scores for having CUX2 bound within 10 kb of a 
stringent female-specific lincRNA were calculated as follows: ES = (number of stringent 
female-specific lincRNAs that have a nearby CUX2 binding site) / (number of stringent 
female-specific lincRNAs that do not have a nearby CUX2 binding site), as compared to 
(number of non female-specific lincRNAs (i.e. male-specific + stringent sex-independent 
lincRNAs) that have a nearby CUX2 binding site) / (number of non female-specific 
lincRNAs that do not have a nearby CUX2 binding site). Since CUX2 is not expressed in 
male liver, no enrichment analysis was carried out for male-specific CUX2 binding. 4) 
Gene set enrichment analysis (GSEA) (Subramanian et al. 2005) was carried out using 
default settings to determine if sex-specific lincRNA TSS regions (-1 kb to +1 kb 




particular chromatin state in one sex, but not the other. These analyses using chromatin 
state maps in male and female mouse liver (Sugathan and Waxman 2013), where each 
consecutive 200 bp segment of the mouse genome was assigned one of 14 chromatin 
states (state 1 to state 14; see Fig. 2-6B, below). Enrichment for chromatin state x in male 
liver was established by comparing the distribution of liver lincRNAs where state x is 
found within its gene body or TSS in male liver, but not in female liver, over the full list 
of 4,961 liver lincRNAs, ranked from high to low male/female expression ratio. This 
analysis was carried out for each of the 14 states (Sugathan and Waxman 2013) in male 
liver, and separately, in female liver. Normalized enrichment scores ≥ 1.45 with FDR ≤ 
0.05 were deemed significant. GSEA was also carried out for 16,124 RefSeq protein-
coding genes, where we excluded genes that have no reads in the RNA-seq datasets used 
to determine sex-specificity. 
 
Clustering of sex-specific lincRNAs. Consensus clustering (Reich et al. 2006) was used 
to identify 5 clusters of male-specific lincRNAs based on the chromatin state patterns of 
each lincRNA in a 2 kb window surrounding the TSS, and in a 2 kb window surrounding 
the TES, in both male and female liver. The number of clusters, n=5, was chosen to give 
robust, reproducible clusters over 100 runs. Each lincRNA was clustered after counting 
the total number of bases across the 2 kb region assigned to each of the 14 states for each 
genomic segment of interest, i.e. male TSS ± 1 kb, female TSS ± 1 kb, male TES ± 1 kb 
and female TES ± 1 kb. The 5 clusters were then sorted from high to low male-specificity 





Other analyses. For TF peak analysis, HNF1A and HNF4A raw data were mapped to 
mm9 using Bowtie2 (Langmead et al. 2009). Biological replicates were combined before 
removing PCR duplicates using Picard (http://broadinstitute.github.io/picard). Peaks were 
then discovered using MACS2 (Zhang et al. 2008). BCL6 peaks (binding sites) identified 
separately in male and female liver (Zhang et al. 2012) were merged to give a single list 
of 6,656 peaks. This merged peak list was compared to the set of genomic regions 
differentially bound by BCL6 between individual male and female liver samples (Zhang 
et al. 2012), as determined by Andy Rampersaud of this laboratory using diffReps (Shen 
et al. 2013) after removing differential binding regions showing < 2-fold difference 
between male and female samples, as well as those diffReps regions mapping to weak 
BCL6 peaks (MACS2 score < 25, or peaks having < 20 ChIP-seq reads). The 6,656 
merged BCL6 peaks were thus classified into 1,459 male-biased, 42 female-biased and 
5,155 sex-independent BCL6 peaks (Table S11 in (Melia et al. 2016)). Statistics for 
human lncRNAs were calculated from GENCODE annotation version 21 (June 2014 
freeze, GRCh38, Ensembl77). For hypothesis testing, p-values were calculated using R. 
P-values < 2.2e-16 were rounded up to 1e-15 due to R’s limitation for representing 
floating numbers. All analyses were done using custom Perl and R scripts unless 
otherwise noted.  
 




The sequencing data sets supporting the results of this article are available at the Gene 
Expression Omnibus (GEO) website (http://www.ncbi.nlm.nih.gov/gds) as series 
GSE48109 and GSE66140. 
 
2.D Results 
Identification of liver-expressed lincRNAs. 45 RNA-Seq datasets, obtained using 
polyA-selected total and nuclear liver RNA isolated from male and female mice under 
various conditions (see Methods), were used to assemble liver-expressed RNA transcripts 
and discover novel gene structures. 7,088 transcribed intergenic loci were identified after 
removing transcripts that overlap RefSeq protein-coding genes on either strand. 
Transcripts showing low expression across samples were filtered out (Fig. 2-1A). A 
second filter removed transcripts < 200 nt in length. A final filter removed transcripts 
whose protein-coding potential score, which indicates the rate of synonymous vs. non-
synonymous substitutions across species, resembles that of protein-coding genes. This 
final filter applied a stricter cutoff for removing transcripts with protein-coding potential 
than that used to define RefSeq noncoding genes (Fig. 2-1B). A total of 4,961 liver-
expressed lincRNAs passed all three filters (Table S1 in (Melia et al. 2016)). Removal of 
188 lincRNAs that overlap small RNAs or pseudogenes on either strand, as well as 319 
lincRNAs with an open reading frame (ORF) > 150 amino acids in length, resulted in 
4,454 stringent lincRNAs. 92% (4,554) of the full set of liver lincRNAs do not overlap 




ncRNAs reported previously (Guttman et al. 2009, Kutter et al. 2012, Luo et al. 2013, 
Xie et al. 2014) (Table S1 in (Melia et al. 2016)).  
 
Liver lincRNA gene structures. To distinguish genuine lincRNAs from spurious 
products of leaky transcription, we looked for associations with histone marks classically 
found at lincRNA promoters (H3K4me3) and gene bodies (H3K36me3) (Guttman et al. 
2009). We examined the frequency of each histone mark at lincRNA genes as compared 
to protein-coding genes after binning both gene sets based on their expression levels, to 
remove bias against genes expressed at a low level. The frequency of each mark 
increased with increasing gene expression in a similar manner for both lincRNA and 
protein-coding genes (Fig. S1A, S1B in (Melia et al. 2016)), as expected for genuine 
transcripts. The lower frequencies of these marks at lower expression levels may reflect 
histone mark intensities below the threshold of detection at the available ChIP-seq 
sequencing depths, as well as incomplete lincRNA gene structures, which can lead to 
incorrect assignment of gene body boundaries.  
 
The completeness of our reconstructed gene structures was assessed by proximity of 
lincRNA transcription start sites (TSS) to 5’ cap site locations identified as CAGE-Seq 
clusters in liver (Balwierz et al. 2009), and by the proximity of lincRNA transcript end 
sites (TES) to 3’ poly(A) tails identified by genome-wide sequencing (Derti et al. 2012). 
Both marks increased in frequency as the level of lincRNA expression increased, similar 




71% of liver lincRNAs have either a proximal CAGE-Seq, poly(A)-Seq or promoter-
associated H3K4me3 peak, supporting our lincRNA gene boundary assignments and our 
conclusion that the liver lincRNAs are independent transcripts, and not extensions of 
nearby protein-coding transcripts. Further, the fraction of lincRNA promoters vs. protein-
coding gene promoters bound by RNA polymerase II was very similar at equivalent 
levels of gene expression (Fig. S1E in (Melia et al. 2016)), suggesting that RNA 
polymerase II makes a substantial contribution to liver lincRNA transcription.  
 
24% of the liver lincRNAs are multi-exonic (Table 2-1, Table S1 in (Melia et al. 2016)). 
This compares to only 10-15% multi-exonic lincRNAs in ribosomal RNA-depleted 
mouse and rat liver RNA-seq libraries (Kutter et al. 2012). The multi-exonic liver 
lincRNAs tend to have longer exons and longer mature transcripts, but intron lengths 
similar to protein-coding genes (Table 2-1).  
 
Liver lincRNAs: nuclear enrichment and tissue specificity. The 4,554 non-RefSeq 
liver lincRNAs are expressed at a lower level than RefSeq protein-coding genes, similar 
level to known RefSeq noncoding genes, and were most highly expressed in the nuclear 
compartment (Fig. 2-1C), indicating nuclear retention. Of 2,399 liver lincRNAs having 
sufficient sequencing depth for analysis, 1,234 showed significant nuclear enrichment, 
while only 93 were enriched in the total RNA fraction (primarily cytoplasmic RNA) 
(Table S1 in (Melia et al. 2016)). In contrast, RefSeq protein-coding transcripts showed 




29% of transcripts). Subcellular compartmentalization captured ~70% of the variance in 
lincRNA expression across the liver RNA datasets and cleanly separated total liver RNA 
from nuclear liver RNA samples (Fig. 2-1D, left). A more minor component (~3% of the 
variance) separated the liver lincRNAs based on sex of the individual mice (Fig. 2-1D, 
right) (also see below).  
 
27% of the 4,961 liver lincRNAs showed strong liver-specificity, defined as > 60% of 
total expression level summed up across the 22 mouse tissues examined occurring in liver 
(Fig. S2A, Table S1 in (Melia et al. 2016)), as compared to only 6% of liver-expressed 
protein-coding genes (Fig. S2B in (Melia et al. 2016)). 1,437 (66%) of the 2,171 
lincRNAs expressed in liver at > 1 FPKM (fragments per kb length per million sequence 
reads), corresponding to an estimated one molecule per cell (Mortazavi et al. 2008), were 
below that minimum expression level in all 21 other tissues examined (Fig. 2-1E, Fig. 
S3A-S3B, Table S1 in (Melia et al. 2016)). Subsets of liver lincRNAs showed co-
expression largely limited to testis or brain (Fig. S3C, S3D in (Melia et al. 2016)). 30 
lincRNAs were expressed at > 1 FPKM in all 22 tissues (Fig. 2-1E, Table S2 in (Melia et 
al. 2016)). Only 29 liver lincRNAs were largely invariant in expression across tissues, as 
compared to 1,069 liver-expressed protein-coding genes (<1.5-fold range of expression 
across 22 tissues). 
 
Conservation of liver lincRNAs. LincRNA conservation was assessed using two 




transcripts and regions upstream of their TSS based on a multi-genome alignment of 10 
supraprimate species; and 2) by using sequence similarity to identify putative orthologs in 
the same 10 species. The first approach relies on the accuracy of the multi-genome 
alignment and the assignment of synteny across species to quantify conservation, whereas 
the second approach identifies genomic regions in each species most similar in sequence 
to each mouse lincRNA, independent of their placement in the multi-genome alignment.  
 
To implement the first approach, we calculated the probability of each base to be 
conserved in a given multi-genome alignment, and then compared the cumulative 
frequency distribution of the per-base conservation score for three gene-centric regions – 
exons, introns, and promoters – between lincRNA and RefSeq protein-coding genes. 
Protein-coding exons showed significantly higher conservation than lincRNA exons, 
which in turn showed modest but significant conservation compared to a random 
(background) sampling of untranscribed intergenic regions, indicating the lincRNA exons 
are subject to moderate evolutionary constraint (Fig. 2-2A). LincRNA introns and RefSeq 
protein-coding introns both showed very low per-base conservation. In contrast, lincRNA 
promoters were significantly more conserved than protein-coding promoters (p < 1e-15, 
Kolmogorov-Smirnov). This pattern of increased lincRNA promoter conservation was 
even more apparent when comparing lincRNA vs. protein-coding promoters of genes that 
are liver-specific (Fig. 2-2B, top; dashed vs. solid blue lines), or genes that are multi 
tissue-expressed (Fig. 2-2B, bottom). Additionally, multi tissue-specific lincRNA 




bottom vs. top; compare two sets of blue dashed lines). The strong per-base conservation 
of lincRNA vs. protein-coding promoters drops abruptly downstream of the TSS; this 
indicates strong purifying selection operating on lincRNA promoters (Fig. 2-2C, left). No 
such conservation was seen surrounding lincRNA TES (Fig. 2-2C, right). Fig. S4C-S4E 
in (Melia et al. 2016) shows examples of individual lincRNA promoters with high per-
base conservation. 
 
Next, we examined whether the greater conservation of lincRNA promoters is associated 
with increased binding of liver TFs. Indeed, for 11 out of 12 liver TFs examined, liver-
specific lincRNA proximal (1 kb upstream) promoters were bound significantly more 
frequently than an FPKM-matched set of liver-specific protein-coding gene promoters 
(Fig. 2-2D, left; p < 0.05 for each TF, Binomial exact test). Further, 47% of the liver-
specific lincRNA promoters are occupied by 3 or more of the 12 liver TFs examined, 
compared to only 29% for the corresponding protein-coding genes. Promoter region 
occupancy was more similar when the upstream region was expanded to 25 kb (Fig. 2-
2D, right), with 72% occupancy by 3 or more factors for lincRNAs vs. 62% for protein-
coding genes, consistent with the rapid drop off in lincRNA sequence conservation in the 
extended upstream region (Fig. 2-2C).  
 
Our second approach to defining lincRNA conservation identified putative orthologs in 
other species based on sequence similarity, as detailed in Methods. We identified at least 




largest number found in rat (60%; 2,984 putative orthologs) (Table S3, Table S4 in 
(Melia et al. 2016)). 91% (2,730) of the putative rat lincRNAs orthologs are at syntenic 
regions based on mouse and rat whole genome alignments, indicating that the homology 
extends to the surrounding genomic regions. Using this approach, we correctly identified 
8 out of 12 annotated lincRNA orthologs (Amaral et al. 2011) in rat, human, chimp 
and/or rhesus (Table S4 in (Melia et al. 2016)). Six of these 8 lincRNAs bind chromatin-
modifying enzymes (Table S5 in (Melia et al. 2016)), consistent with reports that many 
lincRNAs bind chromatin remodelers and contribute to chromatin state regulation (Khalil 
et al. 2009, Guttman et al. 2011). 350 of the liver lincRNAs are in the set of 9,788 PRC2-
interacting RNAs identified in mouse embryonic stem cells (Zhao et al. 2010) (Table S6 
in (Melia et al. 2016)), suggesting that many liver lincRNAs interact with chromatin-
modifying enzymes beyond the ones that have been fully characterized.  
 
GH regulation of sex-specific liver lincRNAs. 247 of the 4,961 liver lincRNAs showed 
a > 4-fold differential expression between male and female mouse liver at adjusted p < 
0.05; 134 of these lincRNAs showed male-biased expression and 113 showed female-
biased expression (Fig. 2-4A, Fig. 2-4B; Table S1 in (Melia et al. 2016)). Further, 59% of 
the sex-specific lincRNAs show high liver-specificity (Fig. 2-3B), as compared to 27% of 
all liver lincRNAs (4.3-fold enrichment, p = 7.04e-28; Fig. S2A in (Melia et al. 2016)), 
suggesting they contribute to liver-specific functions. Moreover, 195 sex-specific 
lincRNAs have a putative ortholog in at least one other species, including 170 with an 





171 of the sex-specific liver lincRNAs (85 male-specific, 86 female-specific) showed a 
change in sex-specificity when circulating GH levels were altered, either by surgical 
removal of the pituitary gland (hypophysectomy) (Wauthier et al. 2010), which ablates 
circulating GH, or by continuous infusion of GH in male mice, which gives a female-like 
plasma GH profile and feminizes the expression of many sex-dependent genes in mouse 
liver (Holloway et al. 2006) (Fig. 2-4A, Fig. 2-4C, Table S1 in (Melia et al. 2016)). These 
171 GH-dependent sex-specific lincRNAs are designated stringent sex-specific 
lincRNAs. An additional 17 sex-specific lincRNAs showed responsiveness to 
hypophysectomy when the threshold for a response was decreased from > 4 to > 2-fold. 
However, many hypophysectomy-responsive lincRNAs are sex-independent and respond 
to pituitary hormone ablation in the same manner in males and females (266 out of 267 
hypophysectomy-responsive, sex-independent lincRNAs; Fig. 2-4C and Table S1 in 
(Melia et al. 2016)), consistent with hypophysectomy affecting many non-sex-specific 
liver genes (Wauthier and Waxman 2008, Wauthier et al. 2010). Sex-specificity was 
verified for select lincRNAs by qPCR analysis of individual male and female mouse 
livers (Fig. 2-5A, Fig. S5 in (Melia et al. 2016)). Further characterization of the GH-
dependence of these lincRNAs was obtained by analysis of liver RNA from mice that 
were: (a) hypophysectomized, to ablate pituitary GH; (b) deficient in the GH-responsive 
TF STAT5, which is required for sex-specific gene expression in liver (Clodfelter et al. 
2006); or (c) deficient in somatostatin, which inhibits pituitary GH release and whose 




Fig. S5 in (Melia et al. 2016)). Finally, sex-specific expression was observed for two of 
the putative rat orthologs, whose sex- and hormone-dependent regulatory patterns in rat 
liver matched those seen in mouse liver, namely, female-specific expression and 
significant up regulation in male rat liver following continuous infusion of GH for 7 days 
(Fig. 2-5B). 
 
We identified subclasses of lincRNAs based on their patterns of response to 
hypophysectomy (Wauthier and Waxman 2008, Wauthier et al. 2010), which either 
reduces or eliminates the differences in lincRNA expression between the sexes (Table 2-
2). 104 (42%) of the sex-specific lincRNAs were down regulated at least 4-fold following 
hypophysectomy in the sex where they are more highly expressed. Thus, these genes, 
designated class 1 lincRNAs, require the correspondingly matched sex-specific pituitary 
GH secretion profile to maintain their sex-specific expression (Table 2-2, and gene sets 
marked C and D in Fig. 2-4A, right). A second, distinct set comprised of 37 other sex-
specific lincRNAs, designated class 2, shows significant up regulation (de-repression) 
following hypophysectomy in the sex where they are less highly expressed (Table 2-2). 
The sex-biased expression of these lincRNAs reflects their active repression by the 
plasma GH profile in the sex showing lower expression. Consequently, class 2 sex-
specific lincRNAs are de-repressed in the sex showing lower expression when pituitary 





Sex-specific lincRNAs: TF binding, chromatin states, and proximity to sex-specific 
genes. We investigated whether sex-specific lincRNA genes are enriched for sex-
dependent binding by TFs previously implicated in GH regulation of sex-specific protein-
coding genes in mouse liver (Conforto et al. 2012, Li et al. 2012, Zhang et al. 2012, 
Conforto et al. 2015). Male-biased binding of STAT5, FOXA1, FOXA2 and HNF6 were 
significantly enriched nearby (within 10 kb) the set of 85 stringent (i.e., GH-regulated) 
male-specific lincRNAs, and was significantly depleted nearby the set of 86 stringent 
female-specific lincRNAs, when compared to a background set comprised of sex-
opposite and stringent sex-independent lincRNA genes (Fig. 2-6A). Similarly, the 86 
stringent female-specific lincRNAs were significantly enriched, and the 85 stringent 
male-specific lincRNAs were significantly depleted of nearby female-biased binding by 
STAT5 and FOXA2. In contrast, female-specific binding of CUX2 was enriched nearby 
stringent male-specific lincRNAs, and male-biased binding of BCL6 was enriched nearby 
stringent female-specific lincRNAs. Consistent with these findings, sex-biased binding of 
STAT5, FOXA1/FOXA2 and HNF6 is associated with increased liver expression of 
nearby and correspondingly sex-biased genes (Zhang et al. 2012, Sugathan and Waxman 
2013, Conforto et al. 2015), whereas the sex-biased repressors CUX2 and BCL6 
preferentially repress nearby male-biased and female-biased genes, respectively (Meyer 
et al. 2009, Conforto et al. 2012, Zhang et al. 2012). Sex-specific binding by these factors 
at individual sex-specific genes is shown in Fig. 2-5C and Fig. S6 in (Melia et al. 2016). 
The stringent male-specific lincRNAs are significantly enriched for nearby (within 10 kb) 




stringent female-specific lincRNAs are enriched for nearby female-biased DHS (ES = 
5.68, p = 3.10e-9; Fig. 2-6A), consistent with these DHS (accessible chromatin regions) 
serving as regulatory regions for the sex-specific lincRNAs. Overall, 94 sex-specific 
lincRNAs have proximal sex-matched DHS; the others do not have any proximal liver 
DHS (45 lincRNAs), or are nearby non-sex-biased liver DHS (108 lincRNAs), 
suggesting they are regulated by sex-biased DHS that are distal. The control gene set, 
comprised of sex-independent, hypophysectomy-responsive lincRNAs (Fig. 2-4C), show 
no significant differential enrichments for either male-specific or female-specific TF 
binding or DHS, as compared to hypophysectomy-unresponsive lincRNAs that are also 
sex-independent. Therefore, responsiveness to hypophysectomy alone, without an 
associated sex-specific gene expression pattern, is not associated with proximal sex-
specific TF binding and sex-specific chromatin accessibility 
 
Next, we investigated whether sex-specific lincRNA expression is associated with 
specific chromatin states, which may be critical for maintaining their sex-specific 
expression. Specifically, we used GSEA (Subramanian et al. 2005) to determine if 
lincRNAs that are preferentially at a given chromatin state in one sex, but not in the 
other, are enriched for being either male- or female-specific lincRNAs. These analyses 
used liver chromatin state maps (Sugathan and Waxman 2013) based on genome-wide 
data for DHS and six chromatin marks for male and female mouse liver, which were used 
to assign defined chromatin states to each consecutive 200 bp segment of the mouse 




indicative of inactive chromatin states, state 4 is devoid of any of the chromatin marks 
that were interrogated, states 5-12 represent various active and poised chromatin states, 
and states 13 and 14 are associated with marks for transcribed genomic regions (Fig. 2-
6B). States 5 to 12 are distinguished by their patterns of DHS and activating chromatin 
marks: states 5, 6, 9, 10 and 11 have various combinations of classical enhancer marks 
(DHS, H3K4me1, H3K27ac), states 7 and 8 are marked as promoter states by the 
presence of H3K4me3 marks, and state 12 is a poised enhancer state (bivalent state; 
combination of H3K4me1 (activating) and H3K27me3 (repressive) marks).  
 
Chromatin state enrichments were identified by GSEA for sex-specific lincRNA TSS 
regions and gene bodies, and then compared to those identified for matched sets of sex-
specific protein-coding genes. For both male-specific and female-specific lincRNAs, we 
observed significant enrichment of the promoter-associated active chromatin state 7 in 
lincRNA TSS regions in the sex where each lincRNA set is more highly expressed, 
consistent with the sex-specificity of their transcription (Fig. 2-6C). A similar result was 
seen for sex-specific lincRNA gene bodies, and for sex-specific protein-coding genes 
(Fig. S7 in (Melia et al. 2016)). Further, in female liver, H3K4me1-associated enhancer 
states 6 and 11, and the H3K36me3-associated transcribed state 14 were enriched at 
female-specific lincRNA TSS (Fig. 2-6C, right) and gene bodies (Fig. S7 in (Melia et al. 
2016)), but we did not see corresponding enrichments at male-specific lincRNAs in male 
liver. In male liver, H3K27me3-associated chromatin states (inactive states 1 and 2, and 




lincRNA TSS regions (Fig. 2-6C, left). Similar patterns were seen at lincRNA gene 
bodies, and for protein-coding gene TSS and gene bodies (Fig. S7 in (Melia et al. 2016), 
left). However, a corresponding enrichment of H3K27me3-associated chromatin states 
was not found at male-specific lincRNA TSS or gene bodies in female liver, indicating 
H3K27me3 repressive marks are preferentially used to down regulate female-specific 
lincRNA genes in male liver. Finally, male-specific lincRNA TSS and gene bodies 
showed significant enrichment for being in chromatin state 4 in male liver. No such 
enrichments were seen for male-specific protein-coding genes in male liver, or for 
female-specific lincRNAs or protein-coding in female liver. State 4 has little or no signal 
intensity for any of the chromatin marks investigated (Sugathan and Waxman 2013) 
(similar to state 15 of (Kundaje et al. 2015)), suggesting that one or more novel 
chromatin marks not examined may positively regulate male-specific lincRNA 
expression.  
 
Next, male-specific lincRNAs were grouped into 5 clusters using consensus clustering 
(Monti et al. 2003) based on the local chromatin states surrounding each lincRNA’s TSS 
and TES in both male and female liver (Fig. S8A, S8B in (Melia et al. 2016)). Several of 
the clusters showed differences in chromatin state in male compared to female liver (Fig. 
S8C in (Melia et al. 2016), arrows). The most notable differences were the TES of male-
specific lincRNA cluster A, which was marked by transcribed state 13 in male liver and 
by inactive state 2 in female liver, and the TSS of male-specific lincRNA clusters A and 




frequency of inactive states in male compared to female liver. Correspondingly, male 
lincRNA clusters A and B have the highest male-specificity (Fig. S8D in (Melia et al. 
2016)). Further, the TSS regions of male lincRNA clusters D and E are depleted of state 
11 in male compared to female liver, in line with our finding that state 11 is enriched at 
female-specific lincRNA TSS in female compared to male liver (Fig. 2-6C). Chromatin 
state differences between male and female liver were less dramatic for female-specific 
lincRNAs clustered in the same manner (Fig. S8E in (Melia et al. 2016)). 
 
Finally, we investigated the proximity of sex-specific lincRNAs to sex-specific protein-
coding genes, given the finding that many lincRNAs are active in regulation in cis (Guil 
and Esteller 2012). We found that 36 of the 247 sex-specific lincRNAs (15%) are 
proximal (within 25 kb) of a sex-specific protein-coding gene with a matched sex-
specificity (Fig. S9, Table S9 in (Melia et al. 2016)), whereas only 3 sex-specific 
lincRNAs are proximal to sex-opposite protein-coding genes. This frequency of gene 
proximity is similar to that of sex-specific RefSeq protein-coding genes to other sex-
specific coding genes with a matched sex-specificity (135 of 807 sex-specific coding 
genes, 17%). Overall, sex-specific lincRNAs are significantly enriched for proximity to a 
co-regulated sex-specific RefSeq protein-coding gene as compared to a sex-independent 
gene (ES = 4.5, p = 7.5e-11). Nevertheless, more than 200 sex-specific lincRNAs are 
distant from correspondingly regulated protein-coding genes, consistent with distal 






The gene expression landscape is shaped by the interplay between local chromatin 
environment and the binding of TFs and other regulators, including lincRNAs (Ernst and 
Kellis 2013, Sugathan and Waxman 2013). LincRNAs act by diverse mechanisms, 
including genome site-specific interactions with chromatin-modifying enzymes that read, 
write and erase histone marks (Khalil et al. 2009, Guttman et al. 2011, Engreitz et al. 
2013). We characterized the mouse liver transcriptome under multiple biological 
conditions, which enabled us to discover 4,961 liver-expressed lincRNA genes, 59% of 
them novel. These lincRNA genes displayed characteristic lincRNA features, including 
H3K4me3 marks and RNA polymerase II binding at the promoter, H3K4me36 marks 
along the gene body, high tissue specificity, fewer exons than protein-coding genes, and 
in many cases, preferential retention in the nucleus, consistent with their proposed roles 
in epigenetic regulation (Khalil et al. 2009, Guttman et al. 2011). 247 liver-expressed 
lincRNAs showed strong (> 4-fold) sex-differences in expression, with the pituitary 
hormone GH serving as the major regulator of sex-biased expression, acting through both 
positive and negative regulatory mechanisms. Sex-specific lincRNA transcription was 
associated with significant enrichment for nearby, matched sex-specific open chromatin 
regions (sex-specific DHS regions) (Ling et al. 2010), as well as matched sex-specific 
binding by GH-regulated transcriptional activators and matched sex-opposite binding by 
GH-regulated repressors, strongly suggesting a role for these genomic regulatory regions 
and their bound factors in sex-specific lincRNA expression. Finally, sex-specific 




specificity, consistent with these lincRNAs contributing to regulation in cis; however, the 
majority of sex-specific lincRNAs are distant from any co-regulated protein-coding 
genes. 
 
LincRNA conservation landscape. LincRNA conservation based on a multi-genome 
alignment of 10 supraprimate species revealed that lincRNA promoters are significantly 
more conserved than protein-coding promoters, while lincRNA exons are much less 
conserved than protein-coding gene exons. Putative orthologs of the liver lincRNAs were 
also identified in the same 10 species based on sequence similarity. We correctly 
identified orthologs for 8 of 12 experimentally validated lincRNAs characterized in 
multiple species, of which 6 lincRNAs are reported to interact with chromatin modifying 
enzymes in one or more species (Khalil et al. 2009, Zhao et al. 2010, Guttman et al. 
2011). In the rat, where overall patterns of sex-specific liver gene expression are 
conserved (Waxman and O'Connor 2006), we identified orthologous genomic regions for 
170 of 247 sex-specific mouse liver lincRNAs. We experimentally validated two 
predicted rat orthologs, which exhibited the same female-specificity and continuous GH-
inducible expression as their mouse lincRNA counterparts. 
 
Liver-expressed lincRNA promoters showed greater enrichment for proximal binding of 
liver TFs than protein-coding gene promoters, consistent with the higher conservation of 
liver lincRNA promoters, discussed above. Mouse liver lincRNA regulatory regions are 




suggests that the liver lincRNA genes evolved more recently, and have not yet dispersed 
their regulatory regions to more distant genomic loci, as appears to have occurred with 
regulatory elements of liver-expressed protein-coding genes (Odom et al. 2007). Our 
finding of high liver lincRNA promoter conservation contrasts with other studies 
reporting either similar (Guttman et al. 2009) or lower (Orom et al. 2010) conservation of 
lincRNA promoters compared to protein-coding genes promoters in other systems. We 
can also anticipate that liver-expressed lincRNA and protein-coding gene promoters will 
be enriched for distinct sets of TF motifs, as was found for human lincRNAs (Alam et al. 
2014). Finally, we found that multi-tissue expressed liver lincRNAs show an even higher 
level of proximal promoter conservation than liver-specific lincRNAs. Tissue-specificity 
could therefore be a confounding variable when comparing promoter conservation 
between lincRNA and protein-coding genes. 
 
Regulation of sex-specific lincRNAs by GH. 171 of the 247 sex-specific lincRNAs 
were responsive to a change in plasma GH profiles by either pituitary ablation 
(hypophysectomy) or continuous infusion of GH in male mice, with the latter leading to 
down regulation of many male-specific liver lincRNAs and up regulation of many 
female-specific lincRNAs, as also occurs with many sex-specific protein-coding genes 
(Holloway et al. 2006, Wauthier et al. 2010). Two major classes of sex-specific 
lincRNAs were identified based on responses to hypophysectomy (Table 2-2). Class 1 
sex-specific lincRNAs are positively regulated by the sex-specific GH secretion pattern 




by pituitary hormone ablation. In contrast, class 2 sex-specific lincRNAs are repressed by 
the GH secretion pattern of the sex where they are less highly expressed, and 
consequently, are up regulated by pituitary hormone ablation. These findings suggest that 
the class 1 lincRNAs are regulated by GH-dependent TFs that confer positive regulation, 
e.g. STAT5, while the class 2 lincRNAs are regulated by sex-specific, GH-dependent 
repressors, such as BCL6 and CUX2 (Conforto et al. 2012, Zhang et al. 2012). 
Supporting this, we found that, overall, male-specific lincRNAs are enriched for nearby 
male-biased binding of the pioneer factors FOXA1 and FOXA2 (Friedman and Kaestner 
2006, Zaret and Carroll 2011), which can induce chromatin opening (Sugathan and 
Waxman 2013), and for male-biased binding of the GH-regulated transcriptional 
activators STAT5 (Zhang et al. 2012) and HNF6 (Conforto et al. 2015), which may 
cooperate with FOXA1 and FOXA2 to induce male-specific lincRNA expression. Male-
specific lincRNAs also showed enrichment for female-specific binding of CUX2 
(Conforto et al. 2012), which represses male-biased gene transcription in female liver. 
Female-specific lincRNAs were significantly depleted of nearby male-biased 
transcriptional activator binding events, but were enriched for nearby male-biased 
transcriptional repressor (i.e., BCL6) binding events, which serves as a mechanism to 
suppress female-biased lincRNAs in male liver; and were significantly enriched for 
female-biased binding by STAT5 and FOXA2, which are proposed to activate 
transcription of the associated female-specific lincRNAs. Of note, only 7 of the 171 GH-
regulated sex-specific lincRNAs were expressed in other tissues with high STAT5 




indicating that STAT5 activity alone is not sufficient to drive expression of these genes 
(data not shown). Two of the 7 co-expressed lincRNAs have a nearby (within 10 kb) 
STAT5 binding site in liver (c.f. nearby STAT5 binding for 107 of the 171 GH-regulated, 
sex-specific liver lincRNAs): LiverLincs_chr14_3799 (expressed in mammary gland, 
Tregs and Th2 cells, but not Th1 cells), and LiverLincs_chr6_1886 (expressed in all three 
T cell subtypes). 
 
Chromatin state analysis revealed striking differences between male-specific and female-
specific lincRNAs regarding sex differential enrichment for certain active and repressive 
chromatin states. Whereas the promoter-associated active chromatin state 7 was enriched, 
both at male-specific lincRNAs in male liver and at female-specific lincRNAs in female 
liver, enhancer-associated states 6 and 11 showed significant enrichment only for female-
specific lincRNAs in female liver. State 11, which is marked by H3K4me1 but not by 
H3K27ac or DHS (Fig. 2-6B), may be viewed as an inactive enhancer state (Creyghton et 
al. 2010, Rada-Iglesias et al. 2011). However, as state 6 is characterized by three active 
marks, H3K27ac, H3K4me1, and DHS, and is thus an active enhancer state, its lack of 
enrichment at male-specific lincRNAs suggests that male-specific lincRNA expression 
primarily involves distal male-specific enhancers. We also found that female-specific 
lincRNA TSS regions were enriched in male compared to female liver for three 
H3K27me3-associated states, namely, inactive states 1 and 2, and poised enhancer state 
12. A corresponding enrichment of repressive chromatin states was not found at male-




mechanism to repress female-specific lincRNAs in male liver. This finding is reminiscent 
of the prevalence of H3K27me3 marks at a subset of the most highly female-specific 
genes in male liver (Sugathan and Waxman 2013), and suggests that GH-regulated male-
specific lincRNAs that interact with PRC2, which catalyzes formation of H3K27me3 
marks, may repress female-specific lincRNAs and certain female-specific protein-coding 
genes by a common mechanism.  
 
Relationship between sex-specific lincRNAs, sex-specific chromatin states and 
protein-coding gene expression. The enrichment of sex-specific lincRNAs for nearby 
and correspondingly sex-biased binding by GH-dependent transcriptional activators and 
sex-opposite binding by GH-dependent repressors suggest a role for these TFs in the 
proximal regulation of sex-specific lincRNA transcription, in addition to their crucial 
roles in regulating sex-specific protein-coding gene expression (Ling et al. 2010, 
Conforto et al. 2012, Zhang et al. 2012, Sugathan and Waxman 2013). One such TF, 
STAT5, is a key GH-responsive factor whose deletion in male mouse liver leads to 
widespread disruption of sex-specific gene expression (Clodfelter et al. 2006). Sex-
specific lincRNAs activated by STAT5 (c.f., Fig. 2-5A, Fig. S5, Fig. S6 in (Melia et al. 
2016)) and other GH-dependent TFs may, in turn, act as scaffolds for chromatin 
regulators to establish or maintain sex-specific chromatin states. Such sex-specific 
lincRNAs could thus link two layers of gene regulation, GH-dependent TFs and GH 
regulation of liver chromatin states. The proposal that sex-specific lincRNAs serve as 




TFs that they regulate, in establishing the distinct chromatin states found in male and 
female liver (Sugathan and Waxman 2013) is supported by the unexpectedly long time 
required for some sex-specific liver genes to respond to feminization of circulating GH 
profiles by continuous growth hormone treatment (response times ranging up to a week 
or longer) (Holloway et al. 2006). Moreover, 350 of the 4,961 liver-expressed lincRNAs 
characterized here are reported in mouse embryonic stem cells to bind PRC2, which 
catalyzes the deposition the repressive histone mark H3K27me3 (Zhao et al. 2010), 
further supporting the role of lincRNAs in regulating chromatin states via chromatin-
modifying enzymes (Guttman et al. 2011). Further work will be required to establish the 
functional roles of the sex-specific liver lincRNAs described here and any contributions 
they may make to the regulation of sex-specific liver gene expression. 
 
In conclusion, by using livers collected under diverse biological conditions, we 
characterized gene structures, expression patterns, and species conservation for ~5,000 
liver-expressed lincRNAs, including ~3,000 novel lincRNA genes. Collectively, these 
liver lincRNAs show unexpectedly high promoter conservation and elevated TF binding 
activity in the proximal promoter region compared to protein-coding genes. We focused 
on a population of condition-specific lincRNAs showing significant sex-specific, GH-
regulated expression. By integrating genome-wide chromatin state maps and genome-
wide binding site data for key GH-regulated TFs, we showed that sex-specific liver 
lincRNA expression is tightly correlated with the surrounding chromatin environment 




two rat liver orthologs with matched sex-specificity and responsiveness to sex-dependent 
plasma GH profiles. These findings illustrate how multi-omics data can be integrated to 
elucidate molecular mechanisms underlying condition-specific lincRNA regulation.  
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Table 2-1. Exon and introns of novel lincRNA, RefSeq protein-coding, and RefSeq 
noncoding genes 













lincRNAs 4,961 1.6 1,075 5,255 1,866 
Multi-exonic 1,179 3.4 998** 5,255 3,393* 
Mono-exonic 3,782 1.0 1,381 - 1,390 
Sex-specific 247 2.5 1,226 5,436 3,792 
RefSeq coding  19,951 10.1 294 5,158 2,897 
RefSeq noncoding  3,156 3.7 384 6,169 1,472 
 
Comparisons for multi-exonic lincRNAs: **, p < 1e-15 vs. RefSeq coding RNAs, and 








Table 2-2. Sex-specific mouse liver lincRNAs that respond to hypophysectomy 
(hypox) 
Sex specific 








change| ≥ 2 
Hypox, |fold 
change| ≥ 4 
Adjusted p-value ≤ 0.05 
  Sex-specific lincRNAs (number) 
Male class 1 Down - 65 61 
Male class 1A Down - 46 45 
Male class 1B Down Down 17 15 
Male class 1C Down Up 2 1 
Male class 2 - Up 12 10 
Male class 2A - Up 9 9 
Male class 2B Up Up 3 1 
Female class 1 - Down 44 43 
Female class 1A - Down 33 33 
Female class 1B Down Down 11 10 
Female class 1C Up Down 0 0 
Female class 2 Up - 27 27 
Female class 2A Up - 18 20 











Figure 2-1. Liver-expressed lincRNAs.  
Liver-expressed lincRNAs. (A) Scheme for filtering 7,088 intergenic transcripts to 
remove transcripts with very low expression, small RNAs, and transcripts that resemble 
protein-coding genes. The set of 4,961 liver-expressed lincRNAs was analyzed to flag 
identify small RNAs and pseudogenes, and sequences with ORFs > 150 amino acids, 
giving a set of 4,454 stringent lincRNAs. (B) Protein-coding potentials across 29 
mammals, based on genes that are represented in the multiple-genome alignment of the 
29 mammals. Data shown are based on 3,036 of 4,554 liver-expressed lincRNAs without 
RefSeq annotations (i.e., non-RefSeq lincRNAs, a subset of the 4,961 liver-expressed 
lincRNAs), 2,217 RefSeq ncRNAs, and 6,567 RefSeq coding RNAs. An increasing 
positive score along the X-axis indicates greater similarity of the codon substitution 
pattern to known protein-coding genes. The protein-coding potential filter applied to 
liver-expressed non-RefSeq lincRNAs was more stringent than the one used to identify 
RefSeq ncRNAs. (C) Distribution of RNA expression levels in total vs. nuclear RNA 
fractions for each of the indicated gene sets (19,951 RefSeq protein-coding genes, 1,557 
RefSeq ncRNA genes expressed in at least one liver sample, and 4,554 non-RefSeq 
lincRNAs). Data shown are based on the maximum expression level of each gene across 
RNA-seq datasets whose biological conditions are represented in both total liver RNA 
(n=20 data sets) and nuclear liver RNA (n=20 data sets). The 4,554 lincRNAs show a 
greater difference in expression in nuclear compared to total liver RNA fractions than the 
other two gene sets. P-values are based on student’s t-test. (D) Principal component 
analysis of lincRNA expression per sample based on read counts over exons, based on 
analysis of the 500 most-varying lincRNAs across samples. Each data point represents a 
single RNA-seq dataset. The largest variance across datasets (first principal component, 
~70% of total variance) separates nuclear from total RNA samples, and the fifth principal 
component (~3% of total variance) separates male from female samples. (E) Tissue-
specific expression for the set of 2,171 lincRNA genes expressed in liver at ≥ 1 FPKM 
(also see Fig. S3 in (Melia et al. 2016)). Shown is the number of tissues, other than liver, 
where each lincRNA is expressed at ≥ 1 FPKM. 1,437 of the 2,171 lincRNAs are 
expressed at ≥ 1 FPKM only in liver, and 30 lincRNAs are expressed at ≥ 1 FPKM in all 
22 tissues, of which 23 lincRNAs are known RefSeq noncoding RNAs (Table S2 in 











Figure 2-2. Conservation of lincRNA promoters.  
(A) Per-base conservation analysis of different gene-centric regions of lincRNAs, RefSeq 
coding genes, random background sequences, and control promoter regions (1 kb 
downstream of TSS; see text). The thickness of the background curve represents the 95% 
confidence interval based on 100 random samplings of gene structure-matched and 
length-matched untranscribed intergenic regions, which mimic our lincRNA gene set. 
Curves for protein-coding introns and lincRNA introns overlap. LincRNA promoters 
showed significantly higher conservation than protein-coding promoters (p < 1e-15, 
Kolmogorov-Smirnov). A background set of promoter-associated sequences, using 1 kb 
downstream of the lincRNA TSSs, was used as a benchmark to compare promoters of 
lincRNA genes to those of RefSeq protein-coding genes. (B) Per-base conservation 
analysis of the promoter regions of the most highly expressed (top 33%) liver-specific 
genes (222 lincRNAs, 282 protein-coding genes; Fig. S4A, S4B in (Melia et al. 2016)) 
(top) and multi-tissue expressed genes (289 lincRNAs, 3,619 protein-coding genes; Fig. 
S4A, S4B in (Melia et al. 2016)) (bottom). In both panels, lincRNA promoters showed 
consistent high conservation compared to protein-coding gene promoters (dashed vs. 
solid blue lines); and multi-tissue promoters, for both lincRNAs and protein-coding 
genes, showed greater conservation than the corresponding liver-specific promoters. (C) 
Aggregate plots of mean per-base conservation scores surrounding lincRNA and RefSeq 
protein-coding gene TSS (left) and TES (right). See Fig. S4C-S4E in (Melia et al. 2016) 
for corresponding plots of select, individual lincRNAs. (D) TF occupancy frequency 1 kb 
(left) and 25 kb (right) upstream of sets comprised of 114 FPKM-matched liver-specific 
lincRNA and liver-specific protein-coding genes, whose expression level is >0.52 FPKM 
(see Fig. S4A in (Melia et al. 2016)). The TF occupancy rate at lincRNAs promoters was 
significantly higher (*: p < 0.05, Binomial exact test) than at protein-coding gene 











Figure 2-3. Liver lincRNA species conservation and tissue specificity.  
(A) Heat map showing species conservation of 3,479 species-conserved liver lincRNAs, 
i.e., lincRNAs that have an ortholog in at least one of the 10 species investigated. 
Orthologs were required to span > 10% of the full length, mature mouse lincRNA 
transcript and be > 600 bp in length (see Methods). (B) Heat map displaying tissue 
specificity of 247 sex-specific lincRNAs. The map is based on the summation of the 
expression levels of each lincRNA across the 22 indicated mouse tissues, with the color 
intensity indicating the fraction of expression seen in each tissue. Data shown are based 
on two RNA-seq samples for each tissue. Liver data are also presented as two samples, 
one representing total RNA samples and the nuclear RNA samples (see Methods). 146 
(59%) of the sex-specific lincRNAs have at least 60% of their cumulative expression 
across the tissue panel concentrated in liver (red); 105 (42%) have 80% of their 
cumulative expression concentrated in liver. (C) Subset of the heat map shown in (A), 
where species conservation is displayed for the set of 195 sex-specific liver lincRNAs 
conserved in one or more species. Magnitude of the sex-difference in lincRNA 
expression is as indicated (FC, fold-change, corresponding to the ratio of male and 
female liver expression levels of each lincRNA). In data not shown, 105 (76%) of the 138 












Figure 2-4. GH regulation of sex-specific liver lincRNAs.  
GH regulation of sex-specific liver lincRNAs. (A) Heat map of 247 sex-specific liver 
lincRNAs. The first six heat map columns present the sex-specificity of the lincRNAs in 
four total liver RNA datasets (T1-T4) and in two nuclear RNA datasets (N1, N2), the 
next three columns show the changes in liver lincRNA expression after continuous GH 
treatment of male mice for 1, 4 or 7 days, and the last two columns show the changes in 
expression following hypophysectomy (Hypox, Hx) of male (M) and female (F) mice. 
Color bar specifies the log2 gene expression ratios for the indicated sets of liver RNA 
samples. LincRNA genes marked A (right) are female-biased genes that are up regulated 
following continuous GH treatment, and genes marked B are male-biased genes that are 
down regulated following continuous GH treatment (columns D1, D4, D7). Genes 
marked C are male-biased genes that require the male plasma GH pattern to maintain sex-
specificity (and hence are down regulated in M-Hx livers), and genes marked D are 
female-biased genes that require the female plasma GH pattern to maintain their sex-
specificity (and hence are down regulated in F-Hx livers). (B) MA plot presenting sex 
ratio vs. gene expression level, in FPKM, for 247 sex-specific lincRNAs and for 240 sex-
specific protein-coding genes showing > 4-fold sex-differences. Values are based on the 
maximum FPKM value (x-axis) and the maximum fold-difference between male and 
female samples (y-axis) across the datasets considered in this study. Male-specific 
lincRNAs show a similar range of sex ratios but lower FPKMs than male-specific 
protein-coding genes; whereas, there are many fewer highly female-specific lincRNAs 
than highly female-specific protein-coding genes. (C) Venn diagrams showing overlaps 
between 247 sex-specific lincRNA genes, 411 hypophysectomy-responsive lincRNA 
genes, and 252 continuous GH treatment-responsive lincRNA genes. The thresholds for 
sex-specificity and responsiveness to hypophysectomy were set at ≥ 4-fold and adjusted 
p-value ≤ 0.05 (except as noted in Methods); the threshold for responsiveness to 
continuous GH treatment was set at ≥ 2-fold and adjusted p-value ≤ 0.05. 171 of the 247 
sex-specific genes are responsive to either continuous GH or hypophysectomy (78 + 66 + 
27). Of note, the size of the non-sex-specific gene sets that respond to continuous GH 
treatment or hypophysectomy are sensitive to the choice of significance level cutoff. 
Thus, of the 147 sex-independent lincRNAs that respond to continuous GH treatment 
(109 + 38), 53 (36%) are sex-specific when the threshold for sex-specificity is relaxed, 
from ≥ 4-fold to ≥ 2-fold. Robustness of sex specificity: 75% (129), 57% (97) or 38% 
(65) of the 171 sex-specific, GH-responsive lincRNAs exhibit consistent sex-specificity 
in at least 2, 3 or 4 datasets at fold change ≥ 2 and adjusted p ≤ 0.05. The finding of 267 
(=38 + 229) hypophysectomy-responsive lincRNAs that are sex-independent presumably 
reflects regulation by pituitary-dependent hormones other than GH, a common feature of 
non-sex-specific protein-coding genes (Wauthier et al. 2010). These 267 genes were used 











Figure 2-5. Regulation of select sex-specific liver lincRNAs.  
Regulation of select sex-specific liver lincRNAs. (A) qPCR analysis of individual male-
specific (top) and female- specific (bottom) lincRNAs. Sex-specific expression of the 
male lincRNA is lost when GH pulsatile secretion is abolished, as seen in 
hypophysectomized mice (where GH is ablated) and in somatostatin-knockout mice 
(where the plasma GH pattern is female-like). This lincRNA is also regulated by the GH-
responsive STAT5, as its expression becomes sex-independent in hepatocyte-specific 
STAT5-knockout mice. The female-specific lincRNA shows dependency on the 
continuous secretion of GH: its expression is ablated in hypophysectomized female mice 
and is highly induced in somatostatin-knockout male mice; this lincRNA is not dependent 
on STAT5 for its expression. (B) qPCR analysis of rat liver RNA mapping to rat genomic 
regions (rn4) orthologous to two sex-specific mouse lincRNAs. Data shown are for RNA 
samples isolated from individual rat livers (mean + SD for triplicate reactions), and 
indicate that the rat lincRNA orthologs are expressed in a female-biased manner and are 
inducible to female-like levels in livers of male rats given a continuous infusion of GH 
for 7 days (male + GH). Rat qPCR primers are shown in Table S10 in (Melia et al. 2016). 
(C) Genome browser screenshots for one male-specific (left) and one female-specific 
(right) lincRNA. The gene models track (orange) shows the gene structures for each 
lincRNA, RNA-Seq tracks show the expression level in male (blue) and female (pink) 
liver, chromatin state map tracks show the chromatin state separately in male and female 
liver (see Fig. S6 in (Melia et al. 2016) for color legend), DHS and TF binding tracks 
show open chromatin regions and binding sites that are either male-enriched (blue 
rectangle), female-enriched (pink rectangle) or sex-independent (gray rectangle), and 
chromatin mark tracks show signal intensity for either H3K4me3, H3K27ac and 
H3K4me1 in male (blue) and female (pink) liver. For each sex-specific lincRNA, we 
observed: matched sex-biased binding for activating TFs (STAT5, FOXA1, FOXA2, 
HNF6); sex-opposite binding by the repressors BCL6 and CUX2; and matched sex-












Figure 2-6. Sex-specific TF binding and chromatin states at sex-specific lincRNAs.  
(A) Enrichment and depletion scores of stringent sex-specific lincRNAs as well as a 
control gene set (comprised of 38+229 = 267 hypophysectomy-responsive, sex-
independent lincRNAs; Fig. 2-4C) for nearby (10 kb) sex-biased DHS and six GH-
responsive TFs implicated in sex-specific liver gene expression. *, p < 5e-2; **, p < 5e-4; 
and ***, p < 5e-6. The background used for the enrichment was the set of sex-opposite + 
stringent sex-independent lincRNAs for stringent sex-specific lincRNAs or 
hypophysectomy-unresponsive, sex-independent lincRNAs for the control gene set. (B) 
Emission probabilities across six chromatin marks and DHS for each of 14 chromatin 
states, as reported previously (Sugathan and Waxman 2013). The darker the blue color, 
the greater the emission frequency of the indicated chromatin mark or DHS in a given 
chromatin state. (C) GSEA analysis of chromatin state enriched in either male-specific or 
female-specific lincRNA TSS regions. 4,961 liver lincRNAs are ordered along X-axis by 
male/female expression ratio. Input gene lists are displayed below the X-axis, with each 
vertical mark indicating a lincRNA whose gene body is in the indicated chromatin state 
in male but not female liver (left), or in female but not male liver (right). As an example, 
results at left show that, in male liver, states 4 and 7 are enriched at male-specific 
lincRNA TSS (positive NES values), and states 1, 2 and 12 are enriched at females-
specific lincRNA TSS (negative NES values). See Fig. S7 in (Melia et al. 2016) for 










Chapter 3 Genetic factors increase the variability of sex-specific gene patterns in 
Diversity Outbred mouse liver 
 
3.A Abstract 
The mammalian liver transcriptome features widespread sex differences affecting ~1,000 
genes, many of which are implicated in sex differences in drug and lipid metabolism, as 
well as disease susceptibility. Growth hormone (GH) is a major regulator of sex-biased 
gene expression through its sex-differential activation of various transcriptional 
regulators. Genetic polymorphisms have been shown to impact the transcriptional 
regulation of select sex-biased genes. Global assessment of the impact of genetic factors 
on sex-biased gene expression, however, is lacking, Here, we show that genetic factors, 
working in tandem with GH, have widespread effects on individual variability in sex-
biased gene expression in livers of Diversity Outbred (DO) mice, an outbred population 
derived from 8 founder strains. Significant associations between single nucleotide 
polymorphisms (SNPs) and gene expression (eQTLs) were identified, a subset of which 
correlated with sex-biased genes and showed stronger association in one sex, as 
compared to the other. Sex-biased gene expression was highly variable between DO 
founder strains. Remarkably, 46% of the cases of gain or loss of sex-specific gene 
expression in individual founder strains can be explained by genetic modifiers identified 
by eQTLs. eQTLs with strong sex-biased associations are enriched for genetic modifiers 
identified for highly sex-specific genes with matching sex-specificity. eQTL regions for 




(DHS) and binding sites for the transcriptional activator STAT5. Sex-biased binding of 
the transcriptional repressor BCL6 was enriched at both cis and trans eQTL regions for 
female-specific genes in male liver. A subset of co-regulated gene clusters identified 
based on overlapping eQTLs encompassed highly correlated genes from different 
chromosomes. Thus, genetic factors are pervasive in regulating sex-biased genes in liver, 
which has important consequences to discern individual variability of liver phenotype 
and disease outcome. 
 
3.B Introduction 
Sex differences in mammalian gene expression are not limited to reproductive tissues, but 
also occur somatic tissues (Rinn and Snyder 2005), notably the liver, as seen in mouse 
(Clodfelter et al. 2007, Renaud et al. 2011, Conforto and Waxman 2012), rat (Wauthier 
and Waxman 2008) and human (Tanaka 1999, Zhang et al. 2011). ~1,000 genes are 
differentially expressed between male and female mouse liver (Conforto and Waxman 
2012), imparting sex differences in various liver functions, such as metabolism of drugs 
(Anthony and Berg 2002, Guengerich 2006, Zanger and Schwab 2013), other xenobiotics 
(Klaassen and Aleksunes 2010, Liu et al. 2013), and fatty acids (Wang et al. 2011), as 
well as disease susceptibility (Lu et al. 2009, Tessari et al. 2009, Baik et al. 2011, Zhang 
et al. 2011). Sex differences in the liver transcriptome are widespread and characterize 
both protein-coding transcripts (Conforto and Waxman 2012) and long noncoding RNAs 
(lncRNA) (Melia et al. 2016). Growth hormone (GH), secreted by the pituitary gland, has 




Jaffe et al. 2002, Waxman and O'Connor 2006) via its sex-dependent pattern of pituitary 
secretion: pulsatile in males and nearly continuous in females (Veldhuis et al. 2001, 
Veldhuis and Bowers 2003). The resultant sex differences in plasma GH profiles lead to 
the sex-differential activation of the JAK2/STAT5 signaling pathway. GH-activated 
STAT5, in turn, works with other GH-dependent TFs to propagate sex-differences in 
liver transcription through sex-biased binding to liver chromatin (Laz et al. 2007, 
Conforto et al. 2012, Zhang et al. 2012, Conforto et al. 2015). Sex differences are also 
evident in the liver epigenome, which includes sex differences in open chromatin regions 
(DNase I hypersensitive site; DHS) (Ling et al. 2010), chromatin marks (Sugathan and 
Waxman 2013), and DNA methylation (Reizel et al. 2015), all of which are tightly linked 
to the transcription of sex-specific genes.  
 
Genetic modifiers can contribute to the regulation of sex-biased genes (Krebs et al. 2003, 
Krebs et al. 2005, Krebs et al. 2009, Krebs et al. 2012). In one well studied example, 
male-biased expression of Cyp2d9 is abolished by a SNP in a 5’ flanking regulatory 
region (Sueyoshi et al. 1995). In a second example, Regulator of Sex-Limitation (Rsl) 
gene was shown to repress several sex-specific genes, and was associated with activation 
and repression of other sex-specific genes via indirect mechanisms (Krebs et al. 2009, 
Krebs et al. 2012). Genetic polymorphisms contribute to individual differences in several 
drug-metabolizing enzymes (Hines et al. 2008), many of which are encoded by sex-
specific genes (Mugford and Kedderis 1998, Waxman and Holloway 2009). Genome-




expression have identified many expression quantitative trait loci (eQTLs) for liver-
expressed genes (Gatti et al. 2007, Gatti et al. 2010, Chick et al. 2016, Gatti et al. 2017, 
Tyler et al. 2017). None of these studies, however, assessed the impact of eQTLs on the 
individual variability of sex-biased gene expression. A global assessment of the extent to 
which genetic factors alter sex-biased gene expression is still lacking. Understanding the 
source of variability in sex-biased gene expression in liver has far-reaching implications, 
as sex-biased genes contribute to liver diseases with known sex-differential susceptibility, 
including hepatocellular carcinoma (Ruggieri et al. 2010, Baik et al. 2011), polygenic 
dyslipidemia (Bittner 2006) and coronary artery disease (Zhang et al. 2011).  
 
To ascertain the global impact of genetic regulation on sex-specific gene expression, we 
utilized the Diversity Outbred (DO) mouse model (Churchill et al. 2012, Schmidt 2015), 
an outbred population derived from eight inbred mouse strains. DO mice have high 
natural allelic variance (Svenson et al. 2012, Chesler et al. 2016) and diverse phenotypes 
(Bogue et al. 2015, Odet et al. 2015), which may lead to finer genetic mappings for liver-
specific traits. Further, genome sequences from all DO founder strains are available 
(Keane et al. 2011), allowing genotypes in the DO mouse to be traced back to select 
founder strains. Using the DO mouse model, we find unexpectedly high rates of gain and 
loss of sex-specific gene expression across DO founder strains. ~13,000 autosomal 
eQTLs – many novel and including eQTLs for long noncoding RNAs (lncRNAs) – were 
identified in DO mouse liver. A subset of these eQTLs show sex-bias genetic 




DO founder mice. Sex-specific binding of GH-regulated TFs and sex-specific open 
chromatin regions (DHS) were shown to be enriched at eQTL regions identified for genes 
with the expected sex-specificity. Finally, co-regulated genes were identified on the basis 
of overlapping eQTLs, a subset of which contain highly correlated genes from different 
chromosomes. These findings establish the pervasive role of genetic regulation in 
increasing the variability of sex-specific gene expression across DO founder strains. 
Understanding the source and extent of this variability has important implications for our 
understanding of individual variability as it relates to sex-differences in liver disease and 
function.  
 
3.C Materials and methods 
DO mouse liver samples and analyses. Liver RNA sequencing expression data and 
genotyping data based on SNP arrays was downloaded from GEO for 438 individual DO 
mice using accession numbers GSE45684 (Munger et al. 2014, Gu et al. 2016) and 
GSE72759 (Chick et al. 2016). These datasets are derived from 219 male and 219 female 
DO mice, which were further divided into tissues from mice fed a high fat diet (107 
males and 109 females) or a standard chow diet (112 males and 110 females). 264 DO 
samples were genotyped at 7,854 SNPs using the Mouse Universal Genotyping Array 
(MUGA) (Consortium 2012) and 174 were genotyped using a higher density array, 
MegaMUGA (Morgan et al. 2015), encompassing 77,725 SNP probes. Haplotype 
reconstruction. I used quantile normalization, implemented in DOQTL (Gatti et al. 




further used DOQTL to calculate from the normalized microarray intensity values at each 
SNP probe the founder strain that the SNP is most likely inherited from, i.e. the founder 
haplotype. Two founder haplotypes, referred to as founder diplotype, are possible at each 
SNP locus. Thus, there are 36 possible founder diplotypes for a population generated 
from 8 founder strains: 8 homozygous diplotypes and 28 heterozygous diplotypes. 
Briefly, DOQTL uses the intensity of each SNP probe to generate a probabilistic estimate 
for each diplotype state at each SNP in each DO mouse using a hidden Markov model 
(HMM), where the hidden states are the diplotype states. DOQTL assigned each SNP 
locus to the diplotype state with the highest posterior probability. Individual mouse 
genome reconstruction. I used Seqnature (Munger et al. 2014) to construct an individual 
diploid genome for each DO mouse using founder haplotypes that were inferred at the 
previous step. Recombination boundaries are simply the midpoint between neighboring 
SNPs that were assigned to different founder diplotypes. For each recombination block, 
Seqnature recapitulates the founder genome of interest by incorporating high quality 
SNPs and small indels (<100 bases) that were found in that particular genome, 
downloaded as a vcf file from the Sanger Mouse Genome project (release 1211, (Keane 
et al. 2011)). RNA-Seq read mapping. I mapped RNA-Seq reads from each individual 
DO mouse liver sample to its diploid genome, containing both paternal and maternal 
allele sequences, using Tophat2 (Langmead et al. 2009, Kim et al. 2013) with default 





Other mouse liver RNA-Seq samples and data analyses. I downloaded three publicly 
available liver gene expression datasets for the eight DO mouse founder strains: 1) a 
microarray dataset comprised of 96 samples, six replicates/sex/strain, assayed on the 
Illumina Sentrix Mouse-6 V1.1 platform (http://cgd.jax.org/gem/strainsurvey26/v1); 2) 
an RNA-Seq dataset with 128 male liver samples, six replicates/strain/diet, where the two 
options for diet are standard chow and high fat diet (GEO accession GSE45684) (Munger 
et al. 2014, Gu et al. 2016); and 3) an RNA-Seq dataset with 12 male and 12 female 
C57Bl/6J mouse livers (GEO accession GSE59222) (Lowe et al. 2015). All of the RNA-
Seq datasets were mapped to the genome that matched their respective strain generated 
by Seqnature, based on SNPs/indels retrieved from the Sanger Mouse Genome project 
(release 1211) (Keane et al. 2011), using Tophat2 with default parameters. A published 
mouse liver RNA-Seq dataset from the CD-1 mouse strain, consisting of three pools of 
male and three pools female liver samples, was downloaded from GEO accession 
GSE98586 (Lau-Corona et al. 2017). These samples were mapped to the reference 
genome using Tophat2 with default parameters (Fig. S3-1).  
 
Expression quantification. Gene expression was quantified by counting sequence reads 
that overlap any exon by at least one bp using featureCounts (Liao et al. 2014). For RNA-
Seq datasets that were mapped to a haploid genome, e.g. the C57Bl/6J reference mouse 
genome and any of the eight DO mouse founder strains, only unique reads were used, 
whereas for datasets that were mapped to a diploid genome, e.g. individual DO mouse 




unique reads for diploid genomes would limit the read counts to only include those reads 
that mapped to genomic locations where the paternal and maternal allele differ, and thus 
could substantially underestimate expression of any given gene. Further, the gene 
expression level obtained for diploid genomes is based on the total number of reads that 
overlap the counted regions in either the paternal or maternal allele. Reads counts were 
then transformed to fragments per kilobase of exon per million reads mapped (FPKM) for 
downstream analysis. For FPKM calculation on diploid genomes, exon lengths are based 
on the average length of exons from the two alleles of each gene. 
 
Sex-specificity of gene expression. I used three liver expression datasets, described 
above, to establish the sex-specificity of protein-coding genes: 1) RNA-Seq dataset of 
male and female CD1 mouse livers, 2) RNA-Seq dataset of male and female C57Bl/6J 
mouse livers, and 3) Illumina Sentrix Mouse-6 V1.1 expression microarray dataset of 
male and female livers from the eight DO mouse founder strains. I used edgeR (Robinson 
et al. 2010) to perform differential analysis for the two RNA-Seq datasets; and limma 
(Smyth 2004) was used for the microarray dataset with default parameters. For genes 
with multiple microarray probes, we chose the probe with the smallest adjusted p-value. 
A total of 1,033 protein-coding genes showed a male/female gene expression |fold-
change| > 2 at FDR < 0.05 for any RNA-Seq dataset or |fold-change| > 1.5 at FDR < 0.05 
for the microarray dataset, and were designated sex-specific (Table S3-1). 168 multi-
exonic, intergenic liver-expressed lncRNAs were designated sex-specific, as described in 





Gene expression variability across DO founder strains. Inter-strain gene expression 
variability across the 8 DO mouse founder strains was quantified for each gene using 
RNA-seq data for 8 male livers per strain, as follows: [standard deviation of (mean gene 
expression value for each of the 8 strains)] / [average of (the mean gene expression value 
for each of the 8 strains)]. Intra-strain gene expression variability was quantified for each 
gene in each strain as follows: [standard deviation of (gene expression for n = 8 male 
livers in strain s)] / [mean of (gene expression value for n = 8 male livers in strain s)]). 
 
eQTL mapping. eQTL analysis was carried using liver gene expression data from 438 
DO mice, comprising 219 male and 219 female mice that were either fed a high fat or 
standard chow diet (Fig. S3-1).  We used the additive haplotype model in DOQTL (Gatti 
et al. 2014) to perform QTL mapping by regressing each gene’s expression level on the 
estimates of each of the eight founder strain’s contribution, i.e., founder diplotype 
probability, at each SNP marker. Adjustments to account for relatedness amongst DO 
mice, batch, sex, diet, and interaction between sex and diet were included in the 
regression as additive covariates, written as the following in R: model.matrix(~sex + diet 
+ diet*sex + generation + batch, data = data). The strength of the association between 
gene expression and genotype is given as a likelihood ratio (LOD), which is the -log10(p-
value) when comparing the full model to the null model, where the latter model excludes 
diplotype probabilities. QTL mapping also gives eight regression coefficients, whose 




regression coefficient indicates the genetic variant is associated with high expression of 
the gene of interest, whereas a negative regression coefficient indicates the genetic 
variant is associated with low expression of the gene of interest. The DO founder strain 
with the largest gene expression alteration by genetic factors identified in each eQTL, as 
indicated by the largest absolute value of the regression coefficients, is designated as ‘the 
regulating strain’. A Bayesian credible interval, defined as 95% of the region under the 
LOD^10 curve, as implemented in DOQTL (Gatti et al. 2014), was defined for each 
eQTL; this interval delineates the genomic location where the highest association occurs, 
as defined by the uppermost 5% area under the peak of the LOD score curve. 
Significance level. A genome-wide p-value for each association was determined by 
doing 1,000 permutations on the gene expression data. To assemble a list of associations 
between gene expression and SNPs, I recorded the SNP with the highest LOD score for 
each gene; subsequent high-scoring SNPs were only retained if their p-value < 0.05 and if 
they are on a different chromosome than the SNP with the highest LOD score. An FDR 
correction was then applied to the genome-wide p-values. Any eQTL with FDR < 0.05 
was deemed significant. To identify genetic variants whose association with gene 
expression was only found in one sex, we repeated the eQTL mapping analysis twice 
more, once using only male DO liver samples, and a second time using only female DO 
liver samples. Gene expression pre-processing. Gene expression levels in FPKM were 
transformed into normal scores using the inverse normal transformation in DOQTL (Gatti 
et al. 2014) before they were used for eQTL mapping. eQTL mapping was carried out for 




in at least one liver sample, namely: 20,559 (18,543 protein-coding and 2,016 lncRNA 
genes), 20,268 (18,275 protein-coding and 1,993 lncRNA genes), and 20,190 (18,207 
protein-coding and 1,983 lncRNA genes) genes when analyzing all DO livers, male only 
DO livers, and female only DO livers, respectively. Interpolating missing genotype 
information. To preserve the extra information that the higher density SNP array 
provides, I performed QTL mapping on 64,713 SNPs markers (Table S3-2), which 
corresponds to the union of SNP markers from the two genotyping arrays used, after 
removing SNP probes with no differentiating information across the eight strains 
(Morgan et al. 2015). For SNP probes that were unique to one type of array, diplotype 
probabilities were assigned from the nearest measured SNP. All of the SNP probes that 
were analyzed are located in autosomes or on the X chromosome.   
 
Sex-biasedness of genetic association. Sex-biased genetic associations for eQTLs that 
are significant in either male liver or female liver samples, are defined by LOD score 
calculated using male only DO liver samples - LOD score calculated using female only 
DO liver samples. 
 
Cis/trans eQTLs. An eQTL was designated cis if the TAD where the gene is located 
overlaps at least one bp with the 95% Bayesian credible interval, which was defined 
based on the interval from the liver sample set (i.e. all livers, male only livers, or female 




its TSS occurs. TAD coordinates for mouse liver were based on (Matthews and Waxman 
2017). 
 
eQTL overlap. An eQTL overlaps a published eQTL if the gene name or RefSeq 
accession number matches, and if the associated variant/ associated region overlaps at 
least one bp the 95% Bayesian credible interval identified in this study for each eQTL. 
We used liftOver (Rosenbloom et al. 2015) to convert genomic regions into mm9 
coordinates using default parameters. bioDBnet:db2db (Mudunuri et al. 2009) was used 
to convert Ensembl gene identifiers to RefSeq accession numbers, where applicable.  
 
Liver gene expression variation for sex-specific genes. Liver expression variation for 
sex-specific genes were quantified across 112 male DO mice, and separately across 110 
female DO mice fed on a standard chow diet using the var function in R. 
 
Co-regulated gene cluster. Each eQTL region is centered at the SNP marker with the 
highest LOD score, i.e. the eQTL peak, boundaries are the 2nd SNP marker from the 
center. Overlapping eQTL regions by at least one bp with a common regulating strain are 
assigned as co-regulated clusters. Co-regulated gene clusters were identified based on 
eQTLs discovered in all DO liver samples, and separately male only DO liver samples, 
and female only DO liver samples. This analysis was based on eQTLs that were 




relevant liver samples sets, i.e., all DO livers, male only DO livers or female only DO 
livers.  
 
Gene expression correlation. A batch effect that correlated with the GEO accession of 
the samples was removed from the gene expression level (in units of log2(FPKM+1)) 
using the ComBat function in the sva R package (Leek et al. 2012) with default 
parameters. The Pearson correlation was then used to calculate pairwise gene expression 
correlations.  
 
TF binding sites and DHS with strain-specific SNPs/indels at eQTL regions. High 
quality SNPs/indels in the 8 DO mouse founder strains were downloaded from the Sanger 
Mouse Genome project (release 1211) (Keane et al. 2011). SNPs/indels that occur in only 
one founder strain were designated as strain-specific variants using a custom R-script 
provided in Supplemental file 1 (available upon request to djw@bu.edu). TF binding sites 
and DHS that are within each eQTL region (95% Bayesian Credible interval, defined 
based on the liver sample set that gives the highest LOD score), and that contain strain-
specific SNPs/indels for the matching regulating strain, were selected for further analysis. 
For analysis depicted in Fig. 3-4, the following eQTL designations were used: eQTLs 
identified for genes with |male/female| > 4 were designated sex-specific (i.e., an eQTL 
for a sex-specific gene), and eQTLs identified for genes with |male/female| < 1.2 were 
designated sex-independent. Male/female expression ratios were determined by edgeR. 




that contains the gene it is associated with were designated trans. The number of eQTLs 
analyzed for the analysis of DHS and TF binding sites varied between 17 and 2,793, and 
is specified for each analysis in the x-axis labels of Fig. 3-4. For each eQTL region, we 
counted the fraction of DHS or TF binding sites that are male-specific, female-specific or 
sex-independent, as defined by their original studies, except for the set of ~72,000 liver 
DHS from (Sugathan and Waxman 2013) of which 4,644 DHS were designated male-
specific and 2,814 were designated female-specific (Ling et al. 2010, Zhang et al. 2012, 
Conforto et al. 2015). 
 
 
Principal component analysis (PCA). PCA was done using the prcomp function in R 
using log2, centered normalized microarray intensity values. 
 
DAVID enrichment. DAVID functional annotation tool (https://david.ncifcrf.gov/) 
(Huang da et al. 2009, Huang da et al. 2009) was used to discover enriched KEGG 
pathways by providing the official gene symbol, i.e. gene name, of sex-specific protein-
coding genes discovered in each strain. Pathways with adjusted P (Benjamini) < 0.05 
were deemed significant. 
 
3.D Results 
Sex-specific gene expression patterns show high variability among DO mouse 




expression in mouse liver in one or more of the nine strains examined (418 male-biased 
genes and 615 female-biased genes) (male/female expression |fold-change| >1.5 based on 
microarray analysis; or male/female expression |fold-change| >2 based on RNA-seq, both 
at FDR < 0.05) (Table S3-1). These strains include CD-1 mice, used in our earlier studies 
of sex-biased liver gene expression (Lau-Corona et al. 2017), and the eight founder 
strains used to establish the DO mouse population (A/J, C57BL/6J, 129S1/SvlmJ, 
NOD/ShiLtJ, NZO/HILtJ, CAST/EiJ, PWK/PhJ WSB/EiJ) (Churchill et al. 2012, 
Svenson et al. 2012). To further delineate differences in sex-biased gene expression 
across DO founder mice, I examined the subset of 471 sex-biased liver protein-coding 
genes that were identified using expression data obtained from the same microarray 
platform for each of the eight founder strains. Sex-biased gene expression was highly 
variable across DO founder strains, and was lost for 451 out of 471 (95%) of liver 
protein-coding genes in one or more of the eight founder strains. High variability of gene 
expression was also seen for the 74 most highly sex-biased protein-coding genes 
(male/female expression |fold-change| > 4 at FDR < 0.05 in at least one founder strain), 
where 58 of the genes (78%) did not show sex-specific expression in at least one founder 
strain (see Fig. S3-2 for examples of variable sex-specificity across DO founder strains). 
220 of the 471genes showed sex-biased expression in at least 2 of the 8 strains. Only 20 
genes showed sex-biased expression in all 8 founder strains (Table S3-1). Heat maps 
confirmed the high variability of sex-specific liver gene expression across DO founder 
mice (Fig. 3-1A), and further, indicated that a subset of genes that showed sex-biased 




multiple strains. The heat map also revealed that the genes that are sex-specific in most, 
or in all, founder strains tend to be the most sex-biased (P < 2.7e-4, Student’s t-test). 
Further, analysis of the 220 sex-specific genes with the highest ratio in male liver for 
[gene expression variability across DO founder strains] / [gene expression variability 
within strains], revealed prominent patterns of expression that are highly selective for 
each strain, further confirming the striking variability of sex-biased gene expression in 
DO founder strain livers (Fig. 3-1B).  
 
The number of sex-specific genes identified in each founder strain ranged from 77 genes 
(strain A/J) to 183 genes (strain PWK/PhJ; Fig. 3-1C, Table S3-1), highlighting the 
possibility of strain-specific differences in the regulation of sex-specific genes. A similar 
pattern was seen for the number of highly sex-specific genes (male/female |fold-change| 
> 4; Fig. S3-3A) across strains, where A/J and CAST/EiJ mice have the lowest number of 
sex-specific genes. To identify similarities between sex-specific genes identified in each 
founder strain, I performed PCA based on gene expression levels (Fig. 3-1D). The largest 
variance (PC1 in Fig. 3-1D) corresponds to the sex of each liver, as expected, whereas the 
second principal component clustered male, and separately, female samples based on 
their evolutionary distance (PC2 in Fig. 3-1D; Fig. S3-3B) (Threadgill et al. 2011). The 
six Mus musculus domesticus subspecies strains are closer together, as compared to the 
other subspecies strains, i.e. Mus musculus castaneus (strain CAST/EiJ) and Mus 




strains, the lone, wild-derived WSB/EiJ strain is separated from the other five strains, 
recapitulating the published phylogenetic tree (Fig. S3-3B) (Threadgill et al. 2011).  
 
Next, I investigated if the sex-specific protein genes identified in each strain are enriched 
for different pathways. DAVID analysis (Huang da et al. 2009, Huang da et al. 2009) 
identified 16 KEGG pathways that are enriched (adjusted P < 0.05) in at least one of the 
eight sets of sex-specific genes (Fig. 3-1E). The enriched pathways are broadly divided 
into two categories (see dendrogram along y-axis, Fig. 3-1E): the first 10 pathways listed 
are enriched in select strains, while the last 6 pathways listed are significantly enriched in 
nearly all strains. Many of the pathways enriched in select strains have lower 
significance. Exceptions include pyruvate metabolism, which is uniquely linked to 
WSB/EiJ livers; and biosynthesis of unsaturated fatty acids and metabolism of 
xenobiotics by cytochrome P450, which are most strongly associated with PWK/PhJ 
livers. 
 
I further explored if the variability of sex-specific gene expression patterns across DO 
founder strains affects the major pathway of GH-dependent gene regulation, as indicated 
by the response to hypophysectomy (Hypox). Hypox involves surgical removal of the 
pituitary gland, which ablates secretion of GH, as well as secretion of all other pituitary-
dependent hormones. Two distinct classes of sex-specific liver-expressed genes have 
been identified based on their responses to Hypox. Class 1 sex-specific genes are 




are more highly expressed, whereas class 2 sex-specific genes are repressed in the liver 
by the GH secretion profile of the sex where they are less highly expressed. 
Consequently, following Hypox, class 1 genes are down regulated in the sex where they 
show higher expression, whereas class 2 genes are up regulated (de-repressed) in the sex 
where they show lower expression. Using published lists of the four Hypox response 
classes of genes (male-specific class 1 and 2 genes, and female-specific class 1 and 2 
genes (Table S3 of (Connerney et al. 2017)), we examined the distribution of each sex-
biased gene class in each DO founder mouse strain. No noticeable difference was seen in 
the proportion of sex-biased genes in each of the four GH-responsive gene sets, as 
compared to the distribution reported for CD-1 mice (Fig. 3-1F; first bar on the left). 
Thus, the major GH-dependent regulatory mechanisms for liver sex-biased gene 
expression captured by the class 1/class 2 classification is largely preserved across DO 
founder strains, despite variability in the expression of many individual sex-specific 
genes.  
 
Genetic regulation of liver-expressed genes. I analyzed 438 DO mouse liver samples 
(Munger et al. 2014, Chick et al. 2016, Gu et al. 2016) to identify SNPs that are 
significantly associated with the gene expression patterns of all liver-expressed genes 
(eQTLs). Genome-wide eQTL analysis was performed across all liver samples, and 
separately, across all male livers (n=219) and across all female livers (n=219). I thus 
identified 10,325 significant autosomal eQTLs associated with protein-coding and 




male livers only, and 8,233 autosomal eQTLs when considering female livers only (Table 
3-1). These eQTLs can be merged into a set of 12,886 autosomal eQTLs (Fig. 3-2A). An 
additional 4,392 eQTLs were found on the X chromosome (Table S3-3B), resulting in 
17,278 eQTLs identified genome-wide (Table S3-3A). 82% of the all liver, 65% of the 
male liver only, and 95% of the female liver only eQTLs are associated with autosomes 
(Table S3-4A). 51% of the autosomal eQTLs identified here confirm previously 
published eQTLs in mouse liver (Gatti et al. 2010, Munger et al. 2014, Chick et al. 2016, 
Gatti et al. 2017, Tyler et al. 2017); the other 49% of eQTLs are novel (6,344 out of 
12,886) and includemany novel autosomal eQTLs for liver-expressed lncRNAs (Melia et 
al. 2016). More eQTLs were identified in female liver than in male liver for both protein-
coding genes and lncRNA genes (Table 3-1), suggesting genetic regulation is more 
prevalent in female liver. A similar observation was reported in BXD mouse liver (Gatti 
et al. 2010). 66% of autosomal eQTLs that are within the same TAD (Matthews and 
Waxman 2017) as the genes they are associated with, indicating proximal genetic 
regulations dominates the eQTLs (cis regulation; Table 3-1).   
 
For each eQTL, the strain whose SNP is most likely responsible for the genetic 
association captured by the eQTL (‘the regulating strain’), was determined by identifying 
the founder strain with the largest regression coefficient, in absolute value, at the SNP 
marker where the strongest association occurs, i.e. the SNP marker with the highest LOD 
score. 60% (6,158 of 10,325) of autosomal eQTLs discovered when considering all DO 




2B). These strains have the largest number of SNPs and indels (Svenson et al. 2012) and 
are the most evolutionary diverged, as compared to the other founder strains (Fig. S3-3). 
The WSB/EiJ strain follows with 10% all of autosomal eQTLs, and the other five founder 
strains are each associated with ~6% of autosomal eQTLs. This observation indicates that 
the gene expression pattern is altered as genetic variants accumulate during evolution. A 
majority of the autosomal eQTLs (54-67%) are associated with up regulation of gene 
expression in the regulating strain (Fig. S3-4). Some eQTLs have contributions from 
multiple regulating strains, i.e., the genetic variant of interest is associated with changes 
in gene expression in multiple strains. 35.8% (3,706 of 10,325) of autosomal eQTLs 
discovered using all DO liver samples have at least one other founder strain whose 
regression coefficient is within 20% of the identified regulating strain, indicating at least 
two strains make substantial contributions to the change in expression pattern (Table S3-
4A).  
 
1,308 genes are associated with multiple eQTLs (2,779 eQTLs; Table S3-4), suggesting 
these genes are subject to multiple, distinct forms of regulation. One example is the 
female-specific Sult3a1 gene, which is associated with an eQTL on chromosome 10 that 
is highly significant in male DO livers, but is not detected in female livers, and with a 
second, distinct eQTL, on chromosome 9, that is uniquely identified in female livers (Fig. 
3-2C). CAST/EiJ is the regulating strain for the eQTL on chromosome 10, and is 
associated with elevated expression of Sult3a1 in male liver (Fig. 3-2D, left; Fig. 3-2E, 




associated with a distinct regulatory mechanism, leading to decreased expression of 
Sult3a1 in female liver (Fig. 3-2D, right; Fig. 3-2E, left). Both eQTLs reduce the sex 
difference in Sult3a1 expression in their respective regulating founder strains (Fig. 3-2E, 
arrows), but by different mechanisms. 
 
Genetic regulation of sex-specific genes. 987 of the liver autosomal eQTLs are 
associated with one of the 1,033 sex-specific protein-coding genes or the 168 sex-specific 
lncRNA genes (Fig. 3-3A, Table 3-1). Most of the eQTLs associated with sex-specific 
genes were discovered when all DO liver samples were included in the analysis, but 66 
and 71 eQTLs, respectively, were discovered only when male livers or only when female 
livers were used. Further, many of the eQTLs discovered using both sets of DO livers 
showed a stronger genetic association in one sex, as compared to the other (Table S3-4B). 
This trend is evident when LOD scores determined using male DO livers are compared to 
female DO liver LOD scores for the set of strongly sex-specific genes (Male/Female 
|fold-change| > 4) (Fig. 3-3B). eQTLs that are stronger in male DO livers are biased to be 
associated with strongly male-specific genes, and eQTLs whose association is stronger in 
female liver tend to be associated with strongly female-specific genes (Fig. 3-3B). 
Further, eQTLs with the greatest LOD score differences in male vs female liver (top 
10%; 1,060 of 10,597 eQTLs; 172 of 1,060 eQTLs are identified for sex-specific genes; 
Fig. 3-2) are enriched 5.1-fold for being associated with genes with matched-sex-
specificity, as compared to genes with the opposite sex-specificity (P-value < 6.5e-07, 




(Table S3-4C), indicating that the expression of these genes are less variable, as 
compared to sex-specific genes with eQTLs, across male DO (P < 0.0016, Student’s t-
test) and female DO (P < 0.011, Student’s t-test) mice. The average gene expression level 
for these two gene sets are similar (P> 0.4 in both sexes, Student’s t-test). Pathway 
enrichment on this gene set showed an enrichment for the PPAR signaling. 
 
Next, I examined whether eQTLs with a sex-bias in genetic association may explain the 
variability in sex-specific gene expression across DO founder strains. I considered four 
conditions where an eQTL may result in the loss of sex specific gene expression (Fig. 3-
3C) and four conditions where an eQTL may enhance sex-specificity (Fig. 3-3D). These 
analyses are based on 360 eQTLs (Table S3-5) that are significant in either male or 
female liver samples, which were examined for correlations with any of the 471 sex-
specific protein-coding genes for which we have complete gene expression data in male 
and female livers for the eight DO founder strains. Overall, these 360 eQTLs are 
associated with 68% (322 of 471) sex-specific protein-coding genes. 172 of these eQTLs 
have characteristics that fit the first four conditions, i.e., they are associated with the loss 
of sex-specificity in the regulating founder strain (categories 1-4) and 188 eQTLs fit the 
second four conditions, i.e., they are associated with a gain in sex-specificity in the 
regulating strain (categories 5-8) (Fig. 3-3C, Fig. 3-3D; examples in Fig. S3-6). 
Remarkably, for 134 of the 172 category 1-4 eQTLs (78%), sex-specificity of gene 
expression is lost in the respective regulating strain, but is retained in at least one non-




from 53.1% (category 2 eQTLs) to 91.7% (category 1 eQTLs). Presumably the impact of 
many category 2 eQTLs is not strong enough to cause a loss of sex-specificity. In the 
case of the 188 eQTLs in categories 5-8, where an eQTL may increase the sex-specificity 
of gene expression, only 47% of eQTLs (85 of 188, with up to 60.8% in category 5) are 
associated with genes that are sex-specific in the matching regulating strain, suggesting 
there may be another layer of gene regulation, or these analyses may be limited by the 
dynamic range of our microarrays and hence their ability to detect sex-specificity. 
Overall, 60.8% of the 360 eQTLs that we examined (219 eQTLs associated with 205 
genes; Table S3-6) were associated either with the loss or gain of sex-specificity of sex-
biased genes in their matching regulating strains, highlighting the extensive role of 
genetic regulation in increasing the variability of sex-specific gene expression across DO 
founder mouse strains. 
 
Genomic regions identified in an eQTL region may regulate sex-specific gene expression 
in the contributing founder strain through strain-specific genetic variants at sex-specific 
regulatory (e.g., enhancer) regions. These regulatory regions include DNase I 
hypersensitive sites (DHS) that are sex-biased in mouse liver, i.e., are significantly more 
open in one sex, as compared to the other, and sex-biased binding sites for key GH-
regulated liver TFs (Ling et al. 2010, Zhang et al. 2012, Conforto et al. 2015). Strain-
specific genetic variants at these sites may alter or abolish GH-regulated TF binding 
activity and, perhaps alter chromatin accessibility (DHS) thereby dysregulate the 




DHS and sex-biased TF binding sites within eQTL regions (i.e. the 95% Bayesian 
credible intervals) and that contain SNPs/indels specific to the identified regulating strain 
(Table S3-4). Only eQTL regions that are < 3MB in width (8,254 of all 12,886 autosomal 
eQTLs; 64%) were used in this analysis. Sex-biased DHS were enriched at eQTL regions 
associated with genes with matching sex-specificity, as compared to eQTLs associated 
for genes expressed with the opposite sex-bias or genes with no sex-specificity (Fig. 3-4; 
top left, first and second panel). The majority of DHS found in any eQTL region, both for 
sex-biased and sex-independent genes, are sex-independent DHS; these DHS showed a 
significant enrichment to be at eQTLs for sex-independent genes, as compared to sex-
specific genes (Fig. 3-4; top left, third panel). A similar pattern of enrichment was found 
for sex-biased STAT5 binding sites (Fig. 3-4, top right). In contrast, male-biased binding 
sites for the transcriptional repressor BCL6, which preferentially represses female-
specific genes in male liver (Meyer et al. 2009, Zhang et al. 2012), showed significant 
enrichment at eQTL regions for female-specific genes, as compared to male-specific or 
sex-independent genes. Moreover, sex-independent BCL6 binding sites were 
significantly depleted at eQTL regions associated with female-specific genes (Fig. 3-4, 
bottom). Further, BCL6 binding sites showed an even greater enrichment for trans eQTL 
regions, as compared to cis eQTL regions (Fig. 3-4; bottom right, as compared to bottom 
left), validating the proposed regulatory role of these trans eQTL regions. Collectively, 
these patterns ofsex-biased DHS and TF binding site enrichments provide strong support 





Gene expression co-regulation inference based on eQTLs. We hypothesize that genes 
with overlapping eQTLs are likely to be co-regulated, presumably due to their shared 
regulatory regions. Any overlapping eQTLs with a common regulating strain is defined 
as a co-regulated gene cluster. 1,521 co-regulated gene clusters, comprised of 4,105 
genes, were identified based on eQTLs discovered in all DO liver samples (Table S3-
7A). Most of the co-regulated gene clusters are small in size, with 65.8% of all clusters 
contains two genes each (Table S3-7D). The lack of many large co-regulated gene 
clusters suggests that genetic variants in DO mice are generally not at master regulatory 
regions for liver-expressed genes, i.e., regions where a single SNP dysregulates many 
genes. Rather, genetic variation typically impacts a small number (<10) of liver-
expressed genes, leading to the observed variability of gene expression across strains, but 
without gross alteration of liver gene expression patterns.. The identified gene clusters 
show evidence of co-regulation, as many of their members show high pairwise gene 
expression correlation (see examples in Fig. 3-5). 50% (762) of the co-regulated clusters 
contain sub-clusters, where the identified eQTL regions are associated with up regulation 
of some genes in the cluster and down regulation of other genes in the cluster. One 
example is the 21-gene cluster on chromosome 2, which is predicted to occur in the 
PWK/PhJ strain (Fig. 3-5A). The first eleven overlapping eQTLs in the top cluster in 
Figure 3-5A have both positive regression coefficients (i.e. higher expression of the 
eleven listed genes; Fig. S3-7) and are located on the same chromosome with the genes 
they are associated with, whereas the last ten overlapping eQTLs have both negative 




and are located on a different chromosome with the genes they are associated with. 
Pairwise gene expression correlation analysis separates these eQTLs into two well-
defined sub-clusters, where each sub-group has either a positive or a negative regression 
coefficient (Fig. 3-5A). The pairwise gene correlations are less tight in the negatively 
correlated sub-cluster (e.g. Zbtb7c), which suggests the eQTL association may result 
from indirect regulation or partial regulation involving another factor. Notably, in the 
case of the eQTL involving Zbtb7c, another, stronger genetic association was identified 
in cis (chr18, Fig. S3-8). The co-regulated cluster in Fig. 3-5A shows that genes from 
different chromosomes may be grouped together (Fig. S3-7), highlighting the ability of 
this approach to identify complex trans regulation. Overall, 10.4% (159) of co-regulated 
clusters group genes from multiple chromosomes. Further, 22.6% (344) of co-regulated 
clusters contain both protein-coding and lncRNA genes, generating testable hypothesis 
for possible functions of the clustered lncRNAs.  
 
Co-regulated gene cluster based on overlapping eQTLs were also discovered in male only 
livers, and separately, female only livers. Differences in co-regulated gene clusters 
identified in male liver, and separately, in female liver were assessed for eQTLs with sex-
biased genetic association. A limited number of co-regulated gene clusters show a switch 
in gene members in clusters identified in male liver samples, as compared to clusters 
identified in female liver samples. This is exemplified by three female-specific genes 
from the Sulfotransferase gene family: Sult2a1, Sult2a3 and Sult2a5 (Fig. 3-6A).  In 




Sult2a5 are predicted to be co-regulated, as their eQTLs are overlapping and are 
associated with the high expression of both genes (Fig. 3-6B; top left and bottom left). In 
contrast, in CAST/EiJ female liver only, Sult2a1 shows co-regulation with Sult2a3, and 
the high expression of both genes is associated with overlapping eQTL regions (Fig. 3-
6B; top right and bottom right). Even though all four eQTL regions overlap, their eQTL 
peaks do not overlap, indicating a need for higher resolution genetic mapping to pinpoint 
the precise regulatory regions and tease apart these two distinct regulations. Sult2a5 and 
Sult2a3 show no significant eQTLs in female or male liver samples, respectively (Fig. 
S3-9). The pairwise gene correlations between the three genes are consistent with these 
patterns, as Sult2a1 and Sult2a3 show higher correlation in female liver samples, as 
compared to male liver samples (Pearson correlation 0.7 vs. 0.3; Fig. 3-6A), and Sult2a1 
and Sult2a5 show higher correlation in the male samples, as compared to female samples 
(Pearson correlation 0.8 vs 0.6; Fig. 3-6A). The relatively strong gene expression 
correlation in female livers between Sult2a1 and Sult2a5, which are not in the same 
CAST/EiJ co-regulated gene cluster, indicates that there is, nevertheless, an overall 
correlation in their expression across female DO mouse livers, once the complexity of 
other DO founder strains is factored in   
 
3.E Discussion 
Sex-specific gene expression characterizes many mammalian tissues (Rinn and Snyder 
2005, Lowe et al. 2015), including liver (Zhang et al. 2011, Conforto and Waxman 2012, 




female differences related to metabolism of drugs (Thurmann and Hompesch 1998, 
Waxman and Holloway 2009, Zanger and Schwab 2013) and xenobiotics (Mugford and 
Kedderis 1998), as well as disease susceptibility (Shimizu et al. 2007, Tessari et al. 2009, 
Baik et al. 2011). Pituitary GH has long been known to be a major regulator of hepatic 
sex-specific genes (Waxman and O'Connor 2006, Lichanska and Waters 2008) via its 
sex-dependent secretion pattern: pulsatile in male and near continuous in female (Jansson 
et al. 1985, Veldhuis et al. 2001), which in turn activate a cascade of TFs, including 
STAT5, HNF6 and BCL6 (Conforto et al. 2012, Zhang et al. 2012, Conforto et al. 2015). 
Here, we describe the role of genetic variants as another layer of regulation that works in 
tandem with the hormonal environment to control transcription of sex-biased genes. We 
used the DO mouse model, a genetically diverse population derived from eight inbred 
mouse strains (Churchill et al. 2012), to dissect the genetic component of sex-biased 
transcriptional regulation. We found that DO mice show high variability in their sex-
specific gene expression patterns across DO founder strains, where the majority of sex-
specific genes either loose or gain sex-biased expression in one or more founder strains. 
~13,000 significant associations between autosomal genetic variants and gene expression 
(eQTLs) were identified in DO mouse liver, of which 49% are novel, and many are 
associated with lncRNAs. 987 of these eQTLs are associated with sex-specific genes, and 
a subset show stronger genetic association in one sex, as compared to the other. eQTLs 
with a large difference in genetic association between males and females (top 10%) are 
significantly enriched for an association with strongly sex-specific genes with matching 




associated with sex-specific genes and show a sex-biased genetic association are 
intimately linked with the loss or gain of sex-biased gene expression in the predicted 
regulating strain, highlighting the surprisingly extensive role of genetic variants in sex-
biased gene expression. Analysis of the subset of TF binding sites and open chromatin 
regions (DHS) that contain genetic variants specific to the strain predicted to be regulated 
by eQTLs, revealed a significant enrichment of sex-specific STAT5 binding sites and 
DHS for eQTLs that are associated with genes with matching sex-specificity. 
Correspondingly, the male-biased transcriptional repressor BCL6 was enriched at eQTL 
regions mapping to female-biased genes, a pattern that was amplified in trans eQTL 
regions. Collectively, these patterns of enrichment highlight the regulatory nature of these 
eQTL regions. Finally, overlapping eQTLs were used to discover co-regulated gene 
clusters, some of which grouped genes from different chromosomes or grouped protein-
coding genes with non-coding genes. These gene clusters provided evidence of co-
regulation based on high correlation of gene expression amongst cluster members.  
 
Genetic factors promote variability of sex-biased gene expression across DO founder 
strains. Sex-specific gene expression shows exceptional high variability across DO 
founder mouse strains, where up to 95% of sex-specific genes either gain or loose sex-
biased expression in at least one founder strain. Their high variability across strains 
indicates that they are not housekeeping or essential genes, however, they may contribute 
to clinically important variables, including liver metabolism and liver disease 




between strains. Genetic variability can increase or decrease the number of sex-specific 
genes, as the two strains that are the most evolutionarily divergent from the reference 
strain (C57BL/6J) have either the most sex-specific genes (PWK/PhJ) or the second 
fewest (CAST/EiJ). Remarkably, we demonstrated a tight connection between genetic 
variants and the variability of sex-specific gene expression across DO founder strains 
insofar as sex-specific gene expression was lost for 78% (134 of 172) of eQTLs which 
were associated with a decrease in sex-specificity in the regulating founder strains. 
Similarly, 47% (85 of 188) of eQTLs that were expected to increase the sex-specificity of 
gene expression were corroborated by the gain of the sex-biased gene expression in the 
respective regulating founder strains. Thus, genetic variants have an extensive impact 
in increasing sex-biased expression variability. The lower accuracy of our prediction for 
eQTLs that are predicted to increase sex-biased gene expression, as compared to those 
that ablate sex-specific gene expression (Fig. 3-3C, 3-3D) suggests another layer of gene 
regulation is involved; alternatively, the limits of the microarray data may decrease our 
ability to detect weaker sex-specific gene expression. Overall, 219 eQTLs were linked to 
the loss or gain of sex-specific expression of 205 genes (46% of the 471 sex-specific 
genes, for which we have complete expression in male and female liver of the 8 DO 
founder strains). The pervasive impact of genetic regulation on sex-biased gene 
expression is potentially greater, as up to 68% (322 genes; 360 eQTLs) of sex-specific 
genes are associated with eQTLs that were predicted to modulate the sex-specific gene 
expression across DO founder strains. Differences of the identified sex-specific genes 




for select founder strains, most notably pyruvate metabolism for WSB/EiJ mice, and 
biosynthesis of unsaturated fatty acids and metabolism of xenobiotics by cytochrome 
P450 for PWK/PhJ mice. Further, DO founder mice exhibit diverse liver phenotypes 
(Svenson et al. 2007, Churchill et al. 2012), including differences in disease 
susceptibility, such as fatty liver disease (Fengler et al. 2016), liver fibrosis (Hillebrandt 
et al. 2005) and hepatoxicity (Tryndyak et al. 2012, Church et al. 2015), as well as 
differences in liver inflammatory responses (Bavia et al. 2015), whose molecular 
mechanisms are thought to involve sex-biased genes (Gonzalez 2005, Shimizu et al. 
2007, Tessari et al. 2009, Ayonrinde et al. 2011, Baik et al. 2011, Takahashi et al. 2014).  
 
We were not able to identify eQTLs for 315 sex-specific genes, and found their gene 
expression across strains to be less variable, thereby preventing us to uncover their 
regulatory regions based on association between genotype and gene expression data 
alone. These genes may be comprised of a core gene set whose sex-biasedness are 
essential to maintain, such that their gene expression variability across strains would not 
be tolerated. This gene set, notably, include important GH-regulated TFs including Bcl6 
and Cux2. A possible hypothesis is that only a limited number of sex-biased genes 
needed to establish the sexual dimorphism characterizing liver transcriptome and liver 
epigenome, and other non-essential sex-biased genes are allowed to vary, leading to 





Relationship between genetic variants and GH in the regulation of sex-biased gene 
expression. We show that the impact of a subset of genetic variants is substantially 
stronger in one sex, as compared to the other, despite the identical autosomal sequences 
of males and females. Thus, a mechanism must exist to allow genetic variants to confer 
regulatory control in a sex-biased manner. GH and its sex-dependent pattern of pituitary 
secretion is a key regulator of liver sex-biased gene expression, and is a primary 
candidate for this role. Differences in plasma GH profiles activate STAT5 in a sex-
differential manner, and STAT5, in turn, cooperates with other GH-dependent TFs to 
regulate the transcription of sex-biased genes through their sex-differential binding to 
liver chromatin. The sex-dependent plasma GH profiles are also linked to the widespread 
differences in histone modifications and chromatin accessibility between male and female 
liver (Ling et al. 2010, Sugathan and Waxman 2013). An earlier study on human whole 
blood samples found that the genetic control on both sexes are largely similar (Kassam et 
al. 2016), in contrast with a subset of eQTLs in our study showing strong genetic 
association selectively in one sex. This discrepancy may be due to the pervasive action of 
GH in imparting sex differences in regulatory regions in mouse liver (Ling et al. 2010, 
Sugathan and Waxman 2013, Connerney et al. 2017) , which may be missing in human 
whole blood cells.  
 
GH signaling pathways and GH-dependent sex-specific gene transcription seem to be 
largely unperturbed across DO founder strains, as indicated by the similar fraction of 




the loss of GH signaling in hypox mice, defined previously (Connerney et al. 2017). 
Further, eQTL regions, including a subset of trans eQTL regions, were enriched for sex-
biased and GH-regulated sites of chromatin accessibility (DHS) and TF binding that 
match the sex-specificity of the gene that each eQTL is associated with, consistent with 
these eQTL regions playing a regulatory role. This analysis was based on the subset of 
sex-biased DHS and TF binding sites that encompass genetic variants specific to the 
founder strain predicted to be regulated by the respective eQTLs. Thus, certain genetic 
variants are proposed to be within GH-regulated accessible chromatins (DHS) and/or 
functional regulatory regions (TF binding sites) that are active in one sex, but not the 
other, which effectively creates a way for genetic variants to alter GH-regulated gene 
expression in a sex-biased manner. One example is the female-specific gene Cyp2b9, 
which loses its sex-biased expression in 129S1/SvImJ mouse liver. An eQTL with a 
strong repression effect (Fig. S3-6, category 4) uniquely linked to 129S1/SvImJ female 
mouse liver is characterized by 129S1/SvImJ-specific SNPs/indels at one female-biased 
DHS and 3 female-biased STAT5 binding sites. The genetic variants at one or more of 
these regulatory sites are proposed to interfere with the transcription of Cyp2b9 (Fig. S3-
10A), leading to the dramatic decrease of Cyp2b9 expression seen in 129S1/SvImJ 
female liver (Fig. S3-10B and S3-10C).  
 
Properties of the genetic regulation of sex-biased genes. The present study reveals 
several features that elucidate how genetic modifiers impact the transcription of sex-




than via a master regulator susceptible to the effects of genetic variants. This conclusion 
is supported by our finding that co-regulated gene clusters, identified through overlapping 
eQTLs in the same regulating strain, are mostly small in size, i.e., clusters of <10 genes. 
However, this does not exclude the possibility that some of the genes regulated by 
genetic variants are themselves regulators, which perhaps regulate many genes, but which 
would not necessarily be sufficiently strong to be discovered as eQTLs in the present 
analyses. One such example is the Rsl gene, which codes for a Krüppel-associated box 
zinc finger (KRAB-ZPF) protein, whose expression varies across mouse strains (Krebs et 
al. 2003, Krebs et al. 2005). Rsl directly represses several sex-specific genes, including 
Slp and others, and it appears to regulate other sex-specific genes by indirect activation or 
repression (Krebs et al. 2009, Krebs et al. 2012). Thus, Rsl exemplifies how genetic 
variation can alter the expression of a sex-biased gene, which then causes a 
transcriptional cascade that has a widespread effect on sex-specific gene expression 
patterns. Another feature of genetic regulation in liver is a slight bias towards up 
regulation of gene expression, a property that is retained for strongly sex-specific genes. 
Finally, we found that eQTLs associated with highly male-specific genes tend to have 
stronger genetic regulation in male liver, and correspondingly, highly female-specific 
genes tend to have stronger genetic association in female liver. 
 
In conclusion, we identified significant genome-wide associations between genetic 
variants and gene expression (eQTLs) in DO mouse liver, a subset of which showed 




characterized the high variability of sex-biased gene expression across DO founder 
strains, and showed that eQTLs with a sex-bias in association can explain the loss or gain 
of sex-specific gene expression, in DO founder strains, for 46% of sex-biased genes. 
eQTL regions associated with sex-specific genes, including a subset of trans eQTL 
regions, were shown to be enriched for sex-biased open chromatin regions and sex-biased 
binding sites for GH-regulated TFs. Finally, co-regulated gene clusters were identified 
based on overlapping regulatory regions (eQTLs), where a subset of clusters grouped 
highly correlated genes from different chromosomes. These findings reveal the extensive 
regulatory role played by genetic variants, working in tandem with GH, in the 
transcriptional regulation of sex-biased genes, many of which are implicated in the sex 





Table 3-1. Number of autosomal eQTLs found when using all, male only or female 
only samples.  
We observed more significant eQTLs in female than male. A similar observation was 
made in BXD liver, where 26.7% more significant eQTLs was reported for female liver 
as compared to male liver (1,638 significant eQTLs in male liver vs. 2,076 significant 

























































































Table S3-1 to Table S3-8.  





Figure 3-1. Protein-coding gene sex-specificity across DO founder strains. (A) 
Heatmap of the log2 male/female fold-change values across DO founder mouse livers for 
471 protein-coding genes that are significantly sex-specific (male/female |fold-change|  > 
1.5 at FDR < 0.05) in at least one DO founder strain based on the microarray dataset. 
Black boxes highlight genes with stronger sex-specificity in select DO founder strains. 
(B) Gene expression level for 220 sex-specific genes showing the highest inter-strain 
variability, but the lowest intra-strain variability (see Methods), across a set of 64 male 
DO founder mouse livers. The map is clustered based on the summation of expression 
levels of each gene across the 8 indicated DO founder strain male livers, with the color 
intensity indicating the fraction of expression seen in each liver. The data shown are 
based on 8 livers for each DO founder strain. (C) Number of sex-specific protein-coding 
genes in each DO founder strain, based on microarray datasets. (D) PCA of the 96 
microarray samples (6 samples/sex/strain) based on the expression level of 471 sex-
specific genes in each DO founder strain. (E) KEGG pathways enriched (adjusted 
Benjamini P < 0.05) in the set of sex-specific protein-coding genes identified in each DO 
founder mouse strain. (F) Distribution of male-biased class 1 and class 2 genes, and of 
female-biased class 1 and class 2 genes across mouse strains. The first bar presents the 
distribution of sex-biased genes across the four Hypox response classes (Connerney et al. 
2017) identified in CD-1 mice. The other 8 bars represent the corresponding distributions 









Figure 3-2. Autosomal eQTLs for liver-expressed genes. (A) Venn diagrams showing 
numbers of autosomal eQTLs discovered using all DO livers, or using male only or 
female only liver samples (Table 3-1) and that are associated with protein-coding genes 
(left) or lncRNA genes (right). Overall, 10,597 autosomal eQTLs are significant in either 
male liver or female liver. (B). Pie chart showing the realtive frequency with which each 
of the indicated DO founder strains has the largest regression coefficient (i.e., is the 
major regulating strain) for the set of 12,886 combined autosomal eQTLs. (C) Genome-
wide association of Sult3a1 in all (left), male only (middle) and female only (right) livers. 
The horizontal red line marks the P < 0.05 significance cutoff based on the permutation 
test. (D) Regression coefficients (top of each panel) and LOD scores (log10(p-value); 
bottom of each panel) across the chromosome that have a significant eQTL peak in male 
(left) or female (right) mouse liver, as marked at bottom. Shaded area in the LOD score 
plot indicates the 95% Bayesian credible interval for each eQTL. (E) Expression of 
Sult3a1 in male and female mouse livers for each DO founder strain (left). Also shown 
are calculated male/female expression ratios (right). The middle hinge of each boxplot 
indicates the median, while the lower and upper hinges correspond to the first and third 
quartiles. Whiskers mark 1.5 * IQR value. Red arrows indicate a decrease in female 
expression in NZO/HiLtJ mice and an increase in male expression in CAST/EiJ mice, 









Figure 3-3. Autosomal eQTLs associated with sex-specific genes. (A) Venn diagrams 
showing overlaps for eQTLs discovered in all, male only or female only liver samples 
that are associated with sex-specific protein-coding or sex-specific, multi-exonic 
intergenic lncRNA genes. (B) Distribution of LOD score differences (log10 values) in 
male vs. female liver for autosomal eQTLs that are associated with sex-independent 
(left), strongly male-specific (male/female |fold-change| > 4; middle) or strongly female-
specific genes (male/female |fold-change| > 4; left). (C) (Left) Percentage of eQTLs in 
categories #1-4 (described at the right) that are associated with a loss of sex-specific gene 
expression in its regulating strain. (Right) Four possible scenarios, whereby an eQTL may 
result in the loss of sex-specfiic liver gene expression. (D) (Left) Percentage of eQTLs in 
categories #5-8 (described at the right) that are associated with a gain of sex-specific gene 
expression in its regulating strain. (Right) Four possible scenarios, whereby an eQTL may 










Figure 3-4. Enrichment of DHS and TF binding sites that contain regulating strain-
specific SNPs/indels at different types of eQTL regions. Fraction of male-specific, 
female-specific and sex-independent DHS (top left), STAT5 (top right), and BCL6 
(bottom) binding sites with regulating strain-specific SNPs/indels at different sets of 
eQTLs. The different sets of eQTL are as follows: eQTLs identified for genes with 
|male/female| > 4 fold-change were designated sex-specific, eQTLs identified for genes 
with with |male/female| < 1.2 fold-change were designated sex-independent, and eQTLs 
identified in a different TAD from the gene it is associated with were designated trans. 
The number of eQTLs analyzed in each boxplot varied between DHS and TFs, and are 
specified in the x-axis labels. The middle hinge of each boxplot indicates the median 
value, while the lower and upper hinges correspond to the first and third quartiles. 
Whiskers marks 1.5 * IQR value. P-values were determined by the Wilcoxon test, where 
***=0.001, **=0.01 and *=0.05. The number of binding sites and DHS for each eQTL is 









Figure 3-5. Co-regulated gene clusters based on overlapping eQTL regions 
discovered in all liver samples. (A) A co-regulated cluster consisting of twenty-one 
overlapping eQTLs with the PWK/PhJ as the regulating strain. (B) Four co-regulated 
clusters containing sex-specific genes. The heatmaps show correlations of gene 










Figure 3-6. Co-regulated gene clusters that show different gene members in male vs. 
female liver. (A) Pearson gene expression correlation of Sult2a1, Sult2a3 and Sult2a5 in 
male liver (left) and female liver (right). (B) Regression coefficients (top figure in each 
panel) and LOD scores (bottom figure in each panel) across chromosome 7 for Sult2a1 in 
male liver (top left) and female liver (top right), for Sult2a3 in male liver (middle left) 
and female liver (middle right) and for Sult2a5 in male liver (bottom left) and female 
liver (bottom right). Shaded area in the LOD score figures indicate 95% Bayesian 









Figure S3-1. Schematic overview of how the SNP array and RNA-Seq data were 






Figure S3-2. High variability of the sex-specificity of gene expression in individual 
livers of CD-1 mice and DO mouse founder strains for select male-specific and 
female-specific genes. Gene expression in individual mouse livers across strains: male 
and female CD-1 mice (first row; left), male and female C57BL/6J mice (first row, right), 
male and female DO mice fed a standard chow diet (second row), or fed a high fat diet 
(third row). The fourth row shows box plots of gene expression level (FPKM) based on 
128 individual male livers for DO founder mice fed a standard chow diet (left), or fed a 
high fat diet (right), and for male and female DO founder strain mice (fifth row; left). The 
first four rows are gene expression measured by RNA-Seq (FPKM values), while the 
gene expression on the fifth row was measured by microarrays. Male/Female sex ratios 
across the DO founder strains based on the microarray dataset was also calculated (fifth 
row; right). Examples shown are for a male-specific gene (Cyp4a12b), where male-
biased expression is reduced or lost in PWK/PhJ mice, and a female-specific gene 














Figure S3-3. Sex-specific protein-coding genes across DO founder strains. (A) 
Number of highly sex-specific protein-coding genes (male/female |fold-change|  > 4 at 
FDR < 0.05 in at least one DO mouse founder strain based on the microarray dataset) in 
each of the DO mouse founder strains. (B) Published phylogenetic tree (Threadgill et al. 
2011) of the eight DO founder strains based on the SNP data for chromosome 11. The 







Figure S3-4. Properties of autosomal eQTLs in DO mouse liver.  
Percentage of autosomal eQTLs that are associated with the up regulation or down 
regulation of gene expression in its respective regulating strain. There are 625, 672, 574, 
593, 616, 3,085, 3,074 and 1,086 autosomal eQTLs whose regulating strain are either the 
A/J, C57BL/6J, 129S1/SvlmJ, NOD/ShiLtJ, NZO/HILtJ, CAST/EiJ, PWK/PhJ, or 
WSB/EiJ strain respectively. This figure uses the 10,325 autosomal eQTLs found when 






Figure S3-5. Examples of genes with stronger genetic association in male or female 
liver.  
For each gene, the figure showsgene expression patterns across strains (see Fig. S3-2 for 
figure explanation), genome-wide eQTL scan (see Fig. 3-2C for figure explanation) and 
regression coefficients across the chromosome with a significant eQTL peak (see Fig. 3-
2D for figure explanation). Cav1 shows strong male-specific expression in the PWK/PhJ 
founder strain and in a subset of male DO mouse livers. Its strong eQTL is seen in male 
livers only and is associated with the PWK/PhJ strain. Hsd3b5 shows male-biased 
expression in CD-1 mice and multiple DO founder strains; its expression in female liver 


























Figure S3-6. Examples of sex-specific genes in categories 1-8, described in Fig. 3-3. 
For each gene, the figure shows gene expression patterns across strains (see Fig. S3-2 for 
figure explanation), genome-wide eQTL scan (see Fig. 3-2C for figure explanation) and 










































































Figure S3-7. Regression coefficients (top figure in each panel) and LOD scores 




























Figure S3-8. Genome-wide LOD score plots for genes that are located in different 


















Figure S3-10. Strain-specific SNPs/indels are hypothesized to contribute to the loss 
of sex-specific gene expression for Cyp2b9.  
(A) Hypothesis involving an eQTL with strong genetic association in female 
129S1/SvlmJ mouse livers, discovered for female-specific gene Cyp2b9. In the identified 
eQTL region, we found one female-specific DHS and three female-specific STAT5 
binding sites that contain 129S1/SvlmJ-specific SNPs/indels. These variants are 
hypothesized to interfere with the transcription of Cyp2b9, leading to a lost of sex-biased 
expression in 129S1/SvlmJ livers. (B) The distribution of gene expression level of 
Cyp2b9 across individual DO mouse livers (Table S3-8) was used to discover eQTLs 
stratified by the genotype assigned at the the SNP marker with the highest LOD score. 
(C) A female-biased STAT5 binding site (fourth red arrow from the top) at a female-
biased DHS (third red arrow from the top), containing two 129S1/SvlmJ-specific 


































Chapter 4 Sex-biased gene co-expression networks in Diversity Outbred mouse liver 
 
4.A Abstract 
Sex differences in liver gene expression and disease susceptibility are primarily regulated 
by pituitary growth hormone secretion patterns, which activate sex-dependent liver 
transcription factor, and establish sex-specific chromatin states. Ablation of pituitary 
hormone by hypophysectomy (hypox) identifies two major classes of liver sex-biased 
genes, defined by sex-dependent positive or negative responsiveness to hypox, 
respectively; however, the mechanism that leads to the different classes of hypox 
responsiveness is unknown. Here, we sought to identify candidate regulatory long 
noncoding RNAs (lncRNAs) that may control hypox responsiveness. First, we used 
mouse liver RNA-seq data for 30 different biological conditions to discover gene 
structures and expression patterns for ~15,500 mouse liver lncRNAs, including antisense 
and intragenic lncRNAs, as well as lncRNAs overlapping active enhancers, marked by 
enhancer RNAs. We identified 157 sex-specific lncRNAs that, were like many sex-
specific protein-coding genes, regulated during postnatal liver development or were 
subject to circadian oscillations. Next, we utilized the high natural allelic variance of 
Diversity Outbred (DO) mice, a multi-parental outbred population, to discover tightly co-
expressed clusters of sex-specific genes (gene modules) in male liver, and separately, in 
female liver. Sex differences in the gene modules identified were extensive. Remarkably, 
many gene modules were strongly enriched for male-specific or female-specific genes in 




DO mouse captures responsiveness to hypox. Hypox-responsiveness was shown to be 
facilitated by multiple, distinct gene regulatory mechanisms, indicating its complex 
nature. Finally, we identified sex-specific lncRNAs whose expression across DO mouse 
livers showed an unexpected significant negative correlation with protein-coding gene 
modules enriched for genes of the opposite-sex bias and inverse hypox class, indicating 
strong negative regulatory potential for these lncRNAs. Thus, we used a genetically 
diverse mouse population to discover tightly co-expressed sex-specific gene modules that 
reveal broad characteristics of gene regulation related to hypox responsiveness and 




Sex differences in hepatic gene expression are extensive (Waxman et al. 1985, Rinn and 
Snyder 2005, Clodfelter et al. 2006, Zhang et al. 2011), and are associated with sex 
differences in liver function and disease susceptibility (Shapiro et al. 1995, Tanaka 1999, 
Rogers et al. 2007, Baik et al. 2011, Li et al. 2012). These sex differences are primarily 
regulated by growth hormone (GH) (Cheung et al. 2006, Waxman and O'Connor 2006, 
Lichanska and Waters 2008), working through its sex-differential pituitary secretory 
patterns: pulsatile in male and near-continuous in female (Waxman et al. 1991, Veldhuis 
and Bowers 2003, Holloway et al. 2006, Conforto et al. 2012). The resultant sex-
differential plasma GH patterns regulate the activity of STAT5 and downstream 




Conforto et al. 2012, Zhang et al. 2012, Conforto et al. 2015). These transcription factors 
are essential for the complex transcriptomic patterns specific to each sex (Clodfelter et al. 
2006, Holloway et al. 2007) and help establish sex-differences in chromatin accessibility 
and chromatin states closely linked to sex-specific gene expression (Ling et al. 2010, 
Sugathan and Waxman 2013). The sex-biased transcriptome includes long noncoding 
RNAs (lncRNAs) (Melia et al. 2016), which have the potential for diverse regulatory 
roles, including epigenetic and transcriptional regulation of both in cis and in trans (Rinn 
et al. 2007, Huarte et al. 2010, Orom et al. 2010, Zhang et al. 2014, Amit-Avraham et al. 
2015, Gayen et al. 2015).  
 
Studies in rodent models have established that the prominent, sex-biased temporal 
patterns of GH secretion, are imprinted in males by neonatal exposure to androgens 
(Jansson et al. 1985). Sex-specific liver gene expression does not, however, become 
widespread until puberty (Conforto and Waxman 2012, Lowe et al. 2015). Surgical 
removal of the pituitary gland by hypophysectomy (hypox) identifies four major classes 
of sex-biased genes in mouse liver based on their responses to the loss of GH and other 
pituitary hormones (Wauthier et al. 2010, Connerney et al. 2017). Male class 1 and 
female class 1 liver sex-specific genes are activated by the GH secretion pattern of the 
sex where they are more highly expressed, whereas, male class 2 and female class 2 liver 
sex-specific genes are repressed by the GH secretion pattern of the sex where they are 
less highly expressed (Fig. S4-1). Consequently, following hypox, class 1 genes are down 




a near global loss of sex-specific gene expression (Wauthier et al. 2010, Connerney et al. 
2017). The molecular bases of these four phenotypes in response to hypox is poorly 
understood. 
 
Gene clustering has been used to identify groups of genes (gene modules/gene clusters) 
whose expression is strongly associated with different molecular phenotypes (gene 
signatures), including cancer subtypes (Alizadeh et al. 2000, Perou et al. 2000, 
Bhattacharjee et al. 2001, Sorlie et al. 2001) and various cellular processes (Ficklin et al. 
2010, Eising et al. 2017, Tyler et al. 2017). An early study used gene modules discovered 
in mouse fat, brain, liver and muscle to study sex differences in the organization of gene 
expression networks. Gene modules discovered in liver and fat were found to be the least 
conserved between the sexes (van Nas et al. 2009).  
 
Here, we use mouse liver RNA-Seq data for 30 distinct biological conditions to discover 
and characterize more than 15,000 liver-expressed lncRNAs, including many sex-
dependent lncRNAs subject to postnatal regulation during liver development (Peng et al. 
2014, Lowe et al. 2015) or circadian oscillations (Menet et al. 2012, Fang et al. 2014). 
We exploited the high genetic variability of DO mice, a multi-parental outbred 
population derived from eight genetically divergent inbred mouse strains (Churchill et al. 
2012, Schmidt 2015) to discover biologically meaningful clusters of sex-biased genes, 
and we investigated their enrichment for the above hypox-response classes. Our findings 




DO mouse livers between sex-specific lncRNAs and gene modules enriched for protein-
coding genes of the opposite sex and inverse hypox-response class, generating testable 
hypotheses for lncRNA regulatory roles. 
 
4.C Materials and methods 
LncRNA discovery. We collected 186 RNA-Seq samples of male and female mouse 
liver, representing 30 different biological conditions (Table S4-1A) (Menet et al. 2012, 
Renaud et al. 2014, Schmitt et al. 2014, Lowe et al. 2015, Connerney et al. 2017, Lau-
Corona et al. 2017, Lodato et al. 2017). Tophat2 (Kim et al. 2013) was used to map a 
total of 10.7 billion reads to the C57Bl/6J mouse mm9 reference genome. LncRNA gene 
structures and isoforms were discovered using the method we recently published 
(Chapter 2) (Melia et al. 2016), with the following changes: (1) the expression filter 
removed lowly expressed genes at the level of 10% FPR, instead of 15%; (2) only gene 
structures overlapping one or more protein-coding gene exons on the same strand were 
removed. The latter modification allowed us to retain gene structures that correspond to 
antisense lncRNAs and intragenic lncRNAs. LncRNAs that do not overlap with any 
protein-coding gene were designated intergenic. LncRNAs that overlap protein-coding 
genes were designated antisense if they were transcribed on the opposite strand of the 
protein-coding gene; otherwise they were designated intragenic.  
 
Gene expression quantification for lncRNAs. We devised four approaches for counting 




exon; (2) counting reads that overlap any region from the transcription start site (TSS) to 
the transcript end site (TES) (gene body); (3) counting reads that overlap genomic 
regions that were assigned as exons in all isoforms of a gene (exon-only counting); and 
(4) counting reads that overlap genomic regions that were designated introns in all 
isoforms of a gene (intron-only counting). These counting methods closely follow a 
recent publication for protein-coding genes (Connerney et al. 2017). Reads that mapped 
to regions that can be attributed to more than one gene were not counted, consequently, 
intragenic lncRNAs that are wholly within another gene will have no read counts when 
using the second or fourth counting method. All of the analyses presented in this study 
are based on the first counting method. 
  
Sex-specific and GH-regulated lncRNAs. I used 8 mouse liver RNA-seq datasets 
(Table S4-1B) to assess the sex-specificity of lncRNA gene expression, as follows. 
Datasets # 1-3: Three independent poly(A)-selected total liver RNA datasets, 
encompassing 7 pools from each sex from CD-1 mouse liver (Connerney et al. 2017, 
Lau-Corona et al. 2017). Datasets # 4-6: For each sex, three pools of poly(A)-selected 
nuclear RNAs, three pools of ribosomal RNA-depleted total RNAs and three pools of 
ribosomal RNA-depleted nuclear RNAs from CD-1 mouse livers (Lau-Corona et al. 
2017). Dataset # 7: 12 male and 12 female livers from 15-20 week old C57Bl/6J mouse 
liver (Lowe et al. 2015). Dataset # 8: 12 male and 12 female C57Bl/6J mouse liver at 
embryonic day 17.5 (Lowe et al. 2015). Differential analysis using edgeR (Robinson et 




Any lncRNA with male/female |fold-change| > 4 at FDR < 0.05 in any of the eight 
datasets was designated as a sex-specific lncRNA. A listing of all 684 sex-specific 
lncRNAs and their expression data is provided in Table S4-2A. Pituitary regulation. 
Pituitary-regulated lncRNAs are those that show significant response to hypox in either 
male or female liver at hypox/intact |fold-change| > 2 and FDR < 0.05, as determined by 
edgeR. Sex-specific liver lncRNAs were categorized into four classes based on their 
response to hypox: class 1 and class 2 male-specific lncRNAs, and class 1 and class 2 
female-specific lncRNAs. RNA-Seq data from two independent hypox mouse liver 
datasets was used to establish each lncRNA’s response to hypox: PolyA-selected liver 
RNA and ribosomal-depleted liver RNA (Connerney et al. 2017). Analysis of the 
ribosomal-depleted hypox liver RNA dataset was carried out by Christine Nykyforchyn 
of the Waxman lab. All but four lncRNAs were assigned to the same hypox-response 
class by both hypox datasets; those four inconsistencies were resolved by choosing the 
classification indicated by the dataset with the higher male/female |fold-change|. The 
hypox-response class of each sex-specific lncRNA is shown in Table S4-2A.  
 
Regulated lncRNAs during liver development. edgeR was used in ten separate 
differential expression analyses of C57BL/6J male mouse liver RNA-Seq datasets 
comparing lncRNA expression profiles between day 0 (immediately after birth and 
before the start of suckling) with liver RNA-Seq datasets for each of the following 
postnatal ages: day 1 (exactly 24 h after birth) and days 3, 5, 10, 15, 20, 25, 30, 45 and 60 




at any of the above ages were designated developmentally regulated lncRNAs. See Table 
S4-2A for developmental data for lncRNAs. 
 
Regulated lncRNAs in a 24-hour period. Five differential expression analyses were 
performed to compare liver lncRNA RNA-Seq expression profiles in C57BL/6J male 
liver at Zeitgeber times (ZT) ZT6, ZT10, ZT14, ZT18, ZT22 to gene expression at ZT2 
using edgeR. LncRNAs with gene expression |fold-change| > 2 at FDR < 0.05 at any ZT 
time point were designated circadian regulated lncRNAs. Circadian expression data for 
lncRNAs is shown in Table S4-2B. 
 
Gene expression quantification in Diversity Outbred (DO) mouse liver. RNA-Seq 
data obtained for comprised of 112 male and 121 female DO mouse livers samples, all 
from mice fed standard chow diet, were downloaded from GEO, accession numbers 
GSE45684 (Munger et al. 2014, Gu et al. 2016) and GSE72759 (Chick et al. 2016). Read 
mapping and gene expression quantification for each sample was as described in Chapter 
3. Briefly, reads were mapped to a specific diploid genome constructed for each 
individual mouse (Chapter 3). Gene expression was then quantified by counting 
sequenced reads that overlap any exon by at least one bp using featureCounts (Liao et al. 
2014), using the best mapped location for each read. The restriction of only using unique 
reads for diploid genomes would limit the read counts to only include those reads that 
mapped to genome locations where the paternal and maternal allele differ, and thus could 




expression level obtained for diploid genomes is based on the total number of reads that 
overlap the counted regions in either the paternal or maternal allele. Reads counts were 
then transformed to fragments per kilobase of exon per million reads mapped (FPKM) for 
downstream analysis, where gene lengths are the average length of the gene in the two 
alleles. A batch effect that correlated with the GEO accession of the samples was 
removed from the gene expression level (transformed to log2(FPKM + 1)) using the 
ComBat function in the sva R package (Leek et al. 2012). A listing of expression level 
across male and female DO mouse livers are in Table S4-7. 
 
Gene expression quantification for antisense lncRNAs based on unstranded RNA-
Seq datasets. The FDR for antisense lncRNAs was set to 1 for all differential analyses 
performed using unstranded RNA-Seq datasets, as the unstranded nature of such data 
prevents us from reliably attributing sequence reads to antisense lncRNAs. Unstranded 
RNA-Seq datasets include: the first 2 datasets used to determine lncRNAs sex-specificity 
(Table S4-1B; first two rows), polyA-selected hypox dataset used to identify pituitary 
hormone-regulated lncRNAs (Table S4-1A; rows: male hypox and female hypox), liver 
development RNA-Seq datasets in male liver (Table S4-1A; any row with samples from 
(Renaud et al. 2014)), RNA-Seq datasets for DO mouse liver samples, and RNA-Seq 
datasets that assess liver gene expression changes due to circadian rhythm (Table S4-1A; 





Sex-specific and GH-regulated protein-coding genes.  We used the set of 1,033 sex-
specific genes protein coding described in Chapter 3 (Table S3-1), which consists of 
genes that showed significant sex-specific gene expression in either CD-1 mouse liver or 
in any of the eight DO mouse founder strains (A/J, C57BL/6J, 129S1/SvlmJ, 
NOD/ShiLtJ, NZO/HILtJ, CAST/EiJ, PWK/PhJ and WSB/EiJ) (Churchill et al. 2012, 
Svenson et al. 2012). A list of 531 pituitary hormone-regulated protein-coding genes, 
defined as genes responsive to hypox, was downloaded from Table S3 in (Connerney et 
al. 2017).  
 
Clustering sex-specific protein-coding genes. I clustered sex-specific protein-coding 
genes based on their gene-expression correlation across 112 male, and separately across 
121 female DO mouse liver samples using the weighted correlation network analysis 
(WGCNA) (Langfelder and Horvath 2008). WGCNA identifies co-expressed groups of 
genes (i.e., gene clusters/gene modules/gene networks) based on pairwise gene 
expression correlations across all samples. The correlation matrix is transformed into an 
adjacency matrix, which reflects the distance between genes, based on weighted gene 
expression correlations. Weights are introduced by raising the actual gene expression 
correlation to a power of ß, which leads to more robust gene similarity measures. 
WGCNA parameters were set as follows: correlation function = the bicor function 
(Langfelder and Horvath 2012) with the maxPOutliers set to 0.1, type of network = 
signed hybrid, minimum module size = 5 genes, soft thresholding power (ß) = 3, 




used at their default settings. Genes that were not expressed (FPKM = 0) in any set of 
livers (male liver samples, or separately, female liver samples) as well as those genes 
whose variance is 0 (MAD = 0) were excluded from the clustering analysis, this resulted 
in 1,018 and 1,014 of the 1,033 sex-specific protein-coding genes (Table S3-1) to be 
clustered in male and female DO liver samples, respectively; the overlap is high (1,013 of 
1,019 genes) between the two gene sets.  
 
Relationship between protein-coding gene modules. Similarities between protein-
coding gene modules in each sex were measured by pairwise Pearson correlation between 
their first principal components, as calculated using the moduleEigenGenes function in 
WGCNA. The correlation matrix was then clustered using average linkage hierarchical 
clustering with default parameters.  
 
Enrichment of various gene sets for protein-coding gene clusters (gene modules). To 
determine if any of the identified protein-coding gene clusters is enriched for any gene set 
with biological meaningful properties, I used the Hypergeometric test to assess the 
significance of overlap between the gene sets being compared; an overlap at p < 0.05 
indicates significant enrichment for the overlapping gene set. Enrichment for each of the 
following gene sets was tested for each gene cluster: male-specific genes, female-specific 
genes, strongly sex-specific genes (i.e., male/female |fold-change| > 4), male class 1 
genes, male class 2 genes, female class 1 genes, and female class 2 genes (see Table S3-1 




the hypox-response gene classes). To calculate the enrichment of male-specific genes in 
cluster i, we let mc = number of male-specific genes in cluster i, gc = number of genes in 
cluster i, g = number of genes included in the cluster analysis (1,018 sex-specific genes in 
male liver samples and 1,014 sex-specific genes in female liver samples, as described 
above) and m = the number of male-specific genes in g. Next, the probability of 
observing at least x male-specific genes in cluster i (P(#male-specific genes >= x)) was 
defined by the probability of drawing x or more male-specific genes, given that we are 
drawing gc number of genes from g genes, which has m male-specific genes. This was 
implemented using the following R command: 1 - phyper(x-1, m, g-m, gc, lower.tail = 
TRUE, log.p = FALSE). The same formula was used to calculate enrichment for other 
gene sets, except we replaced the male-specific gene set with the other gene sets of 
interest. 
 
Properties of protein-coding gene clusters. Nine properties were assessed for each gene 
cluster (see lower panels in Fig. 4-3 and Fig. 4-4): (1) the number of genes in each 
cluster; (2) the number of distinct TADs where the genes in each cluster are found; (3) 
the percentage of genes in each cluster with strong sex-specificity (male/female |fold-
change| > 4 at FDR < 0.05; Table S3-1); the percentage of male-specific (4) or female-
specific (5) genes in each cluster (Table S3-1); and the number of male-specific class 1 
(6), male-specific class 2 (7), female-specific class 1 (8) and female-specific class 2 (9) 
genes in each cluster, expressed as a percentage of all hypox-responsive genes in each 




Fig. 4-4 add up to 100%. For properties # 3-9, percentage values are only shown for those 
gene clusters with significant overlap with the relevant gene set, i.e. p-value < 0.05, as 
determined by the Hypergeometric test, described above. 
 
Correlating lncRNA with protein-coding genes clusters. To identify lncRNAs that 
show a significant positive correction or negative correlation with protein-coding gene 
clusters, we calculated the Pearson correlation between: 1) the expression pattern of each 
sex-specific lncRNA across the full set of 112 male DO mouse livers, and separately, 
across the full set of 121 female DO mouse livers, and 2) the first principal component of 
each protein-coding gene module across the same DO mouse liver sets. The first principal 
component of each protein-coding gene module was calculated using the 
moduleEigenGenes function in WGCNA with default parameters. We determined all 
lncRNA-gene module correlation pairs in male samples, and separately in female 
samples. P-values for the significance of the correlations were obtained using the cor.test 
function in R and adjusted by the FDR method. Due to the unstrandedness of the DO 
mouse liver RNA-Seq datasets, this analysis was limited to the set of 168,multi-exonic, 
intergenic sex-specific lncRNAs (Table S4-2A). Top correlations were those that met a p-
value of < 0.01 at FDR < 0.001.  
 
eRNA identification. 27 GRO-Seq C57BL/6J male liver samples were downloaded 
using GEO accession # GSE36916 and GSE59486 (Menet et al. 2012, Fang et al. 2014). 




the following parameters: motif: AAAAAA or TTTTTT, mismatch = 2, minMatchLength 
= 5 and -min = 20. Sequence reads were mapped to the C57BL/6J mm9 reference 
genome using Bowtie2 (Langmead and Salzberg 2012), and mapped reads were used to 
discover peaks using HOMER with the follower parameter settings: L = 3 and bodyFold 
= 3. Every peak in the positive strand was paired with the nearest peak in the reverse 
strand. Any peak pairs that were > 500 bases apart and converging into the same direction 
were removed. eRNA loci were defined as the 1 kb region centered at the overlapping 
region in each peak pair. The 15,853 eRNA loci that overlap any published H3K27ac or 
H3K4me1 peaks for young adult mouse liver (Sugathan and Waxman 2013) were 
retained (Table S4-6).  
 
4.D Results 
Discovery of 15,558 liver-expressed lncRNAs. We recently described 4,961 liver-
expressed intergenic lncRNAs (Chapter 2) (Melia et al. 2016), and characterized their 
gene expression, conservation level and transcriptional regulation. We, and others, have 
since produced many strand-specific RNA-Seq datasets, where the direction of 
transcription is preserved. These datasets enabled us to discover other types of lncRNA 
that were not included in our initial study, namely antisense and intragenic lncRNAs, 
many of which may contribute to the transcriptional regulation of nearby genes (Zhang et 
al. 2014, Amit-Avraham et al. 2015, Schein et al. 2016). We collected 186 RNA-Seq 
datasets encompassing mouse liver representing 30 different biological states, spanning 
from embryonic day 15.5 to 15-20 week old mice (Fig. 4-1A). Other biological 




foreign chemical agonists of liver nuclear receptors, mice whose GH secretion patterns 
were altered, and mice euthanized every 4 h to identify gene expression changes due to 
circadian rhythm (Menet et al. 2012, Renaud et al. 2014, Schmitt et al. 2014, Lowe et al. 
2015, Connerney et al. 2017, Lau-Corona et al. 2017, Lodato et al. 2017). A total of 10.7 
billion reads were mapped to the reference genome. LncRNAs were discovered using the 
approach described in Chapter 2 (Melia et al. 2016), except that we only removed gene 
structures whose exons overlap protein-coding gene exons transcribed in the same 
direction (Fig. S4-2). 15,558 lncRNAs were discovered (Table S4-2A), of which 13,343 
do not overlap any protein-coding gene, and were therefore designated intergenic (Fig. 4-
1B). 1,966 lncRNAs were designated antisense lncRNAs based on their overlap with the 
antisense strand of protein-coding genes (Fig. 4-1C). Finally, 249 lncRNAs were 
intragenic, i.e., transcribed in the same direction as an overlapping protein-coding gene, 
but without any exonic region overlap (Fig. 4-1D). 16% (2,098) of the intergenic 
lncRNAs have multiple exons (multi-exonic lncRNAs), while 47% (916) of the antisense 
and 55% (138) of the intragenic lncRNAs are multi-exonic. A subset of lncRNAs (18%; 
2,847) may be involved in the activation of other genes due to their overlap with 
enhancer RNAs (eRNAs) (Table S4-2A), which were previously shown to correlate 
positively with enhancer activity (Kim et al. 2010). Overall, 44% of the 15,558 liver-
expressed lncRNAs are not found in any prior annotation or database for noncoding 





Regulation of sex-specific lncRNAs in male liver. The liver transcriptome undergoes 
significant changes during postnatal liver development (Peng et al. 2014, Gordillo et al. 
2015). Notably, sex-biased gene expression emerges at ~4 weeks of age, with many more 
sex-specific genes showing developmentally regulated expression in male liver as 
compared to female liver (Conforto and Waxman 2012). We identified 684 sex-specific 
lncRNAs that showed significant sex-biased gene expression (male/female |fold-change| 
> 4 at FDR < 0.05; Table S4-2A) in any of 8 independent datasets comparing male liver 
to female liver samples (Fig. S4-3, left panel). 168 of these lncRNAs were multi-exonic 
and intergenic. We assessed their regulation during postnatal male liver development, by 
comparing their gene expression patterns on day 0 (immediately after birth and before the 
start of suckling) to that on day 1 (i.e., 24 h after birth), and to that on days 3, 5, 10, 15, 
20, 25, 30, 45 and 60 of age (Fig. S4-3, right panel). 144 of the sex-specific lncRNAs 
were regulated at least 2-fold at FDR < 0.05 on at least one of the above developmental 
time points (Fig. 4-2A; Table S4-2A and S4-2C). The majority of male-biased lncRNAs 
were up regulated by 25 days of age in male liver, consistent with the patterns found for 
male-biased protein-coding genes (Fig. 4-2, gene set I) (Conforto and Waxman 2012). A 
subset of the male-specific genes in set I, however, showed a significant increase in 
expression as early as the first week of life. Correspondingly, a subset of female-specific 
genes was down regulated in male liver by 20 days of age (Fig. 4-2, set II). A smaller 
subset of male-specific genes was strongly repressed after birth, and showed either 
continued repression (Fig. 4-2, set III) or up regulation around 30 days of age (Fig. 4-2, 




specific genes were up regulated earlier in male liver development and were either 
maintained or tapered off their up regulation at adulthood (60 days of age; Fig. 4-2, set 
V). The latter gene set still showed female-biased expression in adulthood, likely due to a 
stronger up regulation in female liver, as compared to male liver. This pattern was 
previously seen for a limited number of female-specific protein-coding genes (Conforto 
and Waxman 2012).  
 
Many organisms exhibit oscillating gene expression patterns with a period of ~24-hour 
(circadian rhythms). In mammals, these circadian patterns are maintained by feedback 
loop mechanisms orchestrated by several transcription factors (Ko and Takahashi 2006, 
Dardente and Cermakian 2007, Menet et al. 2012). We quantified gene expression for 
lncRNAs expressed in male liver, every 4 h in a 24-h period (ZT2, ZT6, ZT10, ZT14, 
ZT18 and ZT22). Five separate differential expression analyses were performed to 
compare ZT6 – ZT22 to ZT2, where ZT2 corresponds to 2 h after animals were exposed 
to light during a 12-h light and 12-h dark cycle. 241 lncRNAs, including 52 sex-specific 
lncRNAs, showed regulation at one or more circadian time points (|fold-change| > 2 at 
FDR < 0.05; Fig. 4-2B; Table S-42B and Table S4-2D). Subsets of both male-specific 
and female-specific lncRNAs showed higher expression at one or more time points after 
ZT2 (Fig. 4-2B, set I and III; Fig. 4-2C, top), and another subset showed the opposite 
pattern (Fig. 4-2B, set II and IV; Fig. 4-2C, bottom). We identified fewer circadian 
regulated female-specific lncRNAs, especially those that were down regulated after ZT2, 




biased lncRNAs were regulated during postnatal liver development or responded to the 
circadian rhythm. 
 
Protein-coding gene clusters are enriched for biologically relevant traits. Sex-
specific genes display at least two distinct phenotypes following the ablation of pituitary 
GH secretion by hypox, indicating there are at least two distinct classes of male-biased 
and two classes of female-biased genes, one subject to positive regulation and the other 
subject to negative regulation by GH (Wauthier et al. 2010, Connerney et al. 2017). Little 
is known about the underlying mechanisms whereby these distinct regulatory responses 
to hypox are achieved. We hypothesized that sex-specific lncRNAs might play a role in 
this regulation. To examine this possibility, I first examined whether a strong genetic 
regulatory component is evident for the four distinct hypox-response classes. To 
accomplish this, I utilized a large panel of liver gene expression datasets available for DO 
mice, which have a natural high allelic variance that manifests as a variable gene 
expression pattern in each individual mouse. Specifically, I used WGCNA (Langfelder 
and Horvath 2008) to cluster sex-specific protein-coding genes based on their gene 
expression correlations across male DO livers, and separately, female DO livers. I 
identified 40 gene clusters in male livers, and 44 other gene clusters in female livers (Fig. 
4-3 and Fig. 4-4; Table S4-3A and Table S4-3B). The average number of genes per 
cluster was comparable in the two sets of livers (25.5 genes/cluster for male livers, 23 
genes/cluster for female livers). Unexpectedly, more than half of the sex-biased gene 




coding genes (Fig. 4-3 and Fig. 4-4; rows 4-5), even though the analyses were performed 
using expression data from a single sex. Even more striking, many of the clusters were 
significantly enriched for one of four biologically relevant traits, defined by the change in 
gene expression following hypox, i.e., class 1 or class 2 male-specific genes, and class 1 
or class 2 female-specific genes (Fig. 4-3 and Fig. 4-4; rows 6-9; Table S4-4A-D). These 
enrichments are unexpected, as the liver samples used to discover gene clusters come 
from DO mice, which have an intact pituitary gland, and are thus not expected to 
manifest the four hypox-responsive phenotypes. Further, in separate analyses, we 
determined that each of the 8 DO mouse founder strains is characterized by a similar 
distribution of sex-biased genes in each of the four hypox response classes (Chapter 3), 
indicating that a subset GH regulatory pathways controlling sex-biased liver gene 
expression are still present in the DO founder strains. Thus, the significant enrichment of 
many DO mouse sex-biased liver gene clusters for a single hypox-response class 
indicates that the genetic diversity of DO mice captures a key mechanistic characteristic 
of sex-biased gene regulation. A subset of gene regulation mechanisms related to hypox-
responsiveness is presumably altered by genetic variants accumulated in DO mouse 
founder strains. 
 
Overall, in the DO male liver samples, 13 gene clusters encompassing 240 male-specific 
protein-coding genes were significantly enriched (p < 0.05, Hypergeometric test) for 
male-specific genes, and an additional 10 clusters encompassing 379 female-specific 




Further, a subset was significantly enriched for strongly sex-specific genes (|fold-change| 
> 4; Fig. 4-3 and Fig. 4-4; row 3). Significant enrichments were also found in DO male 
liver for the four hypox-response gene classes (Table 4-1): 7 gene clusters (encompassing 
85 genes) were enriched for male class 1 genes, 2 gene clusters (encompassing 12 genes) 
were enriched for male class 2 genes, 3 clusters (encompassing 21 genes) were enriched 
for female class 1 genes, and 6 clusters (encompassing 89 genes) were enriched for 
female class 2 genes. 14 of 16 clusters that are enriched for one of the four classes of 
hypox-responsive genes are enriched for sex-specific genes. Protein-coding gene clusters 
with similar patterns of enrichment for sex-biased genes, and for hypox-response gene 
classes, were discovered in DO female liver samples, as is summarized in Fig. 4-4 and 
Table 4-1.  The identified clusters do not consist of genes from the same genomic 
regions, as a majority of genes in every cluster are from different topologically associated 
domains (TADs) (Matthews and Waxman 2017) (Fig. 4-3 and Fig. 4-4; row 2), indicating 
the potential for this approach to identify trans regulation.   
 
Although overall cluster statistics and enrichments are similar between male and female 
liver (Table 4-1), ~82% (33 of 40) of gene clusters discovered in male liver do not have 
any counterpart in the female liver clusters; only 7 of the 40 DO male liver clusters 
overlap (defined as >50% genes in common) with any cluster discovered in female liver 
(Fig. S4-4). Five of the 7 overlapping clusters (circled in Fig. 4-5) are enriched for either 
male-specific or female-specific genes, but not for highly sex-specific genes. An earlier 




the two sexes, which may be due to those analyses clustering all varying genes, as 
opposed to only sex-specific genes. The degree of gene expression correlation within a 
cluster varied among cluster members (Fig. S4-5), with some but not other genes 
showing strong correlations with many genes in the cluster. Thus, there is an inherent 
structure of gene regulation for each cluster, where genes with many connections to other 
genes may play an important role in regulation.  
 
Sex-biased lncRNAs negatively correlate with sex-opposite and inverse hypox class-
enriched protein-coding gene clusters. Next, we considered whether any of the 168 
multi-exonic, intergenic sex-specific lncRNAs identified above might serve as a regulator 
of any of the sex-specific protein-coding gene clusters (gene modules), as indicated by 
gene expression correlations. Significant correlations (FDR < 0.001) were seen between 
sex-biased protein coding gene modules and 73 sex-specific lncRNAs, 40 showing 
correlations in DO male liver (Table S4-5A) and 52 in DO female liver (Table S4-5B). 
Most of these were positive correlations, which could indicate co-expression/co-
regulation between the lncRNA and the protein-coding gene module. I therefore focused 
on negative regulators, because of the difficulty of distinguishing a lncRNA that serves as 
a positive regulator of a gene module from a lncRNA that is simply a co-expressed gene. 
I identified male class 1 lncRNAs whose expression across DO mouse livers shows a 
significant negative correlation with protein-coding gene clusters enriched for female 
class 2 genes in male liver, as well as female class 1 lncRNAs that are negatively 




correspondingly for class 2 sex-specific lncRNAs (Fig. 4-6). A negative correlation of 
gene expression profiles between inverse hypox classes of the opposite sex is consistent 
with the models shown in Fig. 4-6, and would enable a lncRNA to negatively regulate 
protein-coding genes by one of several established mechanisms (Halley et al. 2014, 
Gayen et al. 2015, Ohhata et al. 2015). 16 sex-biased multi-exonic lncRNAs showed 
significant (FDR < 0.001) negative correlations with gene clusters enriched (P < 0.01) 
with sex-opposite protein coding genes of the inverse hypox class (Table 4-2 and Table 
S4-8), consistent with the proposed negative regulatory role for these lncRNAs (c.f. Fig. 
4-6). In some cases, the correlations involve male-specific lncRNAs whose expression in 
female DO liver negatively correlated with clusters enriched for highly female-specific 
protein-coding genes (e.g., ncRNA_inter_chr10_9000) or female-specific lncRNAs 
whose expression in male DO liver negatively correlated with clusters enriched for highly 
male-specific protein-coding genes (e.g., ncRNA_inter_chr2_1430) (Table 4-2). In these 
cases, low levels of the male-specific lncRNA would need to be maintained in female 
liver in order for the inverse hypox class, female-specific gene module to maintain its 
high expression in female liver, and correspondingly for female-specific lncRNAs and 
inverse hypox class, male-specific gene modules in male liver. Overall the negatively 
correlated sex-biased gene clusters shown in Table 4-2 encompass a substantial fraction 
(327 of 1,019) of sex-biased protein coding genes included in our clusters (182 male-
biased genes and 145 female-biased genes; 75 male class 1, 11 male class 2, 22 female 






Negative correlations between sex-opposite lncRNAs and inverse hypox class-enriched 
protein-coding gene clusters (Table 4-2) were also seen when we included more weakly 
correlated (FDR < 0.05) lncRNAs, particularly in male liver (Fig. 4-7, right panels). Fig. 
4-7A plots the hypox class distributions for 94 sex-specific lncRNAs that show positive 
(left) or negative correlations (right) with 16 protein-coding gene modules that are 
enriched for one of the four hypox-response classes. As expected, more male class 1 
lncRNAs are positively correlated with gene modules with strong enrichment for male 
class 1 protein-coding genes, as compared to those that are not (Fig. 4-7A left; first eight 
bars vs the other bars), or as compared to the overall distribution for the 142 sex-specific 
lncRNAs that are varying in male liver (MAD > 0; Fig. 4-7A All; Table S4-2E). A 
similar pattern is seen in female DO livers (Fig. 4-7B left; first six bars vs the others, and 
Fig. 4-7B left vs All; Table S4-2F). Negative correlations between inverse hypox-
response classes were also seen, with more female class 2 lncRNAs being negatively 
correlated with protein coding gene modules enriched for male class 1 protein-coding 
genes, as compared to those that are not (Fig. 4-7A right; first seven bars vs the others) or 
as compared to the overall distribution for all sex-specific lncRNAs that are varying in 
male liver (Fig. 4-7A right vs All; Table S4-2E). A similar, albeit less prominent, 
negative correlation between female class 1 lncRNAs and protein-coding gene modules 
enriched for male class 2 genes was observed (Fig. 4-7B right; first two bars vs the 




lncRNAs negatively regulate protein-coding modules that are enriched for class 2 sex-




Many genes in mammalian liver are differentially expressed between males and females 
(Rinn and Snyder 2005, Clodfelter et al. 2006, Zhang et al. 2011, Lowe et al. 2015), 
including lncRNA genes (Melia et al. 2016), which are thought to contribute to liver sex 
differences by establishing or maintaining the widespread sex-differences in chromatin 
accessibility and chromatin states that are closely linked to sex differences in liver 
transcription factor binding and chromatin states (Ling et al. 2010, Zhang et al. 2012, 
Sugathan and Waxman 2013, Conforto et al. 2015). Here, we expanded the repertoire of 
liver-expressed ncRNAs to include more than 15,500 lncRNAs, including many novel 
genes, based on liver gene expression data collected under 30 distinct biological 
conditions. A subset of these lncRNAs showed strong sex-biased expression, as well as 
regulation during liver development or in response to circadian rhythm. Further, we 
identified sex-specific lncRNAs whose expression across DO mouse livers shows a 
significant negative correlation with protein-coding gene modules enriched for the genes 
of the opposite sex-bias and inverse hypox-response class, consistent with the proposal 
that these lncRNAs play an important negative regulatory role in controlling sex-biased 
gene expression. The broad characteristics of sex-biased gene expression revealed by this 
study include an indication that multiple, distinct gene regulatory mechanisms likely 




usefulness of gene modules for generating hypotheses for lncRNA function, and reveal 
underlying characteristics governing sex-biased gene regulation. 
 
Regulation of lncRNA gene expression in male liver. We examined the expression of 
sex-biased lncRNAs during postnatal male liver development, where a majority of 
changes relevant to the emergence of liver sex-biased gene expression have been found to 
take place (Conforto and Waxman 2012). We found that a majority of male-specific 
lncRNAs were up regulated postnatally, as early as the first week of life. Further, we 
identified two patterns of up regulation for female-specific lncRNAs: sustained or 
dynamic up regulation after birth, with the latter pattern showing either down regulation 
or reduced up regulation of gene expression around 4 wk of age. These sex-specific 
lncRNAs may contribute to the acquisition of sex-biased gene expression at puberty and 
in early adulthood. We also evaluated the regulation of sex-specific lncRNAs by 
circadian rhythms in male liver, which gives rise to a diurnal rhythm affecting the 
expression of a large number of liver-expressed protein coding genes (Menet et al. 2012, 
Fang et al. 2014). Sex-biased lncRNAs showing significant gene expression changes in 
response to the alternating light and dark cycle in male liver could contribute to the 
regulation sex-specific protein-coding genes with the matching circadian rhythm, which 
characterizes a subset of liver sex-biased genes (Menet et al. 2012).  
 
Complex regulation characterizes the four hypox-response gene classes. We 




which almost half of the identified clusters are enriched for either male-specific or 
female-specific genes. Hierarchical clustering of these gene modules showed that, both in 
male and female DO mouse liver, almost all of the modules that are enriched for male-
specific genes segregated into their own branch, separated from the gene modules that are 
enriched for female-specific genes (Fig. 4-3, Fig. 4-4). This indicates that genetic 
variation in the population has a major impact on sex-biased gene expression, which in 
the case of DO mice is easy to discern given the genetic variability in this mouse 
population. One mechanism for genetic factors to exert their regulatory effect in a sex-
biased manner is through genetic variants that are within GH-dependent open chromatin 
regions (DHS) or GH-regulated TF binding sites. GH has been shown to impart sex 
differences in liver through its regulation of several GH-dependent transcription factors 
(Clodfelter et al. 2006, Clodfelter et al. 2007, Holloway et al. 2007, Conforto et al. 2012, 
Zhang et al. 2012, Conforto et al. 2015). On the other hand, gene modules that were 
enriched for one of the four hypox-response gene classes were found in multiple, separate 
branches, and mixture of both class 1 and class 2 genes can be found within the same 
branch (Fig. 4-3, Fig. 4-4). Each co-regulated gene cluster enriched for one of the four 
hypox-response classes is thus likely to be distinctly regulated, which in turn shapes their 
gene expression pattern differently across DO mice, as compared to other gene clusters 
enriched for the same hypox-response gene class. This suggests that multiple, distinct 
regulatory mechanisms are at play in shaping each of the four major classes of hypox-
responsive genes, highlighting the complexity of their regulation. Further characterization 




enrichments for TF binding sites, developmental time points, or circadian groups, all of 
which may help delineate molecular mechanisms characterizing the four hypox-response 
classes. Protein-coding gene modules discovered in male and female liver showed 
substantial overlap for only 7 clusters, encompassing 223 (of 1,033) sex-specific genes 
based on clusters discovered in male liver, indicating that a large fraction of gene 
regulation governing sex-biased expression involves sex-differential mechanisms. 
 
Sex-biased lncRNAs are proposed to negatively regulate select protein-coding gene 
modules. 73 multi-exonic, intergenic sex-specific lncRNAs showed a highly significant 
correlation (FDR < 0.001) with at least one sex-specific protein-coding gene module. 
Further, 16 of these sex-specific lncRNAs showed significant negative correlation with a 
protein-coding gene module(s) enriched for genes with the opposite sex-bias and inverse 
hypox-response class, allowing us to hypothesize that these lncRNAs negatively regulate 
their inversely correlated protein-coding gene modules. The eight scenarios, where 
negative gene expression correlations between inverse hypox classes may indicate 
negative regulatory role (Fig. 4-6), can be broadly divided into two groups: in one group, 
high expression of sex-specific lncRNAs is needed to repress protein-coding genes of the 
opposite sex-bias, e.g., male class 1 lncRNAs and female class 2 gene modules in male 
liver; and in the second group, lower expression of lncRNAs is needed to prevent 
repression of protein-coding genes of the opposite sex bias, e.g., male class 1 lncRNAs 
and female class 2 gene modules in female liver.  These strong negative correlations 




intact pituitary gland and presumably maintain sex-specific plasma GH patterns are. 
Genetic variants that have accumulated in individual DO mice, an outbred population 
derived from 8 inbred founder mouse stains (Svenson et al. 2007, Churchill et al. 2012), 
must therefore alter a subset of regulatory regions that are responsible for the four hypox-
response phenotypes. This hypothesis is supported by our finding that genetic variants are 
associated with gene expression changes in select correlated lncRNA—protein coding 
gene module pairs. In particular, we used the list of single nucleotide polymorphisms 
(SNPs) that are significantly associated with liver gene expression (expression 
quantitative trait loci, eQTLs) identified in Chapter 3. An example is the darkgrey cluster 
in male liver, a female class 2-enriched gene module, which negatively correlates with 
ncRNA_inter_chr8_7423, a male class 1 lncRNA (Table 4-2). eQTLs identified for both 
this lncRNA and for 7 of its 11 gene cluster members point to the genotype of the 
PWK/PhJ strain as being associated with the largest changes in expression of the protein-
coding genes (Hao2, Cyp2a22, Sult1e1, Sybu, Tm4sf4, Setbp1 and Dcbld1; Table S4-
4A). Further, eQTLs for 3 of the other 4 gene cluster members identified the PWK/PhJ 
strain as the strain whose genetic variants make the second to fourth largest contribution 
to the observed changes in each of the 3 protein-coding gene expression (Cyp2b9, 
Cyp2a4 and Cep112). Many of these eQTLs map to different chromosomes, consistent 
with this male-specific lncRNA being involved in trans regulation. 
 
In conclusion, we expanded our earlier characterization of liver-expressed lcnRNAs by 




identified many lncRNAs showing strong sex-biased gene expression. A subset of these 
sex-specific lncRNAs is dynamically regulated during postnatal liver development in 
male mice, and an overlapping subset shows significant oscillating gene expression 
patterns over a 24-hour period. We further identified sex-specific protein-coding gene 
clusters in male, and separately, female liver using a mouse population with rich genetic 
diversity (DO mouse), many of which showed unexpected enrichment for one of the four 
hypox-response classes. Sex-specific lncRNAs that are significantly correlated in 
expression with at least one protein-coding gene cluster were identified. Strikingly, a 
subset of sex-specific lncRNAs showed a significant negative correlation with protein-
coding gene modules that were enriched for genes of the opposite sex-bias and inverse 
hypox classes, suggesting a negative regulatory role for these lncRNAs. These findings 
elucidate the sex-bias liver transcriptome, and illustrate the utility of gene modules to 
reveal broad characteristics of sex-bias gene regulation and generate hypothesis for 
regulatory roles for sex-bias lncRNAs. 
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Table 4-1. Enrichments of gene modules discovered in male, and separately, in 
female liver for sex-specific and hypox-responsive genes. 
#Cluster columns indicate the number of cluster that are enriched for each respective 
gene set. The #Gene columns indicate the number of genes belonging to each respective 
gene set in these enriched cluster. The common genes row indicates the number of genes 













































































Male  13 240 10 379 7 85 2 12 3 21 6 89 
Female  12 201 9 339 6 68 3 11 5 23 3 82 
Common 






Table S4-2. List of sex-specific lncRNAs that are negatively correlated (FDR < 













































































































































































































































































Table S4-1 to Table S4-7 






Table S4-1 to Table S4-7 




Figure 4-1. Liver-expressed lncRNAs.  
(A) PCA of the 186 RNA-Seq samples used to discover liver-expressed lncRNAs. The 
first principal component corresponds to the age of the mice from young to old (right to 
left). (B)  Examples of novel intergenic lncRNAs discovered in this study: 
ncRNA_inter_chr10_9193, ncRNA_inter_chr10_9194 and ncRNA_inter_chr10_9195. 
Gene structures of lncRNAs are shown in green. Liver gene expression in select samples 
is shown as wig files. F, forward strand, R, reverse strand. (C) An antisense lncRNA, 
ncRNA_as_chr14_12073, that is transcribed on the forward strand and overlaps Gjb2, 
which is transcribed on the reverse strand. (D) An intragenic lncRNA, 
ncRNA_intra_chr2_1648, that is transcribed on the reverse strand, overlaps the gene 







Figure 4-2. Sex-specific lncRNAs showing significant regulation during postnatal 
liver developmental and during a 24-hour light-dark cycle periods in male mouse 
liver.  
(A) Heatmap of 144 sex-specific lncRNAs (male/female |fold-change| > 4 at FDR < 0.05 
in any of the 8 datasets assessed) that show a significant change in expression (|fold-
change| > 2 and FDR < 0.05) at any time point from birth to maturity (Table S4-2A). The 
first 8 columns of the heatmap correspond to the 8 datasets to used to identify sex-
specific lncRNAs; blue color indicates male-specific lncRNA expression, while red color 
indicates female-specific lncRNA expression. The last 10 columns track the change in 
expression of each lncRNA at a particular age, as compared to birth (day 0) in male liver. 
Blue denotes up regulation of gene expression, as compared to day 0, and red denotes 
down regulation. Set I designates male-specific genes that are up regulated after birth, set 
II are female-specific genes that are down regulated after birth, set III are male-specific 
genes that are down regulated after birth while maintaining their male-specific expression 
at adulthood, set IV are similar to set III genes, except they are up regulated around 30 
days of age, and set V are female-specific genes that are up regulated by 25 days of age. 
See Table S4-2C for listings of lncRNAs in set I to V. (B) Heatmap of 52 sex-specific 
lncRNAs (male/female |fold-change| > 4 at FDR < 0.05 in any of the 8 datasets 
evaluated) that showed a significant change in expression (|fold-change| > 2 and FDR < 
0.05) at one or more time points from ZT4-ZT22, as compared to ZT2 (Table S4-2B). 
The first 8 columns in the heatmap correspond to the 8 datasets used to identify sex-
specific lncRNAs; blue color indicates male-specific gene expression, and red color 
indicates female-specific expression. The last 5 columns show the fold-change of 
expression at a particular ZT time, as compared to time ZT2. Blue indicates activation 
after ZT2; red indicates repression after ZT2. Set I and III are sex-specific lncRNAs that 
were up regulated at any time point after ZT2, and set II and IV are sex-specific lncRNAs 
that were repressed at any time point after ZT2. See Table S4-2D for listings of lncRNAs 
in set I to IV. (C) 24 h oscillating gene expression profiles are shown for four sex-
specific lncRNAs, where the top figures show up regulation by ZT10, and the bottom 










Figure 4-3. Sex-specific gene clusters (gene modules) discovered in DO male mouse 
liver.  
(Top) Hierarchical clustering showing the relationship between all clusters, as defined by 
the correlation of their first principal component. Clusters are named by colors, as 
indicated. (Bottom) The first row indicates the number of genes in each cluster, and the 
second row indicates the number of distinct TADs represented in each cluster. The next 
three rows show the percentage of genes in each cluster that are either strongly sex-
specific (FC>4; row 3), or that are male-specific (row 4) or female-specific genes (row 
5). The next four rows indicate the percentage of genes distributed in each of the four 
hypox-response gene classes: male-specific class 1 and class 2, and female-specific class 
1 and class 2; these percentages were calculated with respect to the subset of genes in 
each cluster that show a significant response to hypox, consequently, the sum of 
percentages for the last four rows in each cluster should equal to 100%. However, for 
rows 3-9, the percentage values are only listed for clusters that show a significant overlap 
with relevant gene sets in each row (p-value < 0.05, Hypergeometric test). Ovals indicate 
adjacent branches whose nodes are enriched for the same hypox-response gene class. 
Clusters are named by colors, as indicated; in several cases the cluster name (i.e., color) 
assigned to a cluster, discovered in DO male mouse liver is the same name as that 
assigned to one of the clusters discovered in DO female mouse liver and shown in Fig. 4-
4; however, there is no relationship between such clusters. Thus, male DO mouse liver 
cluster Cyan, with 71 genes, displayed here, is not related to female DO mouse liver 
cluster Cyan, with 20 genes, shown in Fig. 4-4. Cluster A consists of protein-coding gene 
modules enriched for female-specific genes while cluster B consists of protein-coding 










Figure 4-4. Sex-specific gene clusters discovered in DO female mouse liver. 
Characteristics of the gene clusters shown are displayed as described in the legend to Fig. 
4-3. Cluster A consists of protein-coding gene modules enriched for female-specific 
genes while cluster B1 and B2 consist of protein-coding gene modules enriched for male-






Figure 4-5. Overlap between clusters discovered in male vs. female liver for clusters 
that are significantly enriched for sex-specific genes and/or hypox-response gene 
classes. 
The number shown next to each cluster name (designated as a color; see legend to Fig. 4-
3) represents the number of genes in that cluster. Clusters discovered in DO male liver 
are shown along the Y-axis; those discovered in DO female liver are shown along the X-
axis. The matrix shows the number of genes common to the intersecting gene clusters 
discovered in the DO livers from each sex. Shades of red (bar at right) represent the 
percentage of overlap with respect to the cluster discovered in male liver. Circles denote 
cluster pairs with strong gene overlap, defined as >50% of gene members in a specific 










Figure 4-6. Schematic diagram of the eight proposed scenarios for negative 
regulatory role of sex-specific lncRNAs.  
(Left) Gene regulatory mechanisms in male liver: the male, pulsatile plasma GH pattern 
activates male class 1 lncRNAs in male liver, which are proposed to repress female-class 
2 protein-coding genes in male liver (first row). Similarly, male-class 2 lncRNAs, which 
are constitutively expressed in male liver, are proposed to repress female class 1 protein-
coding genes in male liver (second row). Female class 1 lncRNAs are constitutively off 
in male liver, and therefore cannot repress male-class 2 protein-coding genes (third row). 
Female class 2 lncRNAs, whose expression is repressed by the male plasma GH pattern 
in male liver, therefore cannot repress male class 1 protein-coding genes (fourth row). 
(Bottom) Gene regulatory mechanisms in female liver: in the absence of pulsatile GH, 
male class 1 lncRNAs are constitutively off in female liver, and thus cannot repress 
female-class 2 protein-coding genes (top row). Male-class 2 lncRNAs are repressed by 
the female plasma GH pattern, and cannot therefore repress female class 1 protein-coding 
genes (second row). The female, persistent plasma GH pattern activates female class 1 
lncRNAs, which are proposed to repress male-class 2 protein-coding genes (third row). 
Female-class 2 lncRNAs are constitutively on in female liver, and can therefore repress 
male class 1 protein-coding genes (fourth row). The inverse regulatory relationship 
between class 1 sex-specific lncRNAs and class 2 sex-specific protein coding genes 
shown here is consistent with the effects of hypox on both classes of sex-specific genes. 
For example, hypox of male mice, which abolishes the GH pulse regulatory circuit 
diagrammed on the left, down regulates class 1 male lncRNAs and up regulates (de-
represses) female class 2 protein coding genes in male liver. That de-repression is 
proposed to involve the loss of the male class 1 lncRNAs required for female class 2 
protein-coding gene repression. Hypox of female mice, which abolishes the persistent 
GH regulatory circuit diagrammed on the right, down regulates class 1 female lncRNAs 









Figure 4-7. Distribution of hypox-response gene classes for intergenic, sex-specific 
lncRNAs whose expression in DO mouse liver is eitherpositively or negatively 
correlated with protein-coding gene modules that are enriched for one the four 
hypox-response classes. 
 (A) Shown is the distribution of hypox-response classes for the 142 multi-exonic, 
intergenic sex-specific lncRNAs that are varying (MAD > 0) in male liver (first bar, 
marked All), 79 sex-specific lncRNAs whose expression is positively correlated with any 
protein-coding gene module enriched for hypox-responsive genes in male liver (left) and 
63 sex-specific lncRNAs that are negatively correlated with any protein-coding gene 
module enriched for hypox-responsive genes in male liver (right). Gene modules in the 
left and right panels are both ordered by their enrichment for male class 1 protein-coding 
genes from left to right (low FDR to high FDR). More male class 1 lncRNAs are seen to 
be positively correlated with protein-coding genes that are strongly enriched for male 
class 1 genes, whereas more female class 2 lncRNAs are negatively correlated with 
protein coding gene clusters enriched for male class 1 genes. (B) Shown is the 
distribution of hypox-response classes for the 143 multi-exonic, intergenic sex-specific 
lncRNAs that are varying (MAD > 0) in female liver (first bar, marked All), 84 sex-
specific lncRNAs that are positively correlated with any protein-coding gene modules 
enriched for hypox-responsive genes in female liver (left), and 59 sex-specific lncRNAs 
that are negatively correlated with any protein-coding gene modules enriched for hypox-
responsive genes in female liver (right). Gene modules in the left and right panels are 
both ordered by their enrichment for female class 1 protein-coding genes from left to 
right (low FDR to high FDR). The number in parenthesis after each gene cluster name 
indicates the total number of lncRNAs whose hypox class distributions are shown in each 
bar graph. More female class 1 lncRNAs positively correlate with protein-coding genes 
that are strongly enriched for female class 1 genes, and more, albeit to a lesser extent, 
male class 2 lncRNAs negatively correlate with protein coding gene clusters enriched for 









Figure S4-1. Four hypox-response classes.  
Genes in male hypox class 1 and female hypox class 1 are activated by the GH secretion 
pattern of the sex where they are more highly expressed, whereas, male hypox class 2 and 
female hypox class 2 genes are repressed by the GH secretion pattern of the sex where 
they are less highly expressed. Consequently, following hypox, class 1 genes are down 















Figure S4-3. A Heatmap of 684 sex-specific lncRNAs in different RNA-Seq datasets.  
The first 8 columns in the heatmap correspond to the 8 datasets used to identify sex-
specific lncRNAs; blue indicates male-specific gene expression, and red indicates 
female-specific gene expression. The last 10 columns track the changes of gene 
expression in male liver at the ages specified at top, as compared to birth (day 0). Blue 
denotes up regulation of gene expression, compared to day 0, and red denotes down 





Figure S4-4. Overlap between clusters discovered in male vs. female liver.  
The number of genes in each matrix cell represents the number of genes in the cluster 
discovered in male DO mouse liver (y-axis) that are present in the indicated clusters 
discovered in female DO mouse liver (x-axis). The last cluster in female: grey, is not 
considered a cluster; it contains 1 gene that was not able to be clustered in female liver. 
The color represents the percentage of overlap with respect to the cluster discovered in 
male liver. The number written along each axis after each cluster name is the number of 
genes in each cluster. Circles denote strong overlap, where >50% of gene members in a 










Figure S4-5. Examples of gene modules that are negatively correlated with sex-
specific lncRNAs (Table 4-2).  
Nodes denote genes, and edges denote the correlation between genes. The darkness of the 
edges indicates the correlation strength between genes. The size of each node represents 
the cumulative gene correlations for a gene, where the larger the node is, the more high 
correlations involve that node. Graphs were drawn using Cytoscape (Smoot et al. 2011). 
Pairwise Pearson correlation for select edges are shown in red. Pairwise correlations 
between gene members with the lncRNA with which the respective module is correlated 
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